The Journal of Pharmacy Practice and Research · Ahmed D See Sonallah H 2014 159 ... Journal of...
Transcript of The Journal of Pharmacy Practice and Research · Ahmed D See Sonallah H 2014 159 ... Journal of...
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 2
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Abarno AC Comprehensive approaches to improving minds and lives [letter] 2009 331
Abarno AC See Cheh RM 2010 184
Abarno AC See Winter SJ 2013 11
Abbott F Certification in geriatric pharmacy exam in Hobart 2002 95
Abd Wahab MS Liberalisation of pharmacist training: the need to reflect on pharmaceutical education in Malaysia
[letter]
2013 162
Abdelmessiah D Ensuring appropriate use of high cost drugs: octreotide [letter] 1997 250
Abdolkarim P Survival following severe aluminium phosphide poisoning 2002 297
Abdollahi M See Abdolkarim P 2002 297
Abdollahi M Review of drug-induced skin reactions 2003 12
Abdulwahab A Do Saudi community pharmacists know how to use MDIs? [letter] 2012 77
Abu Hassan F See Leow FH 2006 194
Accordino A A short-term stability study of an oral solution of dexamethasone 1994 312
Accordino A The stability of a topical solution of cocaine hydrochloride 1996 629
Acharya LD See Ghosh S 2006 246
Acharya R See Thunga G 2013 163
Acharya RV See Singh A 2014 60
Adams J Pharmacists and complementary medicine in Australia [letter] 2004 73
Adams RC See Seaton SM 2010 199
Addison RS See Roberts JA 2009 198
Adepu R See Nagavi BG 2005 332
Adhikari O See Bedi TR 2006 164
Adu A Ciprofloxacin usage in a community hospital 1994 318
Adu A Drug utilisation review of filgrastim in three teaching hospitals 1995 336
Adu A Survey of pharmacy resources needed to implement hospital antibiotic policies 1999 92
Agar M See Currow DC 2012 91
Agarwal J Need for an acute poisoning registry data base in India [letter] 2014 162
Ahlgren KL See Leversha A 2001 130
Ahmad FJ See Khan ZI 2005 328
Ahmad KM See Hasan SS 2010 294
Ahmadi K See Hasan SS 2010 294
Ahmadi-Abhari SA Lithium erythrocyte concentration and neurological toxicity in bipolar disorder 2005 103
Ahmed D See Sonallah H 2014 159
Ahuja A See Khan ZI 2005 328
Aikman KL Adherence to guidelines for treating community-acquired pneumonia at a New Zealand hospital 2013 272
Ailakis JG See Stafford L 1998 246
Al Hadithy AF Thiopurines for inflammatory bowel disease: role of pharmacogenetics 2005 213
Al Harbi G See Roberts GW 2012 200
Alabid AH Malaysian community pharmacists' professional practices and services [letter] 2010 164
Alabid AH Dispensing practices of general practitioners and community pharmacists in Malaysia - a pilot study 2013 187
Alam K See Bedi TR 2006 164
Alam K See Izham MI 2008 331
Aldama PC Prescribing patterns and consumption of medication in a rural community in Mexico [letter] 2003 330
Alderman CP Hospital pharmacists — believe in yourselves 1994 45
Alderman CP Atypical presentation of the neuroleptic malignant syndrome 1994 245
Alderman CP Nephroprotective effects of the angiotensin converting enzyme inhibitors in diabetic renal disease 1995 410
Alderman CP The role of angiotensin converting enzyme inhibitors after myocardial infarction 1995 511
Alderman CP Cogito ergo sum [ed] 1996 210
Alderman CP See Ng D 1996 358
Alderman CP See Cosh D 1996 673
Alderman CP See Lim JW 1997 33
Alderman CP A preliminary study of the effects of venlafaxine on 24-hour urinary catecholamine excretion profile 1997 232
Alderman CP Clinical pharmacy input into a respiratory rehabilitation program [practice report] 1998 181
Alderman CP Perhexiline-paroxetine drug interaction [clinical communication] 1998 254
Alderman CP Medication alert cards to minimise antidepressant drug interactions [practice report] 1998 259
Alderman CP See Ryan MJ 1998 304
Alderman CP See Cosh DG 1998 334
Alderman CP See Wiese MD 1999
Alderman CP Creating the future of clinical pharmacy in Australia 1999 29
Alderman CP Pindolol augmentation of antidepressant therapy 1999 146
Alderman CP E-Pharmacy - the future is here [ed] 2000 44
Alderman CP Geriatric pharmacy practice - an emerging specialty in Australia [ed] 2000 91
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 3
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Alderman CP Nitrous oxide abuse in a community setting: case report [clinical communication] 2000 109
Alderman CP Syndrome of inappropriate antidiuretic hormone secretion secondary to venlafaxine 2002 35
Alderman CP An international perspective on psychiatric pharmacy 2002 303
Alderman CP See Ng KH 2004 183
Alderman CP See Kethini T 2004 308
Alderman CP Caring in a time of disaster war and tragedy [ed] 2005 7
Alderman CP Caring after traumatic times [ed] 2010 7
Alderman CP See Cheh RM 2010 184
Alderman CP See Winter SJ 2013 11
Alderman CP What should a Journal really be about? Where the JPPR came from and where it is going next? [ed] 2013 93
Alderman CP The health of politics and the politics of health [ed] 2013 176
Alderman CP Our duty of care towards older people [ed] 2013 260
Alderman CP See Chan TW 2013 269
Alderman CP See Tran W 2013 283
Alderman CP The true impact of changes to professional services program in Australian pharmacy [ed] 2014 4
Alderman CP See Westaway KP 2014 44
Alderman CP Some thoughts about a good death [ed] 2014 73
Alderman CP The challenges of HIV [ed] 2014 175
Aldous D Drugs and medical conditions affecting the periodontum 1994 80
Alexander M Does outpatient status really confer lower thrombotic risk? [letter] 2014 163
Alexander M See Thakerar A 2014 231
Alexander S Fred J Boyd Award 2007 2007 315
Alexander SM Expanding roles for technicians 1994 84
Alexander SM Technicians' program — beyond the imprest cupboard. Management's expectations 1996 62
Al-Harbi Y See Abdulwahab A 2012 77
Ali AA See Abd Wahab MS 2013 162
Allen A Adequate training: enough to get by or could there be more to it? [letter] 2010 246
Allen B See Mottram MC 1997 290
Allen K PBS in public hospitals [letter] 2004 244
Allen K See Roberts JA 2007 200
Allen KM See Ryan M J 1998 304
Allen KM Hospital pharmacy- making a difference 2001 9
Allen P Handbook of nonprescription drugs: an interactive approach to self-care [book review] 2005 81
Allinson Y Fred J Boyd Award 2013 2013 304
Allinson YA See O'Leary KM 2012 259
Allinson YM See O'Leary KM 2002 72
Allinson YM See O'Leary KM 2003 93
Allinson YM See O'Leary KM 2004 104
Allinson YM See O'Leary KM 2004 114
Allinson YM See Stowasser DA 2004 293
Allinson YM See O'Leary KM 2006 103
Allinson YM See O'Leary KM 2006 291
Allinson YM See O'Leary KM 2009 28
Alraman H See Barras M 2011 183
Al-Sallami HS MDI with spacer versus nebuliser for acute exacerbation of asthma-a literature review 2001 189
Alshakka M See Maarup N 2011 49
Al-Sulaiti FK See Ibrahim MIM 2013 79
Alurkar VM See Mishra P 2006 81
Alvarez SJ See Harding AM 1999
Alvarez SJ Education outreach to the community: does hospital pharmacy have a role? 2001 13
Al-Worafi YM Do community pharmacists need a workshop about MDI use? [letter] 2013 165
Al-Worafi YM Towards supporting clinical pharmacy research in Arabic countries [letter] 2013 247
Al-Worafi YMA See Manan MM 2014 83
Amadio M Formulation of nitrazepam oral solution [letter] 1996 371
Ambados F Compatibility of morphine and ketamine for subcutaneous infusion [letter] 1995 352
Ambados F Incompatibility between aminophylline and elemental zinc injection [letter] 1996 370
Ambados F Incompatibilities with trace elements during TPN solution admixture 1998 112
Ambados F Precipitation of potassium sulphate in TPN admixture [letter] 1998 444
Ambados F Destabilisation of fat emulsion in total nutrient admixtures by concentrated albumin 20% infusion 1999 210
Ambados F Incompatibility between concentrated albumin 20% infusion and trace element injections [letter] 2000 71
Ambados F Topical haemostatic agents: avoid multi-use containers [letter] 2000 229
Ambados F Incompatibility between calcium and sulfate ions in solutions for injection 2002 307
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 4
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Ambados F Phenytoin stability [letter] 2005 80
Ambados F Surface contamination from cytotoxic chemotherapy [letter] 2008 80
Ambados F See Lee SG 2009 181
Ambados F Eliminating cytotoxic background [letter] 2009 247
Ambados F Preparation method and stability of a temozolide suspension: a pilot study 2012 111
Ambados G See Lee SG 2007 271
Amerena J See Weeks GR 2012 17
Amir M Successful trial of pharmaceutical care services in a community pharmacy in Karachi [letter] 2011 78
Amornsak W See Thawornchaisit P 2012 189
Anderson BA See Toy AC 2006 35
Anderson BA See Yu K 2007 22
Anderson BA See Nguyen A 2007 111
Anderson EA See Cheong EA 2008 267
Anderson EA See Davis SR 2010 31
Anderson PO See Knoben JE 1994 176
Anderson PO Dosage of drugs in breast milk [letter] 1996 288
Anderson S ISOPP/HOPA conference 2008 [letter] 2008 327
Andrews C See McFarlane AE 1996 635
Andrews HP Fall-related hospital admissions in elderly patients: contribution of medication use 2001 183
Ang P See Ng SP 1998 177
Ang T-S Extravasation of high-dose methotrexate: a case about nothing [clinical communication] 1998 430
Ang WC See Manan MM 2014 83
Angalakuditi M Impact of an educational program on antibiotic use in paediatric appendectomy procedures 2005 21
Angalakuditi M Paediatric severe community-acquired pneumonia in India 2005 183
Angley M See Lovgren S 2009 269
Angley M Feasibility and timeliness of alternatives to post-discharge HMRs for high-risk patients 2011 27
Angley M See Padhye V 2012 273
Angley M See Ellis D 2013 190
Angley M Advocating for patients and the pharmacist’s role in primary care [ed] 2014 6
Angley MT See Grzeskowiak LE 2008 9
Angley MT See Bollella G 2008 107
Anh AV Modelling drug loss during IV infusion to premature neonates 2006 262
Anticevich-Bosnic SZ See Nguyen YB 2010 211
Antoni R See Elliott RA 2014 95
Anwar M See Hasan SS 2010 294
Aprea S See Zolezzi M 2007 11
Aqil M See Jindal D 2005 331
Armenores P Survey of clopidogrel use in a teaching hospital 2006 40
Armour CL See Adu A 1994 318
Armour CL See Adu A 1995 336
Armour CL See Katsogiannis W 1996 529
Armour CL Penicillin allergy in two Sydney teaching hospitals 1998 410
Armour CL See Adu A 1999
Armour CL See To NN 1999
Arnold M See Murnane JM 2013 109
Arumugam K European palliative care conference [letter] 2003 329
Asamoah P See Zolezzi M 2007 225
Asghar MN See Young J 2006 275
Askew D See McDonald PK 2003 114
Askew D See McDonald PK 2003 114
Aslani P See Koo MMM 2005 94
Aslani P See Gu P 2011 196
Assef IL See Aldama PC 2003 330
Atif M See Saleem F 2011 333
Atkin PA See Kristoffersen SS 1997 367
Atkin PA See Armour CL 1998 410
Attia MF Warfarin/complementary medicine interaction [letter] 2000 23
Atwa H See Ibrahim MIM 2014 62
Austin NC See Kunac DL 2010 290
Avent M Controversies in infectious diseases [letter] 2006 245
Avent M See Coombes I 2010 111
Avent M See Chu KP 2010 119
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 5
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Avent ML See Poh EW 2009 176
Avent ML Drug use evaluation services in Australia and New Zealand: a neglected area of research? 2010 15
Avent ML See Shah SS 2013 129
Awaisu A See Ibrahim MIM 2014 62
Awasthi S Corticosteroid an ambiguity in ARDS [letter] 2013 248
Badarudin NZ See Hasan SS 2010 294
Badov D See Lam A 2013 297
Bahri S See Leng CB 2011 250
Bailey M Controversies in vaccination with measles mumps rubella (MMR) vaccine [letter] 1998 443
Bailey M Public health pharmacy practice and pharmaceutical service development 1999 118
Bailey M Pharmaceuticals as new technology: the driving forces 1999 335
Bailey M See George J 2006 99
Bailey MC See Attia MF 2000 23
Bajorek B See Buchan DS 2008 200
Bajorek B See Kong MS 2008 205
Bajorek B See Nasser S 2012 129
Bajorek BV A survey of long-term antiarrhythmic therapy in elderly patients with atrial fibrillation 2001 93
Bajorek BV See Hanes CA 2005 178
Bajorek BV See Valiya SN 2005 279
Bajorek BV See Khoo A 2006 190
Bajorek BV See Kay OC 2006 199
Bajorek BV See Nguyen NA 2008 35
Bajorek BV See Vracar D 2008 96
Bajorek BV See Page MA 2008 286
Bajorek BV See Su EY 2008 292
Bajorek BV See Glover S 2008 300
Bajorek BV Management of - over-anticoagulation in warfarinised hospital patients 2009 13
Bajorek BV See Yip A 2010 285
Bajorek BV Conducting your pharmacy practice research project. A step-by-step guide [book review] 2011 82
Bajorek BV See Cao BY 2011 102
Bajorek BV See Kumar N 2011 108
Bajorek BV See Lee YF 2011 283
Bajracharya O See Shankar PR 2009 245
Bajramovic J See Burrows J 2002 315
Baker JL Mandatory electronic sources of approved product information-are they up-to-date? 2005 295
Baker S Tribute to I Brand [letter] 2000 73
Baker S Community pharmacy: symptoms diagnosis and treatment [book review] 2008 82
Baker SJ Getting published 1994 410
Baker SJ Blurred vision and psychotropics [inform] 1995 47
Baker SJ The light's better over here: new antidepressants on the horizon 1996 98
Baker SJ A history and philosophy of pharmaceutical research I. Some thoughts on Popper Kuhn and other
philosophers
1996 331
Baker SJ History and philosophy of pharmaceutical research II. Is pharmaceutical research scientific? 1996 337
Baker SJ Who can read consumer product information? 1997 126
Baker SJ In Reply to 'Who can read consumer product information?' [letter] 1997 253
Baker SJ Hospital pharmacists a place in mainstream clinical research? 1998 348
Baker SJ Olanzapine for schizophrenia: in reply 1999 54
Ball P Is clinical pharmacy in vein? [ed] 2003 256
Ball P Clinical pharmacy formulation for a better future? [ed] 2006 172
Ball P See Flavel D 2012 121
Ball PA See Monk PM 1997 323
Ball PA See Kunac DL 1999
Ball PA What is a pharmacist? [ed] 2000 44
Ball PA See Scott-Walker TM 2000 157
Ball PA Clinical pharmacy: what stage of evolution have we reached? 2000 250
Ball PA See Al-Sallami HS 2001 189
Ball PA See Mirkov SR 2003 199
Ball PA Anticholinergic burden assessed using general practice electronic records 2013 202
Ball PA See Bushell MA 2013 292
Ballantine DL Use of acid suppression medications in postoperative cardiac surgical intensive care unit patients 2014 108
Bandiera E See Tucci J 2009 223
Banks SL See Lim CB 2003 59
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 6
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Barazanchi N See Tordoff JM 2006 12
Barker BJ See Hambridge JA 2001 121
Barlow MJ Pharmacological management of erectile dysfunction in the older male 1995 168
Barnes M See Zolezzi M 2007 11
Barnett LM See van Beurden E 2003 51
Barras M Abnormal laboratory results 2002 159
Barras M Effective conference presentations [letter] 2004 157
Barras M See Sim L 2005 276
Barras M See Roberts JA 2007 200
Barras M See Gujral GR 2009 202
Barras M Bayesian optimisation of tobramycin dosing in paediatric patients with cystic fibrosis 2011 183
Barras M Abnormal laboratory results 3rd edition [book review] 2011 330
Barras MA See Rofail S 2006 29
Barras MA Individualised vs conventional enoxaparin dosing [letter] 2008 77
Barratt JD See Bell JS 2011 316
Barratt JD See Kalisch LM 2013 182
Barry AR Making hospital pharmacists indispensable on the healthcare team: revolution in waiting [ed] 2009 256
Barton-Smith KY Developing a medication reconciliation form [letter] 2008 162
Basavanagowdappa H See Joseph J 2010 279
Basheti IA See Nguyen YB 2010 211
Basurto I See Traverso ML 2004 246
Batagol RP Drugs and breastfeeding [letter] 1996 454
Bates I See Coombes I 2010 111
Bates I See Coombes I 2011 17
Bates I See Coombes I 2012 261
Batty KT Manual of travel medicine: a guide for practitioners at pre-travel clinics 1999 181
Batty KT See Clifford RM 2003 260
Batty KT See Nita Y 2005 9
Baume P New realities 1994 12
Bayles M Cytotoxic manufacturing: what a load of rubbish 1999 213
Bayles M See Siderov J 2002 178
Bayles M See Siderov J 2003 68
Bayles M See Siderov J 2003 244
Baysari MT Implementation of revised aminoglycoside guidelines: Australian hospitals 'left in the lurch' [ed] 2012 178
Baysari MT Error prone abbreviations in hospitals: is technology the answer [letter] 2012 246
Baysari MT See Teo CK 2013 32
Baysari MT See Brett J 2013 97
Baysari MT Electronic medication information sources: understanding the needs and preferences of health
professionals
2013 288
Beaton M Cardiotoxicity from non-sedating antihistamines [inform] 1995 193
Becket G See Fawcett JP 1996 552
Bedi TR Corticosteroid-induced avascular necrosis [letter] 2006 164
Begg EJ See Pearce MJ 1995 13
Begg EJ See Mottram MC 1997 290
Behan KP Not seeing the light? 2010 222
Behayaa M See Garg S 2008 28
Behjati M Elevated INR despite warfarin discontinuation [letter] 2012 77
Bekur R See Singh A 2014 60
Belfrage MK See Elliott RA 2009 216
Bell JS See Moles RJ 2007 265
Bell JS Prescriber feedback to improve quality use of medicines among older people: the Veterans' MATES
program
2011 316
Bell JS See Grzeskowiak LE 2012 5
Bell JS See Chan TW 2013 269
Bell K Federal Government support for the quality use of medicines 1996 55
Bell SC See Burrows J 2002 315
Bellette PK See Clark LM 2001 134
Bellomo R See Klemz K 2008 296
Belz MM See Crosara SLR 2013 221
Belz SA Afatinib after disease progression with gefitinib in advanced adenocarcinoma of the lung 2013 137
Bennett A Perceived barriers by hospital pharmacists to become accredited to perform med reviews in the home 2003 183
Bennett A Pharmacist's role in chronic disease management [letter] 2007 81
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 7
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Bennett AA See Hargraves TL 2008 103
Bennett S Australian Clinical Pharmacy Award 2013 2013 309
Bennett S See Angley M 2014 6
Benoussan Al See Drew A 2000 71
Benporath CH See Jackson JK 2001 262
Benrimoj SI A review of drug distribution systems: part 1—current practice 1995 119
Benrimoj SI A review of drug distribution systems: part 2—automated dispensing for unit dose systems 1995 230
Benrimoj SI See Smith MA 2002 227
Benrimoj SI See Moles RJ 2007 119
Benson HA Optimisation of drug delivery I. Principles of oral absorption and limitations of conventional oral
dosage forms
1997 222
Benson HA Optimisation of drug delivery 2. Principles of drug delivery and limitations of conventional non-oral
dosage forms
1997 313
Benson HA Optimisation of drug delivery 3. Sustained/controlled-release oral drug delivery 1997 381
Benson HA Optimisation of drug delivery 4. Transdermal drug delivery 1997 441
Benson HA Optimisation of drug delivery 5. Pulmonary drug delivery 1998 19
Benson HA Optimisation of drug delivery 6. Modified-release parenteral 1998 99
Benson HA See Prankerd RJ 1998 165
Benson HA Optimisation of drug delivery 8. Mucosal drug delivery via the nose and mouth 1998 236
Benson HA Optimisation of drug delivery 9. Mucosal drug delivery via the eye vagina uterus and rectum 1998 318
Benson HA Optimisation of drug delivery 10. Site-specific drug delivery of small-molecules 1998 417
Benson HA See Prankerd RJ 1999
Benzie JL Experience with clinical indicators 6.2 and 6.3 [letter] 1994 174
Benzie JL Support staff in hospital pharmacy practice - a decade of change 1997 430
Berbatis CG Response to `TDM: clinical pharmacy activity with a shortening half-life?' [letter] 1996 671
Berbatis CG Methadone programs in Australia [letter] 1996 674
Berbatis CG University training in clinical testing for pharmacists in 1997 [letter] 1997 470
Berbatis CG Methadone programs harm reduction chronic diseases and hospital pharmacists 1998 41
Berbatis CG National evaluation of pharmacy services in methadone maintenance treatment 2001 309
Berbatis CG National study of pharmacy practice in Australian community settings in 2002 2002 16
Berbatis CG National survey of Australia's community pharmacies in 2002: rationale and methodology 2002 143
Berbatis CG National Community Pharmacy Database Project 2002 177
Berbatis CG See Wibowo Y 2012 26
Bereznicki L Closing the gap between evidence and practice [ed] 2005 173
Bereznicki LR Ximelagatran cost effectiveness for stroke prevention in atrial fibrillation [letter] 2006 162
Bereznicki LR Improving clinical outcomes for hospital patients initiated on warfarin 2007 300
Bereznicki LR See Luinstra MM 2009 265
Bergin PJ See Korajkic A 2011 126
Berry PR See Scott-Walker TM 2000 157
Bessell TL See Marriott JL 2008 114
Bessell TL See Marriott JL 2008 117
Betke T See FitzGerald KH 2000 21
Bettenay K See Coombes I 2010 111
Betteridge F Evaluation of a weight-based heparin drug chart [letter] 2007 78
Beulke SH First-aid treatment of dermal exposure to hydrofluoric acid [letter] 1998 445
Beulke SH Casarett and Doull's toxicology: the basic science of poisons 5th edition 1999 74
Beulke SH European Association of Poisons Centres and Clinical Toxicologists international congress 2001 62
Bhagvandas NS Need for a poisons database in developing countries [letter] 2013 247
Bhandakar AA See Agarwal J 2014 162
Bhindi AK Optimisation of digoxin maintenance dose in toxicity 2010 50
Bhojraj S See Kaleemuddin M 2001 26
Bhosle MJ See Sansgiry SS 2004 262
Bialy LH Trans-Tasman comparison of non-prescription medicine purchasing behaviour 2007 277
Bian JE See Easton-Carter KL 2002 235
Bicknell ME Off-label drug use in an outpatient setting — a pilot study 1995 527
Biddle RA Survey of women's attitudes to complementary medicines 2003 55
Billy R See Tordoff JM 2006 12
Bingham JM Taxus brevifolia: clinical gem or endangered species 1994 72
Bingham JM Australian register of imported drugs (ARID) [letter] 1994 440
Bingham JM See Vernon GM 1995 32
Bingham JM Neoplastic fever: is there any effective therapy? [inform] 1995 293
Bingham JM Cancer pain and the enigma of analgesia 1996 113
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 8
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Bingham JM Safe handling of early phase investigational agents [letter] 1996 287
Bingham JM See Howitt KM 1996 315
Bingham JM EXTRA a database to record analyse and disseminate information on the extravasation of cytotoxic
drugs [letter]
1996 372
Bingham JM EXTRA a database to record and review cytotoxic drug extravasation events 1998 89
Bird MR Gonadal hormone replacement therapy in the elderly 1996 564
Bird MR Urinary incontinence in the elderly 2004 319
Birdsey G Australian Clinical Pharmacy Award 2010 2010 315
Birdsey GH Pharmacist-initiated electronic discharge prescribing for cardiology patients 2005 287
Bista D See Mishra P 2005 165
Black AJR See Birdsey GH 2005 287
Blackah J Written consent and SAS drugs [letter] 1994 281
Blennerhassett J Lithium concentration in liquid preparations made from lithium carbonate tablets [letter] 1994 439
Blennerhassett J Medication safety and patient participation: pharmacist emergency department and beyond 2005 244
Blennerhassett J A novel medicines management pathway 2006 175
Blennerhassett J Medicine management in older people from non-English speaking backgrounds 2011 33
Blewitt P See deClifford JM 2012 134
Blogg LC Prescribing benzodiazepines in residential aged-care facilities 2012 287
Blumgart AF See Loe EA 2008 209
Boddy M See Smith BA 1996 560
Boeker EB Development and implementation of a ward-based pharmacy intervention for Dutch surgical patients 2013 41
Boermeester MA See Boeker EB 2013 41
Bogovic A Development of a home infusion program for the treatment of children with primary pulmonary
hypertension
2000 222
Boland C See Aldous D 1997 341
Boland C See Bereznicki LR 2007 300
Bollella G Optimal level of liaison pharmacist intervention to facilitate a post-discharge home medicines review 2008 107
Bollenhagen S Technicians over the border [letter] 2004 73
Bolton PG Impact of medication review by general practitioners and patient peer education 2004 8
Bong XJ See Angley M 2011 27
Bong XJ See Padhye V 2012 273
Bonollo M See Stell R 2008 132
Bonwick RJ The role of antidepressants in the elderly [geriatric therapeutics] 1998 187
Boon Ou DK See To TP 2005 33
Booth D See Chieng R 2014 105
Booth J Operating suite pharmacy practice in the UK [letter] 2011 332
Booth J See To T-P 2013 177
Booth JC Establishing clinical pharmacy services in the operating suite 2012 296
Booth JC See To TP 2014 89
Booth JC See Elliott RA 2014 258
Booth JL The ACHS' changing approach to quality in health care 1996 86
Borgstedt J Pre-admission and post-hospital management of heart failure in patients not enrolled in specialist
programs
2009 186
Bortoletto DA Patients' attitudes to discharge medications supplied under the PBS 2004 288
Bortoletto DA See Birdsey GH 2005 287
Bortoletto DA See Muir PR 2007 187
Boston A Epidural infusions 1999 346
Boulton DW The stability of an enalapril maleate oral solution prepared from tablets 1994 151
Boulton DW See Fawcett JP 1995 19
Bounda G-A See Hui HZ 2012 166
Bowen L Stability of frusemide tablets repackaged in dose administration aids 2007 178
Bowman SL See Simpson MD 2004 26
Boxall A-m See Lehnbom EC 2009 207
Boyce LE Audit of general practitioner medication lists for older patients at a regional hospital 2013 105
Boyce M See Yu K 2007 22
Boyce M See Nguyen A 2007 111
Boyd IW Co-dispensing of contraindicated drugs with cisapride 2008 23
Boyd RGD See Jackson JK 2005 28
Boyle Clare M Missed doses: an evaluation in two drug distribution systems 1998 413
Bradshaw-Leung H See Zolezzi M 2007 11
Braitberg G See McD Taylor D 2006 96
Braitberg G Therapeutic guidelines: toxicology & wilderness [book review] 2008 334
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 9
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Braitberg G See Marmor GO 2011 113
Braitberg G Toxicology handbook 2nd edition [book review] 2011 164
Bramley-Moore SR Patterns of analgesic prescribing for patients with chronic non-malignant pain in NSW 1998 83
Brand IAG Fred J Boyd award [conference presentation] 2000 16
Branford D See Wheeler AJ 2007 33
Branley P See Pellizzer AM 1998 432
Braun L Herbal medicinal products [book review] 2004 160
Braun L Herbal remedies. 5th edition, [book review] 2004 160
Braun LA Australian hospital pharmacists' attitudes perceptions knowledge and practices of CAMs 2007 220
Brealey J See Ambados F 1998 112
Brealey J See Ambados F 1998 444
Brett J See Baysari MT 2012 178
Brett J Pneumonia severity scores and prescribing antibiotics for community-acquired pneumonia at an
Australian hospital
2013 97
Brien J Clinical pharmacy services in 2020 [editorial] 2013 9
Brien JE See Campbell B 1995 327
Brien JE See Simioni D 1996 221
Brien JE Career opportunities for pharmacists [career opportunities] 1998 267
Brien JE See McConachy KA 1999
Brien JE See McLennan DN 1999
Brien JE A new course in clinical pharmacy in Victoria 1999 95
Brien JE Pharmacokinetics made easy 1999 236
Brien JE Challenges to the profession [ed] 2000 46
Brien JE Pharmacy practice research [ed] 2000 192
Brien JE See Tan EL 2003 65
Brien JE See Easton-Carter KL 2003 106
Brien JE See Slader CA 2003 157
Brien JE Pharmacy leadership and multidisciplinary partnerships [letter] 2003 158
Brien JE Pharmacogenomics-clinical and social implications 2003 224
Brien JE See Sabet P 2004 36
Brien JE See Gallego G 2004 100
Brien JE See Cocks HJ 2004 109
Brien JE See Lawler C 2004 174
Brien JE See Tan EL 2004 178
Brien JE See Kay O 2004 259
Brien JE See Kay OC 2004 300
Brien JE See Slader SA 2005 15
Brien JE See Gallego G 2005 18
Brien JE Planning the future [ed] 2006 10
Brien JE Evidence-based practice [ed] 2006 94
Brien JE Clinical governance [ed] 2006 174
Brien JE See Kay OC 2006 199
Brien JE Pharmaceutical review-a view from academia [ed] 2006 256
Brien JE Access and quality use of medicines [ed] 2007 10
Brien JE Plus ça change [ed] 2007 93
Brien JE See Moles RJ 2007 119
Brien JE Clinical training - the inconvenient truths [ed] 2007 172
Brien JE Integration - putting it all together [ed] 2007 257
Brien JE Pharmacogenetics and the future of clinical pharmacy practice [ed] 2008 7
Brien JE Keeping up with the evidence trials and journals [ed] 2008 91
Brien JE See Hargraves TL 2008 103
Brien JE What is ethical research? [ed] 2008 178
Brien JE See Page MA 2008 286
Brien JE Is it advertising or evidence? [ed] 2009 10
Brien JE See Lehnbom EC 2009 45
Brien JE Drug interaction alerts in dispensing and prescribing software [letter] 2009 81
Brien JE Lifelong learning [ed] 2009 94
Brien JE Healthcare reform 2009 [ed] 2009 175
Brien JE See Lehnbom EC 2009 207
Brien JE Leadership and succession planning [ed] 2010 12
Brien JE Medication errors - research and practice partnerships [ed] 2010 91
Brien JE Patient safety beyond the hospital [ed] 2010 179
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 10
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Brien JE The Journal of Pharmacy Practice and Research what do we want to be? [ed] 2010 264
Brien JE Understanding non-inferiority trials [ed] 2011 16
Brien JE Principles of quality prescribing [ed] 2011 97
Brien JE Health services evidence the message and the audiences [ed] 2011 263
Brien JE Don't be admitted to hospital on a weekend [ed] 2012 7
Brien JE Have your say! [ed] 2012 93
Brien JE Phase four trials and drug safety evidence [ed] 2012 179
Briggs D See Edwards CT 1997 133
Bright JM The clinical services documentation system for documenting clinical pharmacists' services 2000 10
Britton ME Drugs delirium and older people 2011 233
Brizzi J See Roller L 2008 79
Broad JM See Rofail S 1999
Broad N See Siderov J 2005 165
Broadbent RS See Kunac DL 1999
Brodaty H See Peisah C 1997 49
Brodaty H See Peisah C 1997 159
Brooks C See Lauchlan R 1995 342
Brooks C See Howitt KM 1997 302
Brouwers JR See Al Hadithy AF 2005 213
Brown AN Validated competency framework for delivery of pharmacy services in Pacific-Island countries 2012 268
Brown GJE Factors determining prescribing decisions in a teaching hospital setting 1999 311
Brown JA Complementary medicines: hospital pharmacists’ attitude knowledge and information seeking
behaviour
2009 281
Brown KE Pain severity cut-points and analgesic use by community-dwelling people for chronic pain 2012 196
Brown S See Day R 1996 622
Brown S-E See Welch SA 2000 262
Bruno AF See Brown AN 2012 268
Brushett D See Thawornchaisit P 2012 189
Bryant W See Lehnbom EC 2009 45
Buchan D See Masood N 2006 111
Buchan DS Incidence of venous thromboembolism and thromboprophylaxis after total hip or knee arthroplasty 2008 200
Buckley J See Dunning TL 2010 203
Buddhirakkul P See Thawornchaisit P 2012 189
Bui D See Ng C 2013 25
Bui T UK and US perioperative pharmacists’ experience [letter] 2012 334
Buick M See Alvarez SJ 2001 13
Bula N Financial analysis in pharmacy practice [book review] 2011 331
Bull RM See Simpson MD 2006 119
Bulsara C Seniors prefer pharmacists for advice on medications [ed] 2013 7
Burbury K See Alexander M 2014 163
Burford OJ See Parkinson AM 1998 436
Burgess CL Audit of nausea and vomiting management in palliative care hospital patients 2007 306
Burgess N GlaxoSmithKline Medal of Merit 2009 2009 310
Burgess NG See Martin ED 2000 94
Burgess NG See Martin ED 2000 141
Burgess NG See Dooley MiJ 2000 150
Burgess NG See Howitt KM 2001 181
Burgess NG See La Forgia SP 2002 65
Burgess NG See O'Leary KM 2002 72
Burgess NG See Sharley NA 2003 279
Burke R E-prescribing and the future of hospital pharmacy [letter] 2006 76
Burke R GlaxoSmithKline Award 2007 2007 318
Burke R Entering the electronic medication management age - implications for pharmacists [ed] 2008 258
Burke R See O'Connor K 2009 135
Burke R See Lo C 2010 106
Burke RA See McCrudden EA 1995 261
Burke RA Medication incident prevention: the medication chart competition as an educational strategy 2000 69
Burke RA Current medication safety practices within the United States 2002 97
Burnett D Cell-based therapies- a role for pharmacy technicians 2003 296
Burridge N See O'Leary KM 2013 88
Burrows J Association between self-reported adherence to HIV therapy and disease markers 2002 315
Burrows J See Luetsch K 2012 249
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 11
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Burrows S See Joyce AW 2007 42
Burton DL See Simpson MD 2004 26
Burton MA See Simpson MD 2004 26
Bushell MA Case for pharmacist administered vaccinations in Australia 2013 292
Butler R See Sheridan J 2007 19
Bye L See Zolezzi M 2014 188
Byrne A Prescribing for Drug Withdrawal [book review] 2003 161
Byrne GJ Treatment of cognitive impairment in Alzheimer's Disease 1998 261
Byrnes D Access to pharmacy medication review services [letter] 2013 248
Byth K See Cheong EA 2008 267
Cabalag M See McD Taylor D 2009 24
Cabrera A See Silva MA 2013 37
Cadart CR From Melbourne to Martindale [career opportunities] 2000 25
Cain MJ Report on oncology pharmacist activities at Sir Charles Gairdner Hospital WA [letter] 1995 53
Caird CJ See Bollella G 2008 107
Cairns C Where should we be going in pharmacy education? - part 2 [ed] 2008 259
Cairns C What should we be doing in pharmacy education? - part 3 [ed] 2011 89
Calabretto JP So that was IT: the Hawaii International Conference on System Sciences 2002 219
Calabretto JP Initial assessment of an internet-based medication record 2005 99
Calabretto J-P See Gordon J 2011 271
Calcino LJ See Boyd IW 2008 23
Camac KJ Medication errors — a comparative study of drug storage sites 1996 234
Campbell B Pharmacokinetics in spinal cord injured patients 1995 327
Campbell DG Renal effects of high-dose tobramycin and vancomycin impregnated bone cement 2008 140
Campbell S Pharmacological treatment of frailty in the elderly 2009 147
Candiloro JA See Welch SA 2014 161
Cao BY Implementing a pharmacist charting service in the pre-admission clinic 2011 102
Capes DF A review of the restrictive flow infusion devices available for parenteral drug therapy 1997 115
Caplygin FM See deClifford JM 2007 284
Carberry J See Bogovic A 2000 222
Cardiff L See Coombes I 2010 111
Cardiff LM See Radford JM 1998 400
Cardiff LM See Radford JM 1999
Cardiff LM See Matthews JJ 2001 279
Carlos L See Betteridge F 2007 78
Carpenter J The top 100 drug interactions. A guide to patient management [book review] 2002 294
Carpenter J Good things come in small packages-learning to teach evidence-based practice [letter] 2004 73
Carrington C See Gilbar P 2004 159
Carrington C Cancer pharmacists group [letter] 2007 81
Carrington C Doctor of Clinical Pharmacy - evidence-based protocol [letter] 2008 165
Carrington C Pharmacists pharmacovigilance, unapproved indications and the TGA [letter] 2010 249
Carrington CV See Gilbar PJ 2005 195
Carroll JA Stability of flucloxacillin in elastomeric infusion devices 2005 90
Carroll M The American pharmaceutical association drug treatment protocols 1999 349
Carroll M Case studies in practice: medication review-a process guide for pharmacists [book review] 2003 162
Carroll ME Potential support roles for pharmacy technicians in provision of clinical pharmacy services 2003 186
Carroll ME See McLachlan GB 2008 47
Carroll PR See Johnston CF 2011 275
Carter FA See O'Shea TJ 2009 114
Carter L See Harvey PA 2012 246
Casanova JM See Eaton VS 2000 58
Cecchele R See Nasser S 2012 129
Cesnik B See Pappas A 1998 312
Cesnik B See Pappas A 1999
Chaar B Professional code of ethics [ed] 2006 7
Chaar BB See Penm J 2009 192
Chaar BB See Gu P 2011 196
Chaboyer W See Latimer SL 2011 188
Chae J See Khan M 2011 265
Chahadi F See To T-P 2012 118
Challen J International Clinical Trials Symposium 2002 264
Challen J International Clinical Trials Symposium [letter] 2007 333
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 12
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Chambers RA See Accordino A 1994 312
Chambers RA See Amadio M 1996 371
Chambers RA See Accordino A 1996 629
Chambers RA Trissel's stability of compounded formulations 2nd edition 2000 231
Chan E Broaden knowledge and improved networking [letter] 2007 166
Chan EW Artemether-lumefantrine and primaquine for mixed P. falciparum and ovale malaria 2006 134
Chan EW Role for aspirin after total hip replacement 2006 214
Chan EW ASHP Midyear Clinical Meeting [letter] 2009 333
Chan EW International pharmacy preceptorship in emergency medicine [letter] 2010 76
Chan EW Intravenous olanzapine for acute agitation in the emergency department 2011 135
Chan EW Cost-minimisation analysis of midazolam versus droperidol for acute agitation in the ED 2012 11
Chan JG Board of Pharmaceutical Specialties Certification Examination in Nuclear Pharmacy 2002 301
Chan RK See Shah K 2006 301
Chan TW Non-medical use of prescription drugs among clients admitted to an acute psychiatric unit 2013 269
Chandler K See Harding AM 2010 332
Chang DWH See Lam A 2013 297
Chao G See Fawcett JP 1996 552
Chapman AB See Osborne RH 2002 276
Chapman CB See Corallo C 1995 123
Chapman CB See Easton-Carter KL 2002 235
Chapman CB See Easton-Carter KL 2003 106
Chapman CB See Lee CY 2011 98
Chapman R See Wein S 2002 212
Charles B Handbook of basic pharmacokinetics including clinical applications. 6th ed. [book review] 2004 333
Charles BG Fundamentals of population modelling: opportunities for hospital pharmacy practice 1999 88
Charles BG See Anh AVQ 2006 262
Charles PG See McD Taylor D 2009 24
Charlton KE See El-mani SF 2014 113
Chase D Management of cardiac rhythm disturbances in the ageing heart 2008 312
Chau A See Brett J 2013 97
Cheh RM Outcomes of pharmacological management of violent behavioural disturbances in older hospital
patients
2010 184
Chen AWJ Snapshot of antimicrobial stewardship in Australian hospitals 2010 19
Chen AWJ Snapshot of barriers to and indicators for antimicrobial stewardship in Australian hospitals 2011 37
Cheng AC See Fernando S 2012 80
Cheng G See Zolezzi M 2007 225
Cheong EA Home pharmacy service: three years experience 2003 212
Cheong EA Adverse drug reactions associated with home parental therapy 2008 267
Cherukuri H See Devabhaktuni R 2013 333
Chesney K See Tordoff JM 2006 12
Chiang C See Dooley MJ 2008 188
Chieng R ISOPP/HOPA 2008 [letter] 2008 250
Chieng R Implementation of a clinical pharmacy service to an allogeneic stem cell transplant ambulatory clinic 2014 105
Chin DY See Mahler SM 2003 7
Chin KL Behavioural component of patient care [letter] 2011 332
Chin M See Ambados F 2012 111
Ching MS See To TP 2008 219
Ching MS See To TP 2010 101
Ching MS See To TP 2014 89
Chiu F See To NN 1999
Chong DW See Hasan SS 2010 294
Choo C Drug facts and comparisons 1999 edition 1999 301
Choo C World Congress on Pain 2005 291
Choo CS D2 D3-what's the difference? [letter] 2006 246
Choo S See Bingham J 1996 287
Choo S See Dooley MJ 2011 208
Choo S See Tong EY 2012 140
Chow C See Cao BY 2011 102
Chu K-P Evaluation of antifungal treatment guidelines for immunosuppressed patients 2010 119
Chu KPJ Hypothermia associated with olanzapine 2005 216
Chu MTY See Taylor SE 2007 214
Chui SY Incidence of vancomycin-induced red man syndrome in a women's and children's hospital 2007 124
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 13
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Chuong M See Silva MA 2013 37
Ciccia M See Betteridge F 2007 78
Claes MT See Mackenzie FD 2002 31
Clark FC Antiretroviral therapy in 2014 and beyond: simplicity and complexity? [ed] 2014 181
Clark LM Communication of adverse drug reactions between the hospital health care team and general
practitioners: how effective is it?
2001 134
Clark RA See Borgstedt J 2009 186
Clark RA See Lovgren S 2009 269
Clark RP Safety cabinet containment testing [letter] 2002 259
Clifford RM Pharmaceutical care of diabetes patients - let's take up the challenge [letter] 2003 17
Clifford RM Developing key competencies for a clinical pharmacy education and peer review program 2003 208
Clifford RM Prevalence and predictors of complementary medicine usage in diabetes 2003 260
Clifford RM Patient-centred care: are we meeting patients' needs? [letter] 2006 165
Clifford RM See Taylor KL 2007 287
Clifford RM See Burgess CL 2007 306
Clifford RM Post-registration learning trends of community pharmacists 2011 203
Clifford RM See Kiani M 2011 217
Clifford RM See Lie K 2011 278
Clifford RM See Blogg LC 2012 287
Clifford RM See Gudka S 2013 15
Clunie L See Zolezzi M 2007 11
Cocks HJ Evaluation of therapeutic drug monitoring services and comparison of two models of service provision 2004 109
Cocohoba J HIV in the United States: a pharmacy perspective [ed] 2014 177
Cohen B See Renwick J 1998 439
Cohen MM See Braun LA 2007 220
Colarco T See Alderman CP 1999
Cole M We all make mistakes - but what can we do about it? 2002 261
Cole-Sinclair M See Lubliner M 2005 266
Colgan JE A cup of tea my pharmacist and me: can extended communication make the difference? 1997 398
Colley D See Borgstedt J 2009 186
Colley D See Lovgren S 2009 269
Colley D See Angley M 2011 27
Collins DM See Stowasser DA 1997 362
Collins DM See McGuire TM 1997 403
Collins DM See Stowasser DA 2000 47
Collins DM See Stowasser DA 2002 133
Collins DM See Stowasser DA 2002 221
Collins M Continuing professional development as a prerequisite for registration: a worldwide trend 2001 57
Collins MA See Pascuet E 2010 92
Collison C SPA 1997 remuneration survey published [letter] 1997 335
Collyer FM Privatisation on the agenda: policy direction in health care [conference presentation] 1998 108
Colman PG See Rando L 2004 95
Colvin J See Schwantzer M 1994 439
Colvin J Drugs in breast milk — timing of mother's dose and baby's feed [letter] 1995 486
Condon LA Drug utilisation review of cephalothin 1995 238
Connellan P See Thawornchaisit P 2012 189
Connolly J See Robinson MK 1999
Connolly MJ See Wilson RK 2013 51
Cook DA See Mackenzie FD 2006 185
Cook GK Extemporaneous compounding in Queensland hospitals 2007 204
Coombes I Pharmaceutical review-Queensland health's experience [ed] 2006 256
Coombes I See Lum E 2007 7
Coombes I See Hale A 2009 163
Coombes I GlaxoSmithKline Medal of Merit 2010 2009 318
Coombes I Improvement in pharmacist's performance facilitated by an adapted competency-based general level
framework
2010 111
Coombes I Developing and recognising advanced practitioners in Australia: an opportunity for a maturing
profession? [ed]
2011 17
Coombes I See O'Leary KM 2012 259
Coombes I Advancing pharmacy practice in Australia: the importance of national and global partnerships [ed] 2012 261
Coombes I See Hale A 2013 256
Coombes I See Angley M 2014 6
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 14
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Coombes ID Quality of medication ordering at a large teaching hospital 2001 102
Coombes ID The PBS-Its future involvement in the debate? 2002 15
Coombes ID Extended role of the clinical pharmacist in the management of heart failure and acute coronary
syndromes
2002 17
Coombes ID Australian Clinical Pharmacy Award 2003 2003 305
Coombes ID Identification of medication errors by nurses during a simulated ward medication safety orientation
program
2005 190
Coombes ID See Shah SS 2013 129
Coombes J See Coombes I 2010 111
Coombes JA See Radford JM 1997 140
Coombes JA See Stowasser DA 2000 47
Coombes JA See Matthews JJ 2001 279
Coombes JA Piloting an objective structured clinical examination to evaluate the clinical competency of pre-
registration pharmacists
2003 194
Cooper G Developing the skills and attributes of a clinical pharmacist within a master of pharmacy curriculum
[ed]
2006 172
Cooper GM See Brown AN 2012 268
Cooper JM Providing medicines information and education to hospital in-patients: patients’ experiences and
preferences
2014 213
Copeland TS See Wilmott V 2004 210
Corallo CE Determination of insulin concentrations in plastic infusion systems 1995 129
Corallo CE Anaphylactic shock following intravenous vitamin K1 1997 146
Corallo CE See Jenney A 1999 36
Corallo CE See Coutsouvelis J 2011 225
Corallo CE See Fernando S 2012 80
Cosh DG Collaborative approach to TDM [letter] 1996 673
Cosh DG Clinical pharmacy - being there 1997 15
Cosh DG The 23rd federal conference [ed] 1997 357
Cosh DG Australian perspectives on the BPS examinations 1998 334
Cosh DG See Ng D 1999
Cosh DG See Wiese MD 1999
Cosh DG Australian Clinical Pharmacy Award 1999 2000 283
COSP Aged Care Medication management in residential care facilities by hospital pharmacists 1995 541
COSP Cancer
Services
SHPA standards of practice for the provision of oral chemotherapy for the treatment of cancer 2007 149
COSP Drug Dist Evaluating the effectiveness of drug distribution systems 1994 93
COSP Drug Info Drug information: management clinical trials and clinical pharmacy perspectives 1994 89
COSP Drug Info SHPA standards of practice for drug information services 1999 171
COSP DUE SHPA standards of practice for drug usage evaluation in Australian hospitals 1996 240
COSP DUE SHPA position statement on the provision of drug utilisation data 1996 247
COSP DUE SHPA standards of practice for drug use evaluation in Australian hospitals 2004 220
COSP Home Health
Care
A survey of parenteral therapy services provided to home patients by Australian hospital pharmacies 1997 373
COSP Investigation
Drugs
SHPA standards of practice for pharmacy investigational drugs services 1999 227
COSP Med Safety SHPA standards of practice for medication safety 2012 300
COSP Oncology SHPA standards of practice for the oncology pharmacist 1995 455
COSP Oncology SHPA standards of practice for the safe handling of cytotoxic drugs in pharmacy departments 1999 108
COSP Oncology SHPA standards of practice for the transportation of cytotoxic drugs from pharmacy departments 2000 116
COSP Oncology Guidelines for counselling patients receiving drugs used in the treatment of neoplastic disease: a
pharmacist's guide to advisory labels and patient information
2001 51
COSP Oncology SHPA standards of practice for the provision of clinical oncology pharmacy services 2002 115
COSP Oncology SHPA standards of practice for the safe handling of cytotoxic drugs in pharmacy departments 2005 44
COSP Outpatient
Services
SHPA practice guidelines for outpatient services 1994 421
COSP Pharm Manage How to win in the right sizing game [workshop] 1994 88
COSP Pharm Manage Format for practice standards 1995 156
COSP Poisons Info SHPA standards of practice for Australian poisons information centres 1995 161
COSP Poisons Info Guidelines for information sources for poisons information centres 1995 163
COSP Poisons Info Guidelines on minimum staffing levels of professional staff for poisons info centres 1995 460
COSP Poisons Info SHPA policy guidelines on quality assurance for poisons information centres 1996 442
COSP Psych Pharm SHPA guidelines for the practice of psychiatric pharmacy 1995 347
COSP Psych Pharm SHPA standards for the practice of psychiatric pharmacy 2000 292
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 15
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
COSP QA Survive and thrive with quality assurance 1994 92
COSP Rehab Bridging the gap: community liaison pharmacy 1994 91
COSP Rehab SHPA self-medication guidelines 1994 416
COSP Rehab SHPA standards of practice for the community liaison pharmacist 1996 570
COSP Rehab SHPA guidelines for self-administration of medication in hospitals and residential care facilities 2002 324
COSP-Clin Pharm Making the most of medication chart review 1994 90
Costello N Adherence to antiretroviral therapy in hospitalised patients [letter] 2013 79
Costello N See Heath EK 2014 201
Cottrell N See Sim L 2005 276
Cottrell N Australian Clinical Pharmacy Award 2007 2007 319
Cottrell N See Freeman C 2014 240
Cottrell WN See Whitty JA 2001 300
Cottrell WN See Coombes ID 2002 15
Cottrell WN See Coombes ID 2002 17
Cottrell WN See Overland V 2002 232
Cottrell WN See Gujral GR 2009 202
Cottrell WN See LaCaze A 2012 6
Cottrell WN See Freeman C 2012 184
Couch G Continuity of medication supply and provision of patient information on discharge: development of a
survey tool
2007 210
Coulthard K Update on cystic fibrosis 2004 125
Coulthard K See Chui SY 2007 124
Coulthard K Fred J Boyd Award 2009 2009 307
Coulthard KP Clinical pharmacy award [conference presentation] 2000 19
Coulthard KP Australian Society for Antimicrobials [letter] 2000 290
Coulthard KP See Stacey SR 2013 45
Coulthard MG See Roberts JA 2009 198
Coutsouvelis J Systemic absorption from oral vancomycin: check the dose! 2011 225
Coutsouvelis J See Chieng R 2014 105
Cox IR Pharmacokinetics in patients with burns 2005 53
CPI Working Party Standards of practice for the provision of consumer product info by pharmacists in hospitals 1996 434
Crameri QM See Adu A 1995 336
Crane J See Cao BY 2011 102
Crank M Pharmaceutical and medicines information management: principles and practice 2002 160
Crank MY Drug information services: hospital pharmacists' utilisation and opinion 2005 284
Crankshaw DP Stability of methoxyflurane loaded penthrox inhaler 2009 274
Cranswick M See Shah K 2006 301
Cranswick N See Juliana GS 2005 187
Crea J See Ambados F 2012 111
Creasey H Tacrine — for and against. The case against 1995 569
Creber ES See Larmour I 1995 220
Creber ES See Larmour I 1998 226
Cree ML Fifth Congress of the European Association of Hospital Pharmacists 2000 288
Cree ML International Paediatric Pain Symposium 2010 [letter] 2010 81
Criddle D Research — reviving the lost art of questioning 1996 52
Criddle D See Angley M 2014 6
Crookes PA See Mullan JR 2003 284
Crosara SLR Mitomycin-C induced thrombotic thrombocytopenic purpura 2013 221
Crowe DM See Dartnell JG 1994 333
Crowe S See Duncan AJ 2005 291
Crowley PMP Epilepsy: diagnostic and management dilemmas in the elderly 1994 270
Cuell S See McConachy KA 1999
Currow DC Evidence-based practice - where does the buck stop? [ed] 2012 91
Cusack BM See Blennerhassett JD 2006 175
Cutts C Review of information resources on the use of medication in breastfeeding women 2001 207
Cutts C Teaching the teacher - the missing link in Australian clinical pharmacy training? 2003 45
Cutts C Audit of selective and non-selective NSAID use in rural general practice 2003 70
Czajkowski F See Feeney GF 1997 42
D S (Sahiti D.) See Singh A 2014 60
Daftary MN Patients' willingness to pay for cognitive pharmacy services in ambulatory care settings in the USA 2003 265
Dahms K See Behan KP 2010 222
Dakin C See Barras M 2011 183
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 16
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Daly G Australian and New Zealand Children's Haematology and Oncology meeting [letter] 2008 328
Daly GE 21st annual scientific meeting of the Clinical Oncological Society of Australia 1995 466
Daly GE Alteplase for veno-occlusive disease in bone marrow transplant patients [inform] 1995 547
Daly GE Amgen Australia clinical pharmacy practice grant [letter] 1996 373
Daly GE See To NN 1999
Daly GE International bone marrow transplant registry/autologous blood and marrow transplant registry
meeting Keystone USA
1999 287
Daly GE Report from the International Society of Paediatric Oncology Meeting 2001 66
Danby RW See Jackson JK 2001 262
Dartnell JG Learning as a pharmacy educator in Belize Central America 1994 254
Dartnell JG Review of the use of adverse drug reaction labels on medical records 1994 333
Dartnell JG Audit of cefotaxime prescribing at a major teaching hospital 1994 392
Dartnell JG See Brown GJ 1999
Dartnell JG Thinking about prescribing. A handbook for quality use of medicines [book review] 2000 76
Dartnell JG DUE-an essential tool to achieve QUM 2000 251
Darwiche R See Tucci J 2009 223
Darzins P Ethical and practical dimensions of prescribing for older people as quality of life decreases 2008 64
Das R Mirtazapine-induced lower limb oedema 2005 310
Das R Allopurinol-associated angitis [letter] 2006 77
Das RN See Mishra P 2005 165
Das RN Peripheral oedema associated with imatinib [letter] 2007 80
Das RN Skin discoloration and melanonychia associated with hydroxyurea [letter] 2007 82
Dashti-Khavidaki S See Ahmadi-Abhari SA 2005 103
Davey AK See Al-Sallami HS 2001 189
Davey AK Clinical relevance of cytokine-induced changes in drug metabolism 2002 147
Davies D Guidelines for safe handling of contact sensitisers [practice report] 2000 216
Davies G Medicines patients and the care process - tackling the non-adherence agenda [ed] 2008 256
Davies G See Coombes I 2010 111
Davies GE See Lau D 2008 179
Davies J See Alvarez SJ 2001 13
Davies JG See Coombes JA 2003 194
Davis A Self-administration of medication [letter] 1995 52
Davis ID See Siderov J 2002 108
Davis J Intrathecal drug administration [letter] 1995 174
Davis J See Graham B 2002 177
Davis J See Weekes L 2006 91
Davis J See Gilbar P 2007 115
Davis MR See Xu QA 1998 156
Davis S The TAGNet Network 1999 179
Davis SR Ketamine in chronic pain: a review 1998 94
Davis SR See Kelly M 2004 32
Davis SR Creation of a temperature stability database for refrigerated medicines 2010 31
Davis SR Medication reviews for people with developmental disability – a call to action! [letter] 2014 160
Davis TM See Clifford RM 2003 260
Davis W See Clifford RM 2003 260
Davison JG See Ware GJ 1994 329
Dawson AH See Drew A 2000 71
Day R Pharmaceutical Benefits Scheme: rapid change and impetus towards achieving QUM [ed] 2007 4
Day R India: emerging centre of drug development [editorial] 2009 262
Day R Death of the 'blockbuster' and 'pivotal' clinical trial: rethinking the drug development process [ed] 2011 94
Day R See Inam S 2014 195
Day RO Drug committees — the key to quality use of medicines? [ed] 1996 622
Day RO See Bramley-Moore SR 1998 83
Day RO COX-2 specific inhibitors and the hospital pharmacist [ed] 2000 41
Day RO COX-2 specific inhibitors in cancer: in reply [letter] 2000 120
Day RO See Welch SA 2000 262
Day RO See Tan EL 2003 65
Day RO Pharmaceutical health and rational use of medicines committee [ed] 2003 87
Day RO See Tan EL 2004 178
Day RO See Baysari MT 2012 178
Day RO See Teo CK 2013 32
de Boer M See Boeker EB 2013 41
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 17
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
de la Roca J See Aldama PC 2003 330
De Luise MA Thyroid disease in the elderly 2003 228
De Rosa NF Stability of venlafaxine hydrochloride liquid formulations suitable for administration via enteral
feeding tubes
2008 212
De Villiers Smit P See Mann T 2007 281
De Zylva JB Adherence to prophylaxis guidelines for symptomatic VTE at a Darwin hospital 2012 37
Deans K To manager and company director 1999 46
deClifford JM Impact of an emergency department pharmacist on prescribing errors in an Australian hospital 2007 284
deClifford JM Evaluation of a pharmacist-initiated e-script transcription service for discharged patients 2009 39
deClifford JM Implementation and acceptance of a pharmacist-initiated e-script transcription service for discharge
prescriptions
2009 286
deClifford JM See Pang RK 2011 192
deClifford JM How do clinical pharmacists spend their working days a time-and-motion study 2012 134
Dehpour AR See Ahmadi-Abhari SA 2005 103
Deidun DM Participating in an International Pharmacist Exchange Program 2001 44
DeLuise MA See Bird MR 1996 564
Denaro C See Coombes ID 2002 17
DeSantis GN See Stuchbery P 2007 102
DeSantis GN See Stuchbery P 2008 126
Dettwiller P See De Zylva JB 2012 37
Devabhaktuni R Mixed organophosphate and rodenticide poisoning accelerates fulminant hepatic failure [letter] 2013 333
Dhungana K See Das R 2005 310
Diamandis S See Moles RJ 2007 265
Dib JG Ginger for nausea and vomiting in pregnancy 2004 305
Dines A See Avent ML 2010 15
Dinh NT See Tan ISP 2013 279
Dionysopoulos D Pharmacist service in a surgical preadmission clinic [letter] 2011 75
DiPiro JT Biotechnology: are you ready to meet the challenge? 1996 74
Dirnbauer NJ See Hodgkinson MR 2009 19
Ditty A Are proton pump inhibitors over-prescribed in infants? 2014 220
Dixon AE See Mackenzie FD 2006 185
Dixon B See Dooley MJ 2008 188
Dobson PM A nurse’s perspective of HIV: past, present and future [ed] 2014 179
Doecke C Equity of access to pharmaceuticals in Australia [editorial] 2005 4
Doecke CJ Clinical pharmacy in Australia: a personal perspective 1998 105
Doecke CJ Joint appointments in education [career opportunities] 1998 369
Doecke CJ See Martin ED 2000 94
Doecke CJ See Martin ED 2000 141
Doecke CJ Patient safety is paramount 2001 220
Doecke CJ See La Forgia SP 2002 65
Doecke CJ See Sorich MJ 2004 22
Doecke CJ See Kethini T 2004 308
Doecke CJ See Yu K 2007 22
Doecke CJ See Nguyen A 2007 111
Doecke CJ See Poh EW 2009 176
Doecke CJ PBAC recommendation versus PBS approval [editorial] 2011 88
Doggrell SA Medicines management by the older-aged living independently in different types of retirement villages 2012 208
Doherty DA See Lim SC 2008 191
Doherty P Medication safety [letter] 2011 75
Dollman WB Comparison of the bioavailability of vigabatrin tablets and sachets in healthy male subjects 1996 229
Dolton MJ Prevalence of potentially harmful drug interactions in older people in Australian aged-care facilities 2012 33
Donnan GA See Srikanth VK 2000 60
Donnan GA See Srikanth VK 2000 176
Donnelly RJ See Benzie JL 1997 430
Donovan B See Adu A 1994 318
Doogue MP See Polasek TM 2011 77
Doolan G See Hassan FA 2006 266
Doolan SM Clinical oncology in the west 1995 473
Dooley M See Angley M 2014 6
Dooley MJ See Corallo C 1995 129
Dooley MJ See Bingham JM 1998 89
Dooley MJ See McLennan DN 1999
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 18
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Dooley MJ See Poole SG 1999
Dooley MJ See McLennan DN 2000 6
Dooley MJ Multicentre pilot study of a standard approach to document clinical pharmacy activity 2000 150
Dooley MJ See Lau P 2000 175
Dooley MJ Strategy for identification of 'near miss' events and improving dispensing accuracy 2001 125
Dooley MJ Hospital pharmacists fail to record their research in the QUM mapping project 2002 141
Dooley MJ Prescribing of warfarin and brand selection 2002 259
Dooley MJ Publication rate of abstracts presented at the SHPA 24th Federal Conference 2003 111
Dooley MJ See Carroll ME 2003 186
Dooley MJ See Burnett D 2003 296
Dooley MJ GlaxoSmithKline Medal of Merit 2003 2003 302
Dooley MJ See Larizza MA 2006 115
Dooley MJ See Rice CA 2007 303
Dooley MJ See Van De Vreede M 2008 19
Dooley MJ See Tsui M 2008 40
Dooley MJ See Stell R 2008 132
Dooley MJ Phenotyping for thiopurine therapy in clinical practice 2008 188
Dooley MJ Patient-completed medication histories vs those obtained by a pharmacist in a pre-admission clinic 2008 216
Dooley MJ See Van De Vreede M 2008 263
Dooley MJ See Larizza MA 2009 277
Dooley MJ See Korajkic A 2011 126
Dooley MJ Successful implementation of a pharmacist anticoagulant dosing service in ambulatory care 2011 208
Dooley MJ See Fernando S 2012 80
Dooley MJ See Graudins LV 2012 95
Dooley MJ See Tong EY 2012 140
Dooley MJ See Chieng R 2014 105
Dorevitch MI See Moran JA 2001 35
Dotta L Country technician visits the city technician [letter] 2004 331
Dowden JS Quality use of medicines - a Canberra Contribution [editorial] 1998 78
Dowden JS Entangling experts [editorial] 2011 179
Dowling H CPI workshop report 1994 264
Dowling H Consumer product information — where to from here? 1996 293
Dowling H See O'Leary KM 2003 93
Dowling H Corollaries of the vision-challenges as goal setter, net worker, navigator and cheerleader 2005 302
Dowling H The Garling report: thorns in a bed of roses? [editorial] 2010 8
Dowling HV See O'Leary KM 2012 259
Dowling HV See Coombes I 2012 261
Dowling HV See O'Leary KM 2013 88
Dowling HV See Angley M 2014 6
Drew AK A survey of drug information centres in Australia 1995 433
Drew AK Chinese herbal medicine [letter] 2000 71
Driscoll SE See Angley M 2014 6
Drummond MF The rise of pharmacoeconomics: implications for pharmacists 1994 38
Drummond SH Hospital admissions due to drug overdose 1994 231
Druskeit T See Roberts GW 2013 276
D'Souza DC Reporting review and application of near-miss prescribing medication incident data 2004 190
Dubrava S Identification of potential and actual breaches in the cold-chain within a tertiary hospital 2007 16
Duffull SB See Pearce MJ 1995 13
Duffull SB Concepts for critical appraisal of an original research paper 2001 200
Duffull SB See Shaw JP 2013 122
Duffy TM See Riley RH 1999
Dugdale P Toward lucid health care [editorial] 2012 256
Duggan C See Coombes I 2011 17
Duggan C See Coombes I 2012 261
Duguid M Fred J Boyd Award 2005 2005 300
Duguid M See MacPherson RD 2008 88
Duguid M Evaluating new medicines for use in Australian hospitals: lessons from North America 2010 124
Duguid M Pharmacists and antimicrobial stewardship [editorial] 2011 92
Duguid MJ CPI — education or information? [editorial] 1994 229
Duguid MJ Consultant pharmacy — clarifying the issues [editorial] 1995 217
Duguid MJ Labelling of imported products — beware [letter] 1996 673
Duguid MJ See Bajorek BV 2001 93
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 19
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Duguid MJ See Wilcox C 2001 268
Duguid MJ Review of discharge prescriptions by pharmacists integral to continuity of care 2002 94
Duguid MJ SHPA grants program-does it meet members' needs? 2005 201
Duke JM See Adams J 2004 73
Duncan A International AIDS Conference 2010 [letter] 2010 247
Duncan AJ Providing HIV education for health professionals in India 2005 291
Duncan G Pharmacy practice 3rd edition [book review] 2003 42
Duncan GJ See Jackson JK 2004 290
Duncan GJ See Vernon GM 2007 80
Dunkley K Oh you are a chemist! 1999 47
Dunne PF See Peterson GM 1996 545
Dunning TL Do high-risk medicines alerts influence practice? 2010 203
Dutta AP See Daftary MN 2003 265
Dutton J Career opportunities in government: a personal view [career opportunities] 1998 441
Dwari B See Das RN 2007 82
Dwari BC See Paudel R 2006 218
Eakin EG See van Beurden E 2003 51
Easton KL See Maxwell DJ 2004 212
Easton-Carter KL Issues in the interpretation and design of studies investigating drug-related morbidity and mortality 2002 235
Easton-Carter KL Adverse drug reactions in paediatrics: are we getting the full picture? 2003 106
Eaton V Superwarfarin poisoning 2005 56
Eaton V See Chen AW 2010 19
Eaton V See Chen AW 2011 37
Eaton VS Azathioprine hepatotoxicity confirmed by rechallenge [clinical communication] 2000 58
Eaton VS See Hutchinson KA 2001 98
Eaton VS See To TH 2007 30
Ebeling PR Pharmacological management of osteoporosis in 2000 2000 111
Ede J See Robertson K 2012 193
Edmonds E See Kelly AM 1995 487
Edwards CT Gentamicin usage and monitoring in a Sydney teaching hospital 1997 133
Edwards S See Alderman CP 1995 511
Edwards SM See Gailer JL 1996 587
Eikelboom JW See Peng YG 2004 14
Ekert H Current and preferred treatment of haemophilia A 1995 382
El-den S Over-the-counter drugs for pre-menstrual syndrome: is the pharmacist still part of the picture? 2014 224
Elkalmi RM See Hassali MA 2009 245
Elkalmi RM Community pharmacists involvement in the pharmacovigilance program in Malaysia [letter] 2010 245
Elkerton JR The documentation of adverse drug reactions 1995 502
Ellershaw J See Tasker J 1997 251
Elliott P See Snowdon GM 1998 232
Elliott P See Cao BY 2011 102
Elliott PA See Hudson BJ 1995 257
Elliott RA Nasogastric administration of omeprazole [inform] 1998 174
Elliott RA Assessment of a nursing home medication review service provided by hospital-based clinical
pharmacists
1999 255
Elliott RA Indicators of prescribing quality for elderly hospital inpatients 2001 19
Elliott RA Clinical pharmacy: an evolving area of pharmacy practice in India 2001 147
Elliott RA Quality of prescribing for elderly inpatients at nine hospitals in Victoria, Australia 2003 101
Elliott RA Problems with medication use in the elderly: an Australian perspective 2006 58
Elliott RA Complementary medicines in Australian veterans [letter] 2006 80
Elliott RA Is QUM an efficient use of healthcare resources? [editorial] 2008 172
Elliott RA Assessment of risk associated with medication-related problems in elderly outpatients 2009 109
Elliott RA Unplanned medication-related hospital readmission following transfer to a residential care facility 2009 216
Elliott RA Review of instruments used in clinical practice to assess patients' ability to manage medications 2010 36
Elliott RA Impact of hospitalisation on the complexity of older patients' medication regimens and potential for
regimen simplification
2011 21
Elliott RA See Lee CY 2011 98
Elliott RA See Tran T 2012 100
Elliott RA National survey of clinical pharmacy services and pharmacy technician roles for subacute aged-care
inpatients
2012 125
Elliott RA See Harvey PA 2012 246
Elliott RA GlaxoSmithKline Medal of Merit 2012 2012 305
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 20
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Elliott RA Identifying inappropriate prescribing for older people 2013 312
Elliott RA Impact of an expanded ward pharmacy technician role on service-delivery and workforce outcomes in
a subacute aged care service
2014 95
Elliott RA Problems with medicine use in older Australians: a review of recent literature 2014 258
Ellis AG See To TP 2008 219
Ellis AG See To TP 2010 101
Ellis AG See To TP 2014 89
Ellis D What can happen when suspensions are not shaken? [letter] 2011 79
Ellis D See Mihaila B 2012 103
Ellis D Prescribing antipsychotics for young people and monitoring physical health and adverse effects 2013 190
Ellis DP Child and adolescent psychiatry - an update from Hawaii 2002 216
Ellis DP Practical child and adolescent psychopharmacology [book review] 2002 293
Ellis DP See Grzeskowiak LE 2008 9
Ellyard P Creating a healthy future 1996 11
El-mani SF Folic acid and iodine supplementation during pregnancy: how much do pharmacists know and which
products are readily available?
2014 113
El-Saddik RA See Dib JG 2004 305
Elshami SS See Ibrahim MIM 2013 79
Emmerton LM See Mitchinson GH 1996 215
Emmerton LM See Bialy LH 2007 277
Emmerton LM See Tan ACW 2012 48
Emmerton LM See Habak JE 2013 101
Emmerton M See George LJ 2011 212
Emmott N See McKnight DL 1997 390
Enggist S L See Armour CL 1998 410
Eu P Radiopharmacy – it shows the way! [career opportunities] 2000 74
Eu P Radiopharmaceuticals in nuclear pharmacy and nuclear medicine. 2nd ed. [book review] 2006 82
Evans AM See McKinnon RA 2000 102
Evans AM See McKinnon RA 2000 146
Evans AM See Ward MB 2009 55
Ezzy J See Tett S 1997 435
Ezzy J See Stewart P 2000 72
Ezzy J See Stewart P 2001 56
Fahimi F See Ahmadi-Abhari SA 2005 103
Fairley CK See Yin C 2002 320
Fallah H See Su EY 2008 292
Fardell B Drug delivery in palliative care 1994 74
Fardy HJ See Gaetani L 2009 164
Farhoodian A See Ahmadi-Abhari SA 2005 103
Farouque O See Chase D 2008 312
Farouque O See To T-P 2012 118
Farouque O See Grewal J 2012 228
Fawcett JP See Boulton DW 1994 151
Fawcett JP Stability of amiloride hydrochloride oral liquids prepared from tablets and powder 1995 19
Fawcett JP Binding of parabens to sodium carboxymethylcellulose in oral liquid formulations 1996 552
Feeney GFX Alcohol and medication go ahead ask your doctor or pharmacist 1997 42
Fellows L A survey of drug audit practices and promotion of quality prescribing in Australian hospitals with a
focus on psychotropic drugs
2000 196
Feng SR See Hasan SS 2010 294
Feng Y See Hui HZ 2012 166
Fergusson JA Wound management in older people. 1997 461
Fernando S Early-onset vancomycin-associated neutropenia [letter] 2012 80
Ferrari RL See Capes DF 1997 115
Ferrier N See Berbatis CG 1996 674
Ferry DG See Fawcett JP 1995 19
Fiddes K See Stell R 2008 132
Fielding DI See Radford JM 1999
Finch JE Counselling discharged patients in their homes [on a different note] 1998 117
Finckh A See Slader SA 2005 15
Finckh AS See Welch SA 2014 161
Fisher MJ See Camac KJ 1996 234
Fisquet P IV phenoxybenzamine for acute hypertension of phaeochromocytoma a case report 1998 332
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 21
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Fisquet SJ See Ballantine DL 2014 108
FitzGerald KH Progesterone to prevent postnatal depression [clinical communication] 2000 21
Fiumara AM Treatment of nocardiosis: three case reports 1995 532
Flavel D Two examples of student placement tasks: drug use evaluations 2012 121
Fleming AM See Mackenzie FD 2002 31
Fleming G See Coombes JA 2003 194
Flicker L See Guthridge JM 1999
Flood VM See El-mani SF 2014 113
Fong CM Management of osteoporosis in older people 1995 372
Foo J See Milne DJ 2004 272
Foot C See Roberts JA 2009 198
Foran SM See Vernon GM 1995 32
Foran SM See Luu C 1995 548
Foran SM Utilisation of drug information resources by community healthcare practitioners 1996 429
Forbes A See Zolezzi M 2007 11
Forbes A See Zolezzi M 2007 225
Ford D Topical salicylates and warfarin — an unforeseen interaction [letter] 1996 671
Ford D See Power DA 2008 137
Ford DA Pharmacy costs of aged care rehabilitation 1996 325
Ford DA A hospital-based opportunistic immunisation program 1996 539
Ford DA See Brien JE 1999
Ford GA See Le Couteur DG 2010 148
Ford P Medication prescribing - not a task for non-medical health practitioners [editorial] 2008 256
Ford V See Lie K 2011 278
Forrester K See Hattingh HL 2007 174
Foster M Fresenius Kabi Australia Cancer Services Pharmacist Grant 2013: Oncology pharmacy team shining
with potential for pharmacist-led clinic [grant report]
2014 295
Fowler PR Medprofs — individualised medication profiles produced on a word processor 1995 26
Fowler PR Vancomycin-resistant enterococci [inform] 1997 149
Fowler PR See Cosh DG 1998 334
Fowler PR 25th Federal Conference 2001 91
Fowler PR eTG complete the complete Therapeutics Guidelines in electronic format 2002 159
Fowler S From the outback to the city in the world of critical care [letter] 2004 71
Fox C Casemix funding in Victoria — a CEO's perspective 1996 134
Frajman C No encouragement of mature-age pharmacy students [letter] 2003 159
Francis JM See Awasthi S 2013 248
Frank OR See Westaway KP 2014 44
Frank OR See Westaway K 2014 138
Fraser JF See Ballantine DL 2014 108
Freeman C Pharmacists', General practitioners' and consumers' views on integrating pharmacists into general
practice
2012 184
Freeman C The Australian practice pharmacist 2014 240
Freeman JK See Adu A 1995 336
Freeman M See To T-P 2012 118
Friedel H See Tasker J 1997 251
Frost E National registration and accreditation [editorial] 2007 172
Fucile DV See Pearce MJ 1995 13
Fullinfaw R See Lau D 2008 179
Fusha B See Zolezzi M 2007 11
Fyfe R See Weeks GR 2012 17
Gabardi S Drug dosing in acute kidney injury versus chronic renal insufficiency [editorial] 2008 175
Gabardi S See Martin S 2009 257
Gabardi S Risk evaluation and mitigation strategies: implications for US pharmacists [editorial] 2011 5
Gabardi S The evolving role of the transplant pharmacist [ed] 2013 174
Gaboury I See Pascuet E 2010 92
Gaetani L Medication omission rates after inclusion of patients' names on medication drawers 1998 185
Gaetani L See Thomas B 2005 245
Gaetani L Interdisciplinary teaching of pharmacotherapeutics to pharmacy graduates and medical students [letter] 2009 164
Gailer JL SSRIs and anticonvulsants [inform] 1996 587
Gailer JL See Abdelmessiah D 1997 250
Gailer JL Beyond BCPS 2001 227
Galbraith K Australian Clinical Pharmacy Award 2006 2006 313
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 22
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Galbraith K Future of hospital pharmacy: global consensus? [letter] 2008 332
Galbraith K See Coombes I 2012 261
Galbraith K Ancora imparo [ed] 2013 175
Galbraith K SHPA Medal of Merit 2014 2014 300
Galbraith KJ See Cosh DG 1998 334
Galbraith KJ See Dooley MJ 2000 150
Galbraith KJ See Carroll ME 2003 186
Galbraith KJ See Simpson MD 2006 119
Galbraith KJ See Coombes I 2011 17
Gallego G Impact of high-cost drugs for individual patient use 2004 100
Gallego G Access to high-cost drugs: decision makers' perspectives 2005 18
Galloway JG See Peterson GM 1996 545
Ganachari MS See Mohite SS 2006 245
Garas G See Smith BA 1996 560
Garci CS See Welch SA 2003 16
Garg A Sulfur allergies can be misleading [letter] 2013 332
Garg A See Ditty A 2014 220
Garg S Properties of a formulated paediatric phenobarbitone oral liquid 2008 28
Garrett K See To TP 1998 289
Garrett K Pharmaceutical review-hospital pharmacy manager's perspective [editorial] 2006 261
Garrett K See To TP 2008 219
Garrett K See Tran T 2012 100
Garrett K See To TP 2014 89
Garrett K See Elliott RA 2014 95
Garrett MK See To TP 2010 101
Garrett MK See Booth JC 2012 296
Garrett T See Masood N 2006 111
Garrett T Pharmacy workforce recruitment and retention: an Australian area health service perspective 2008 183
Garrett T Beliefs and attitudes that influence reporting of clinical interventions by pharmacists 2009 99
Garrett T Engaging pharmacists in adverse medication incident reporting: pilot of a streamlined reporting
application
2010 269
Garrett T Once-daily IV antibiotics 'best' for home-based cellulitis management [letter] 2012 81
Garrett T Insights into hospital pharmacy safety culture 'Down Under' [letter] 2012 332
Garrett T Does an electronic discharge referral system improve the quality of medication prescribing? 2014 29
Garrett T See Cooper JM 2014 213
Gascard DJ See Toh CT 2010 27
Gayathridevi S See Lakshmi PK 2002 24
GazarI M See Graudins LV 2002 104
Gazarian M See Graudins LV 2006 297
Gebauer M Vitamin D deficiency in aged-care facilities: prescribing support through residential medication
management reviews
2007 194
George J Opportunity to broaden clinical and research knowledge [letter] 2004 244
George J Medication regimen complexity and adherence in patients at risk of medication misadventure 2006 99
George J Smoking cessation: COPD patients' perspective 2006 107
George J Adherence to disease management interventions for COPD patients: patients' perspectives 2006 278
George J See Weeks GR 2010 187
George J See Lee CY 2011 98
George J See Weeks GR 2012 17
George LJ Hospital pharmacy — science or anti-science? [editorial] 1996 307
George LJ Impact of a surgical preadmission clinic pharmacist on the quality of medication management from
preadmission to discharge: a randomised controlled study
2011 212
Ghaeli P See Ahmadi-Abhari SA 2005 103
Ghelani D See Somasundaram R 2011 45
Ghiculescu RA Australian reports of bleeding complications associated with antithrombotic drug combinations 2008 32
Ghiculescu RA Rapidly progressive severe amiodarone-induced hypothyroidism in an elderly female 2009 140
Ghosh S Adverse drug reaction pattern in hospitalised children of South Indian teaching hospital 2006 246
Gibb SM Non-approved consensus indications for drugs [letter] 1994 280
Gibson M See Duguid M 2002 94
Gibson M See Wood PJ 2004 285
Gilbar P Inadvertent intrathecal administration of vincristine [letter] 2004 159
Gilbar P 10th international symposium on oncology pharmacy practice 2006 122
Gilbar P The end is not nigh [letter] 2006 166
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 23
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Gilbar P Retention and recruitment of oncology pharmacists 2007 115
Gilbar PJ Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix) with selected drugs
during simulated Y-site injection
1994 167
Gilbar PJ Intermittent transdermal GTN therapy: survey of prescribing and patient compliance 1995 197
Gilbar PJ Report on the fourth international symposium on oncology pharmacy practice 1995 476
Gilbar PJ Guidelines for drug administration during enteral feeding 1997 214
Gilbar PJ Ticarcillin-potassium clavulanate and vancomycin incompatibility [letter] 1997 470
Gilbar PJ Cancer chemotherapy: potential errors with external referrals 1999 100
Gilbar PJ Seventh International Symposium on Oncology Pharmacy Practice [on a different note] 2000 170
Gilbar PJ See Andrews HP 2001 183
Gilbar PJ Palmar-plantar erythrodysaesthesia associated with an initial course of bolus fluorouracil 2002 178
Gilbar PJ Oral antineoplastic chemotherapy 2005 195
Gilbar PJ External contamination of cytotoxic drug vials [editorial] 2005 264
Gilbar PJ Should the pharmaceutical industry be doing more to reduce the cost of cancer drugs? [editorial] 2011 4
Gilbert A Making medicines safer [editorial] 2006 92
Gilbert A HMRs: is the damage out of control [editorial] 2013 4
Gilbert AL See Roughead EE 1998 7
Gilbert AL See Vial RJ 2002 57
Gilbert AL See Toy AC 2006 35
Gilbert AL See Kalisch LM 2007 292
Gilbert AL See Roughead EE 2008 14
Gilbert AL What will it take for pharmacy practice to change? [editorial] 2009 4
Gilbert AL See Grzeskowiak LE 2010 46
Gilbert AL See Morris S 2010 261
Gilbert AL See Grzeskowiak LE 2010 265
Gilbert AL See Bell JS 2011 316
Gilbert AL See Kalisch LM 2013 182
Gilbert AL Time to rethink the funding model for home medicines review [ed] 2014 9
Gilbert BJ See Brown AN 2012 268
Giles ML The older traveller 1999 222
Gillett M See Corallo CE 1997 146
Gissing PM See Simpson MD 2004 26
Glass B See Haywood A 2005 181
Glass B See Haywood A 2006 25
Glass B See Haywood A 2007 131
Glass B See Bowen L 2007 178
Glass B See Mylrea M 2012 204
Glass B See Kockler J 2013 218
Glasson E See Ng C 2013 25
Glover S Exploring point-of-care testing of capillary blood in warfarin management 2008 300
Goh LH See Tan CH 2014 17
Goh SF See Ng K 1997 307
Goldsworthy SJ See Bollella G 2008 107
Golledge CL See Irawati L 2006 286
Gombert-Handoko
KB
See Boeker EB 2013 41
Goodman M Career opportunities in management in a professional society [career opportunities] 1998 440
Gordon J Unanswered health-related questions in community pharmacy: frequency nature and consequences 2011 271
Gore R Provision of pharmacy services by private practitioners [letter] 1994 281
Gore S See Rao PGM 2005 40
Gore SB See Lakshmi PK 2002 240
Gourlay SG Nicotine replacement therapy for smoking cessation — a review. Part 2 — clinical aspects 1994 200
Gowan J Handbook of nonprescription drugs 12 edition [book review] 2000 291
Gowan S Documenting passage of stools in overdose situations [letter] 1996 372
Goy R See Lim SC 2008 191
Grafanakis H See Welch SA 2003 16
Graham BM Cytotoxic drug safety cabinets 1999 291
Graham BM HEPA filter testing 2001 154
Graham BM What price safety? Changes to test methods and certification for cytotoxic cabinets. 2002 177
Graham KJ Experience of the Master of Clinical Pharmacy degree [letter] 2005 248
Graham R See Cocks HJ 2004 109
Grainger D See Day R 2007 4
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 24
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Grant G See Haywood A 2005 181
Graudins L See Blennerhassett J 2005 244
Graudins L See Maxwell DJ 2006 124
Graudins LV See McCrudden EA 1995 261
Graudins LV Cisapride review-local use after overseas withdrawal 2001 154
Graudins LV Celecoxib use and overuse-too much 'celebration'? 2002 104
Graudins LV COX-2 inhibitors: continuing use and overuse [letter] 2003 157
Graudins LV Pharmacists are an integral component of quality use of medicines 2004 201
Graudins LV Promoting safe use of paracetamol in children 2006 297
Graudins LV See Welch SA 2007 27
Graudins LV Pharmacoepidemiology-QUM vadis? 2007 127
Graudins LV Stability of omeprazole mixtures: implications for paediatric prescribing 2008 276
Graudins LV Variation in paediatric omeprazole dosing 2008 283
Graudins LV Paedpharm: paediatric pharmacy network 2009 290
Graudins LV Adverse drug reactions during hospital stay: evaluation of a model for informing patients 2012 95
Graudins LV ISQua - advancing quality and safety now and into the future [letter] 2013 80
Graudins LV WHO High 5s Project: medication reconciliation international meeting 2013 133
Graudins LV Centre Hospitalier Universitaire Grenoble [letter] 2013 164
Gray MJ See Leversha A 2001 130
Green B See Whitty JA 2001 300
Green B See Barras MA 2008 77
Green L See Blennerhassett JD 2006 175
Greene L See Alvarez SJ 2001 13
Gregory D See Linsley RF 1998 256
Gregory F Danazol effects on platelets [inform] 1995 292
Gregory LA See Clifford RM 2011 203
Grewal J Anticoagulation for non-valvular atrial fibrillation in older people 2012 228
Grey L See Flavel D 2012 121
Grice P Harle's Herbal Baby's Friend [letter] 1995 352
Grima GJ See Belz SA 2013 137
Groves CF See Gilbar PJ 1994 167
Groves CF See Andrews HP 2001 183
Grzeskowiak LE Monitoring physical health and adverse effects in children and adolescents prescribed antipsychotics 2008 9
Grzeskowiak LE Conception and beyond: using population-based record linkage to monitor long-term effects of
medications used during pregnancy
2010 46
Grzeskowiak LE Hospital pharmacy dispensing records for pharmacoepidemiology research into late gestation exposure
to antidepressants
2010 265
Grzeskowiak LE Role of the practitioner-researcher in pharmacy practice [editorial] 2012 5
Grzeskowiak LE See Whennan LD 2012 22
Grzeskowiak LE Paediatric and perinatal health abstracts at SHPA national conferences: trends in presentation and
subsequent publication
2014 22
Gu P Direct-to-consumer advertising of prescription medicines on the Internet: an Australian consumer
perspective
2011 196
Gudka S See Clifford RM 2011 203
Gudka S Future pharmacy-based chlamydia screening: consumer preference 2013 15
Guidone DM Fixed-dose statins with no lipid targets: a new paradigm of dosing? [letter] 2014 64
Guille GP See Aldama PC 2003 330
Guirguis K Prescribing by non-medical practitioners [letter] 2009 82
Gujral G See LaCaze A 2012 6
Gujral GR Myalgia in patients on high-dose and low-to-moderate dose statin therapy 2009 202
Gupta AN See Singh A 2014 60
Gupta S See Seleem M 2011 132
Gurung K See Das RN 2007 80
Guthridge JM Health promoting medications in older people 1999 273
Guymer RH See Lim L 2004 53
Haack LA See Taylor SE 2007 214
Haas SJ European Society of Cardiology Congress 2003 2004 39
Habak JE Prophylactic antibiotic use in breast cancer surgery patients 2013 101
Hachem AH See Saab YB 2004 18
Haines W A technician's role in a TPN service 1996 67
Hale A Pharmacist prescribing - taking steps towards the future [letter] 2009 163
Hale A Hospital pharmacists’ views on collaborative pharmacist prescribing [ed] 2013 256
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 25
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Hall J Introduction to health economics 1994 34
Hall T Are pharmacists allied health professionals? [letter] 2009 330
Hall T See Karaksha AA 2010 208
Hall T See Latimer SL 2011 188
Hall TD See Walker MP 2012 291
Hamblin VA See Maddocks I 1994 400
Hambridge JA Novel use of placebo tablets in the treatment of choking phobia 2001 121
Han P See Nasser S 2012 129
Hancy T Re-engineered healthcare systems — internationally and nationally 1996 18
Hanes CA Pharmacist prescribing: views of Australian hospital pharmacists 2005 178
Hardidge A See To T-P 2013 177
Harding A See O'Leary KM 2006 32
Harding AM A snapshot of admissions to an acute medical unit for the aged [practice report] 1998 359
Harding AM Adverse drug reactions as an educational tool 1999 220
Harding AM The role of an emergency department pharmacist 2001 303
Harding AM Pharmacy practice in the Marshall Islands 2003 216
Harding AM Patch identification poster and education to reduce transdermal medication errors [letter] 2010 332
Harding AM See Khan M 2011 265
Hardy JE Deprescribing in the last year of life 2011 146
Hargraves T-L Developing an outpatient heart failure pharmacy service 2008 103
Harlow MA See Winter SJ 2013 11
Harrhy KL See Coombes JA 2003 194
Harris J See Ng D 1999
Harris M See Barras M 2011 183
Harris R Further education - ever thought of a business degree? 2002 180
Harris RG See Ware GJ 1994 329
Harrison J See Zolezzi M 2014 188
Harrup RA See Wilson RK 2013 51
Harugeri A See Joseph J 2010 279
Harvey PA Management of hypertension in older people 2001 212
Harvey PA See Elliott RA 2009 216
Harvey PA Audit of medication management after discharge from hospital to residential care [letter] 2012 246
Hasan SS Factors influencing concomitant use of complementary and alternative medicines with warfarin 2010 294
Hashemi M See Behjati M 2012 77
Hassali MA Quality use of generic medicines in Malaysia [letter] 2007 334
Hassali MA Introducing the concept of disease mongering to social pharmacy students in Malaysia [letter] 2009 79
Hassali MA Medicine safety seminar for Malaysian community pharmacists [letter] 2009 245
Hassali MA Status of generic medicine use in Malaysia [letter] 2009 329
Hassali MA See Alabid AH 2010 164
Hassali MA See Elkalmi RM 2010 245
Hassali MA See Malik M 2011 73
Hassali MA Lack of medicine safety communication channels: the case of HPV vaccine in Malaysia [letter] 2011 80
Hassali MA See Shafie AA 2011 163
Hassali MA See Chin KL 2011 332
Hassali MA See Saleem F 2011 333
Hassali MA Pharmacy practice in Malaysia 2014 125
Hassali MAA See Alabid AH 2013 187
Hassan FA Potential interactions between drugs taken by ED patients of an Australian hospital 2006 266
Hattingh HL Regulation of the pharmacy profession throughout Australia 2007 174
Hattingh HL See Karaksha AA 2010 208
Hattingh HL See Tan ACW 2012 48
Hattingh LH See Walker MP 2012 291
Havill C Meeting the challenge [letter] 2005 332
Haywood A Extemporaneous isoniazid mixture: stability implications 2005 181
Haywood A Stability implications of repackaging paracetamol tablets into dose administration aids 2006 25
Haywood A Managing extemporaneous oral liquids in practice 2007 131
Haywood A See Bowen L 2007 178
Haywood A See Nissen LM 2009 129
Haywood A See Mylrea M 2012 204
Haywood A See Kockler J 2013 218
Haywood CC Management of obesity in older people 2013 145
Heath EK On-call pharmacist enquiries and outcomes: an on-call database review, 2003-2012 2014 201
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 26
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Hebbard GS Management of oesophageal disease in the elderly 2001 285
Hecker JR Pharmacological management of Alzheimer's disease 2003 24
Heddle R See Hebbard GS 2001 285
Heel AC See Coombes ID 2005 190
Heland M See To T-P 2013 177
Helboe T See Roberts GW 2013 276
Hellyar AG See Dartnell JG 1994 392
Hemmens VJ See Joseph PD 2012 213
Hemming M From hospital pharmacy to publishing [career opportunities] 1998 368
Hemming M Fred J Boyd Award 2003 2003 299
Hemming M Evidence in context [editorial] 2006 94
Hender EA See Magarey J 1996 454
Hender EA Victoria Poisons Information Centre- 25 years in the RCH’s Pharmacy Department 2001 151
Hender L Moclobemide in overdose [inform] 1996 272
Henderson A See Coombes ID 2005 190
Henschke PJ See Scott SD 1994 325
Hetherington N Studying in the US—there's more available than you think! 1999 344
Hewitt J Drug-related unplanned readmissions to hospital 1995 400
Heywood M See Baysari MT 2012 246
Heywood M See Baysari MT 2013 288
Hidalgo FJ See Aldama PC 2003 330
Hijazi R See McD Taylor D 2009 24
Hilbers J See Blennerhassett J 2011 33
Hilet AJ Pharmacy involvement with HITH programs [letter] 1998 142
Hill R Treatment of Wilson's disease in patients unresponsive or intolerant to conventional agents 1995 295
Hill SJ See Ryan RE 2011 295
Hilmer SN See Mitchell SJ 2009 122
Hilmer SN See Hardy JE 2011 146
Hilmer SN See Johnston CF 2011 275
Hilmi SC See Smith BA 1996 560
Hilmi SC See Santoro VA 2013 194
Hines L See Alvarez SJ 2001 13
Hiremath SS See Shankar PR 2009 162
Hirth KE See Dartnell JG 1994 392
Hirth KE Treatment of primary pulmonary hypertension 2002 185
Ho J See McD Taylor D 2009 24
Ho L Renal failure and acute interstitial nephritis associated with NSAIDs 2005 219
Ho L Australian and New Zealand annual scientific meeting on intensive care 2006 44
Ho L Serial point-prevalence studies to investigate hospital antimicrobial prescribing 2007 190
Ho L Preceptorship at the University of Pittsburgh Medical Center [letter] 2008 164
Ho L Liposomal amphotericin and caspofungin: salvage therapy for invasive aspergillosis in hepatic failure 2008 223
Ho L See Klemz K 2008 296
Ho L Insulin e-learning module an effective means of education delivery to hospital health professionals? 2009 34
Ho MC Influenza vaccination and the elderly 1995 36
Ho PC See Wong VK 1996 641
Ho WK Treatment of venous thromboemboliosm in older people 2010 309
Hobbs MR See Aikman KL 2013 272
Hobson LT See Sullivan JA 1994 397
Hodgkinson MR Identification of adverse drug reactions using the ICD-10 Australian modification clinical coding
surveillance
2009 19
Hodgkinson MR See George LJ 2011 212
Hoenemann D Stability of thalidomide suspension - approved use and safety considerations [letter] 2012 248
Hoffman J APEC/APRA project to develop a national competency assessment tool [letter] 1997 158
Hogue VW Community education program on oral antidiabetes medicines 2005 112
Hohaia L Exceptional patient loyalty under the new pharmacy services agreement in New Zealand [ed] 2013 259
Holford NHG See Ware GJ 1994 329
Holmes NJ See Wheeler AJ 2007 33
Hong GW See Hui HZ 2012 166
Hope D See Kockler J 2013 218
Hope ME See Stafford L 1998 246
Hopkins AM Stability study of a thalidomide suspension 2012 115
Hopper I See Graudins LV 2012 95
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 27
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Hopwood MJ Drug treatment in Alzheimer's disease 1994 190
Hopwood MJ See To TP 2000 202
Hopwood MJ Psychotropic medication use in older people 2007 153
Hort AL See Santoro VA 2013 194
Hotham NJ A visit to the Motherisk Program in Canada 2001 230
Hotham NJ Review of: drug therapy and breastfeeding. From theory to clinical practice. 2002 293
Hoti K Pharmacist prescribing in Australia [editorial] 2010 175
Hoti K See Hughes J 2012 172
Howard R Impact of a pharmaceutical care program at a mental health clinic 1996 250
Howarth H See Nicklason F 2000 175
Howarth HD See Simpson MD 2006 119
Howat C See Parke J 2003 268
Howat P See Joyce AW 2007 42
Howden BP See McD Taylor D 2009 24
Howes LG See Edwards CT 1997 133
Howitt KM Casemix funding and pharmacy [letter] 1994 282
Howitt KM Implementation of patient costing software — a pharmacy perspective 1996 315
Howitt KM Refinement of an Australian pharmacy casemix classification for the acute healthcare setting 1997 302
Howitt KM Coding of clinical pharmacy services [editorial] 1997 425
Howitt KM Management tool that allows comparison of pharmacy services 2001 181
Hsieh M Abnormal renal function and electrolyte disturbances in older people 2009 230
Hsu M See Roberts JA 2007 200
Hudson BJ A study of adverse effects following vancomycin administration 1995 257
Hughes J Hospital pharmacy-training ground of consultant pharmacists for the future [editorial] 2005 175
Hughes J See Hoti K 2010 175
Hughes J It all begins with one case [editorial] 2010 258
Hughes J Research: quantity vs quality vs impact (bronze vs silver vs gold) [editorial] 2012 172
Hughes JD See Tenni PC 1996 416
Hughes JD Clinical pharmacy - a career of opportunities [career opportunities] 1998 269
Hughes JD The worth of clinical pharmacy 1998 325
Hughes JD See Fellows L 2000 196
Hughes JD Training consultant pharmacists: the future of clinical pharmacy in hospitals 2002 7
Hughes JD Medicines in the elderly 2002 208
Hughes JD See Irawati L 2006 286
Hughes JD See Wee JS 2007 108
Hughes JD See Ramadaniati HU 2014 205
Hui HZ Evaluation of enoxaparin treatment at a Chinese tertiary referral teaching hospital [letter] 2012 166
Humagain B See Shankar PR 2009 162
Humphris MA See Dubrava S 2007 16
Hung CW A study of aminoglycoside usage in a Hong Kong hospital 1997 235
Huppatz C Testing the Surefuser: a disposable subcutaneous infusion pump [short communication] 1998 241
Hurley E Do ACE inhibitors cause gynaecomastia? [inform] 1995 292
Husband AJ See Westaway KP 2014 44
Husband AJ See Westaway K 2014 138
Hussain A See Malik M 2011 73
Hutchinson J See Patel RP 2013 112
Hutchinson KA Are E-codes the answer to identifying adverse drug reactions? 2001 98
Hynes KI See Bingham JM 1994 440
Hynes KI See Vernon GM 1995 32
Hynes KI Glaxo Medal of Merit 1995 1996 106
Hynes KI See Bingham JM 1996 287
Hynes KI Provision of hospital pharmacy services for clinical drug trials 2010 300
Iansek R Pharmacological management of Parkinson's disease 2004 229
Ibrahim MI See Palian S 2009 329
Ibrahim MI Effective pharmaceutical management and policy in developing countries [editorial] 2010 89
Ibrahim MI See Alabid AH 2010 164
Ibrahim MI See Elkalmi RM 2010 245
Ibrahim MI See Maarup N 2011 49
Ibrahim MI Clinical pharmacy education in the Middle East and Asia: are we doing it right? [editorial] 2011 176
Ibrahim MI See Leng CB 2011 250
Ibrahim MI See Abdulwahab A 2012 77
Ibrahim MIM Do community pharmacists in Qatar practice rationally for a minor ailment? [letter] 2013 79
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 28
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Ibrahim MIM See Alabid AH 2013 187
Ibrahim MIM How do community pharmacists in Qatar respond to patients presenting with symptoms of acute
respiratory tract infections? [letter]
2014 62
Ibrahim MIM See Sonallah H 2014 159
Ibrahim R Knowledge and perceptions of community patients about generic medicines 2012 283
Ibrahim T See Sonallah H 2014 159
Ientile CS Complimentary medicines use by Australian veterans 2005 110
Ilomäki J See Chan TW 2013 269
Inam S A review of strategies to improve rational prescribing in asthma 2014 195
Inderjeeth CA Management of osteoporosis in older people 2010 229
Inglis D Renal study tour [letter] 2005 79
Ioannides-Demos L See Rayner CR 1998 394
Ioannides-Demos L Survey of pharmacy services and drug usage in Victorian public hospital HITH programs 1999 16
Ioannides-Demos L See George J 2006 107
Ioannides-Demos L See George J 2006 278
Irawati L Influence of penicillin allergy on antibiotic prescribing patterns and costs 2006 286
Irving LB See Ho MC 1995 36
Izham MI ADR reporting by community pharmacists in Nepal [letter] 2008 331
Jabbour H See Armour CL 1998 410
Jackson B See Toh CT 2010 27
Jackson J Hospital use of the Pharmaceutical Benefits Scheme [letter] 2004 157
Jackson J See Dunning TL 2010 203
Jackson JK The Society of Hospital Pharmacists of Australia 22nd Federal Conference [editorial] 1995 310
Jackson JK What do hospital pharmacists want from conferences? 1995 464
Jackson JK Use of the Pharmaceutical Benefits Scheme in private hospitals: 1. Associated problems 2001 194
Jackson JK Use of the Pharmaceutical Benefits Scheme in private hospitals: 2. An alternative model 2001 262
Jackson JK Analysis of the impact of public hospital pharmaceutical reforms on discharge medication supply 2001 295
Jackson JK See O'Leary KM 2002 72
Jackson JK Public health-recognising the role of Australian pharmacists 2004 290
Jackson JK Evaluation of drug use indicators in private hospitals 2005 28
Jackson S See Bereznicki L 2005 173
Jackson SL See Bereznicki LR 2006 162
Jackson SL See Bereznicki LR 2007 300
Jalali N See Abdolkarim P 2002 297
James A See Tibballs J 1995 516
James CR Patient's own drugs and one-stop dispensing: improving continuity of care and reducing drug
expenditure
2008 44
James R Privatisation of a repatriation hospital pharmacy 1996 47
James R The Pharmaceutical benefits scheme and public hospitals 2002 175
Janczak MB Team effort produces results 2001 305
Janczak MB Practice developments for hospital technicians in the UK 2005 207
Jankewicz G See Lee S-G 2007 271
Jankewicz G See Ambados F 2008 80
Jankewicz G See Lee S-G 2009 181
Jankewicz GJ See Lee SG 2009 95
Janney EP See Stafford L 1998 246
Jansen LJ See Loe EA 2008 209
Jao K See Khan M 2011 265
Jarvis DA See Sorich MJ 2004 22
Jarvis VI See Tan ACW 2012 48
Jayasinghe C See Mellor JD 2011 42
Jayasuria PH See Angley M 2014 6
Jayasuriya P See Brien JE 2009 81
Jeffery DM See Jackson JK 2001 262
Jeffreys AJ Anaesthesia for the elderly 1994 430
Jenkins B Managing conflicts of interest [editorial] 2013 8
Jenkins BG See Santoro VA 2013 194
Jenney A Interventions of an antibiotic management team 1999 36
Jennings R See Harvey PA 2012 246
Jensen M See Kairuz T 2009 162
Jepsen DM Australian hospital pharmacists reflect on career success 2013 29
Jerums G See MacIsaac RJ 2002 188
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 29
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Jess K See Barras M 2011 183
Jestrimski KW See Leow CC 1994 250
Jestrimski KW Management challenges in large rural hospital pharmacy departments 1999 202
Jha N See Shankar PR 2009 162
Jha N See Shankar PR 2009 245
Jindal D Public perception of community pharmacists in Delhi [letter] 2005 331
Johansen C See Roberts GW 2013 276
Johns C See Patel RP 2013 112
Johns RA See Rai PGM 2005 166
Johnson DW See Ng CS 2008 280
Johnston CF 'You look like a 240 mg': gentamicin dosing at a Sydney hospital 2011 275
Johnstone JM Writing a case report [letter] 1998 68
Johnstone JM Some reflections on writing and publishing [conference presentation] 2000 66
Jones A See Lim CM 2004 11
Jones AL See Lau ET 2013 19
Jones EF Drug therapy of heart failure in the elderly 2000 274
Jones TE See Vial RJ 2002 57
Jordan M See To NN 1999
Jørgensen LE See Roberts GW 2013 276
Jose J Career satisfaction among Indian pharmacists [letter] 2005 333
Joseph J Frequency and nature of medication-related problems in elderly Indian inpatients 2010 279
Joseph PD Stability of oral cholecalciferol (vitamin D3) liquid formulations in olive oil 2012 213
Joyce A See Wibowo Y 2012 26
Joyce AW See Irawati L 2006 286
Joyce AW Community pharmacy's role in promoting healthy behaviours 2007 42
Joyce AW See Wee JS 2007 108
Jukka C See Rothwell M 2011 290
Juliana GS Emergence of adverse reactions to tramadol in children and adolescents at a paediatric hospital 2005 187
Jupe DM See Bereznicki LR 2007 300
Kaesler Sb See Eaton V 2005 56
Kaesler SB Certified Geriatric Pharmacist credential by computer-based testing [letter] 2007 81
Kainey S Hospital-based pharmacy pre-registration training and the hospital pharmacy workforce 2004 70
Kainey SH See Hender EA 2001 151
Kainey SH Pharmacist shortage 2002 175
Kairuz T See Sheridan J 2007 19
Kairuz T See Garg S 2008 28
Kairuz T Prescription interventions in community pharmacy in New Zealand [letter] 2009 162
Kairuz T See Doggrell SA 2012 208
Kairuz T See Lau ET 2013 19
Kairuz TE History of extemporaneous compounding in Australia: changes and developments in the APF 2013 117
Kaleemuddin M Role of the clinical pharmacist in poison-related admissions in a secondary care hospital 2001 26
Kalisch LM Do pharmacists adhere to brand substitution guidelines? The example of simvastatin 2007 292
Kalisch LM See Bell JS 2011 316
Kalisch LM Home medicines reviews: extent of uptake by high-risk veterans 2013 182
Kam FSF See Gilbar PJ 1997 214
Kane M Biotechnology: opportunities and skills required 1996 79
Kapoor P See Jindal D 2005 331
Karaksha AA Quality of discharge summaries sent by a regional hospital to general practitioners 2010 208
Karim S See Jindal D 2005 331
Karimpour H See Abdollahi M 2003 12
Karimzad SH See Agarwal J 2014 162
Karmakar GC See Aikman KL 2013 272
Kastango ES Compounded sterila preparations continue to harm or kill patients [editorial] 2008 173
Katelaris CH See Cheong EA 2008 267
Katsogiannis W Nebuliser versus metered dose inhaler use in hospitals 1996 529
Katz B Pharmacological management of pain in older people 2007 63
Kay O Pharmacist prescribing-lessons from abroad [editorial] 2004 259
Kay OC Pharmacist prescribing: review of the literature 2004 300
Kay OC Pharmacist prescribing activities an electronic survey on the opinions of Australian pharmacists 2006 199
Kaye AE See Drummond SH 1994 231
Kaye K Building sustainability 2006 313
Kaye KI Complementary therapies [letter] 2000 23
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 30
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Kaye KI DUE: a rose by any other name 2000 279
Kaye KI See Kelly M 2004 32
Kaye KI See Maxwell DJ 2006 124
Keefe PA See Targett PL 1997 207
Keefe PA See Targett PL 1997 338
Keefe PA See Targett PL 1997 452
Keefe PA Report on the Ninth World Congress on Pain 2000 286
Keen N CPD-current informed connected [editorial] 2007 89
Keen N Medicines management 2008: education steps out [editorial] 2008 261
Keen N Place for pharmacists in health reform [editorial] 2009 261
Keen N Clinical pharmacy and competency assessment [editorial] 2010 6
Keen N See Jenkins B 2013 8
Keen NJ See Irawati L 2006 286
Kehoe L See Weekes L 2006 91
Keith C See Rando L 2004 95
Keith C Economic evaluation - a tool to support hospital formulary assessments [letter] 2009 165
Keks N Schizophrenia 1996 93
Kelleher PW The pharmacological management of acute myocardial infarction in older people 1995 480
Kelly A-M Are titrated intravenous narcotics an infection risk? [letter] 1995 487
Kelly M Waiting for casemix 1996 130
Kelly M See McFarlane AE 1996 635
Kelly M See McFarlane AE 1997 455
Kelly M Factors influencing adverse drug reaction reporting in New South Wales teaching hospitals 2004 32
Kelly RI See Shen S 2012 150
Kelpie P See Ford D 1996 671
Kemp C The grass isn't always greener … 1999 177
Kemp SM Rurally focused BPharm course: perceptions of graduates 2010 275
Kenneally A See Lubliner M 2005 266
Kenneally AL See Van de Vreede MA 2003 290
Kennedy J See Kunac DL 2010 290
Kennedy JM See Tordoff JM 2004 267
Kennedy JM See Tordoff JM 2005 271
Kent PJ See McConachy KA 1999
Kerr S See Silva MA 2013 37
Kerridge I See Day R 2011 94
Kerridge I See Inam S 2014 195
Kethini T See Kumari R 2003 131
Kethini T Mirtazapine-associated rapid weight gain and decreased physical activity 2004 308
Kettels J ADR case reports [letter] 1997 471
Kevans P See Cocks HJ 2004 109
Khalai S See Abdollahi M 2003 12
Khalessi-Rad See Roberts GW 2012 200
Khalil H Medication reconciliation audit [letter] 2009 166
Khalil H Pharmacy practice in rural Gippsland [letter] 2009 327
Khan GM See Bedi TR 2006 164
Khan M Complementary and alternative medicines use in patients on warfarin and matched controls: a
retrospective cohort study
2011 265
Khan SA Surgical antibiotic prophylaxis in an Indian hospital [letter] 2006 163
Khan SA See Rodrigues GS 2007 78
Khan Z See To NN 1999
Khan ZI Indian hospital pharmacists: patient perspective [letter] 2005 328
Khanal S See Izham MI 2008 331
Khanal S See Maarup N 2011 49
Khar RK See Khan ZI 2005 328
Kheir N See Ibrahim MIM 2014 62
Khera K See Singh A 2014 60
Khoo A Extended roles for pharmacists in warfarin therapy: identifying opportunities for pharmacist
prescribing
2006 190
Khor XY See Shafie AA 2011 163
Khu JV Helicobacter pylori eradication regimens: is there a difference? 2010 194
Khumra S See Chen AW 2010 19
Khumra S See Chen AW 2011 37
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 31
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Kiani M Dexamethasone use in inpatient palliative care 2011 217
Kiani M See Habak JE 2013 101
Kiatying-Angulee N See Phosri J 2005 115
Killen L See Brett J 2013 97
Kilminister I See MacPherson RD 2006 302
Kilminster IM See Hudson BJ 1995 257
Kilpatrick C Management of Epilepsy in older people 2002 110
King B New pharmacy course at James Cook University [letter] 1998 302
King K See Slater W 1999 216
King MA See Sorensen L 2004 122
King MA See Hattingh HL 2007 174
Kini L See Jose J 2005 333
Kirkpatrick CM See Barras M 2011 183
Kirsa S New PBS reforms-PBS saviour but at what cost to hospitals? [editorial] 2007 93
Kirsa S See Siderov J 2009 117
Kirsa S See Siderov J 2011 181
Kirsa S See Thakerar A 2014 231
Kirsa SW See Dartnell JG 2000 251
Kirsa SW See O'Leary KM 2002 72
Kirsa SW See Rice CA 2007 303
Kirsa SW See Dunning TL 2010 203
Kirsa SW See O'Leary KM 2012 259
Kirsa SW See Coombes I 2012 261
Kirsa SW See Moloney MJ 2013 49
Kirsa SW See O'Leary KM 2013 88
Kirsa SW See Angley M 2014 6
Kishore PV See Paudel R 2006 218
Kivi NJ See Graudins LV 2008 276
Klemz K Daily IV chloride load and the acid-base and biochemical status of ICU patients 2008 296
Klusak A Haemorrhagic stroke due to rivaroxaban and use of prothrombin complex concentrate as a reversal
agent
2014 129
Knight AT See Boyce LE 2013 105
Knott JC See Leow FHP 2006 194
Knott JC See Hassan FA 2006 266
Knott JC See Wong J 2008 92
Knott JC See Chan EW 2011 135
Knott JC See Chan EW 2012 11
Knowler CB See Kumar N 2011 108
Kockler J Stability of paracetamol tablets repackaged in dose administration aids for prn use: implications for
practice
2013 218
Koda-Kimble MA The United States experience 1994 16
Koda-Kimble MA The changing face of pharmacy 1994 83
Koju R See Bedi TR 2006 164
Koller L See To NN 1999
Koller LJ See Thornton PD 1994 387
Koller LJ See Ludington JE 1995 422
Koller LJ See McFarlane AE 1996 635
Koller LJ See Ng K 1997 307
Koller LJ See D'Souza DC 2004 190
Kong D National Medicines Symposium 2002 2002 179
Kong D See Chan EW 2012 11
Kong DC 6th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology [letter] 2000 73
Kong DC See George J 2006 99
Kong DC See George J 2006 107
Kong DC See Larizza MA 2006 115
Kong DC See George J 2006 278
Kong DC See Stuchbery P 2007 102
Kong DC See Stuchbery P 2008 126
Kong DC See To TP 2008 219
Kong DC International congress on infectious diseases [letter] 2008 333
Kong DC See Chen AW 2010 19
Kong DC See Chen AW 2011 37
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 32
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Kong DC See Chan EW 2011 135
Kong DC See Pang RK 2011 192
Kong DC 22nd European Congress of Clinical Microbiology and Infectious Diseases [letter] 2012 333
Kong DCM GlaxoSmithKline Medal of Merit 2013 2013 307
Kong F Haemaccel (polygeline) reactions: anaphylaxis or anaphylactoid? [short communication] 2000 107
Kong F Unanswered questions 2000 289
Kong MS Want to learn more about clinical studies? [letter] 2005 331
Kong MS Medications in pregnancy: impact on time to lactogenesis after parturition 2008 205
Kong RE See Tan ISP 2013 279
Koning SI Antimicrobial prescribing in a rapid assessment medical unit – a multi-phase pilot study 2013 261
Konstantopoulos D Patient perspective on the use of antibiotic containing infusor bottles [letter] 2010 77
Koo J See Tordoff JM 2006 12
Koo MMM Consumer use of consumer medicine information 2005 94
Korajkic A Impact of a pharmacist intervention on ambulatory patients with heart failure: a randomised controlled
study
2011 126
Kowalski SR See Cosh DG 1996 673
Kowalski SR See Nyfort-Hansen K 2001 41
Kowalski SR See Sorich W 2008 111
Kowalski SR Plasma potassium concentration changes associated with trimethoprim used for urinary tract infections 2010 180
Kowalski SR See Widagdo IS 2011 122
Krass I See Boyle CM 1998 413
Krass I See Bajorek BV 2001 93
Krass I See Koo MM 2005 94
Krass I See Van C 2007 182
Krass I See Giam JA 2007 260
Kremer L See Young J 2006 275
Kristensen J Sumatriptan and breastfeeding [inform] 1996 460
Kristoffersen SS Use of alternative medicines on Sydney's North Shore 1997 367
Krum H See Pellizzer AM 1997 406
Krum H See Rayner CR 1998 394
Krum H See Pellizzer AM 1998 432
Krum H See Zimmet H 2006 229
Krumins D See Walton N 2010 130
Kubler P See Avent ML 2010 15
Kubler PA See Mackenzie FD 2006 185
Kulsomboon V See Phosri J 2005 115
Kuluru P See Devabhaktuni R 2013 333
Kumar JK See Parthasarathi G 2003 272
Kumar N Facilitating medication misadventure risk assessment in the emergency medical unit 2011 108
Kumari R Clinical pharmacy in a South Indian government maternity hospital 2003 131
Kunac D See Graudins LV 2009 290
Kunac DL In-line intravenous filtration in neonates: help not hindrance 1999 321
Kunac DL Initial experience with a paediatric pharmacy e-mail network 2001 139
Kunac DL Risk factors for adverse drug events and medication errors in paediatric inpatients: analysis by
admission characteristics
2010 290
Kunhikatta V See Thunga G 2013 163
Kunhikatta V See Awasthi S 2013 248
Kunst AM Northern exposure: renal pharmacy study tour [letter] 2009 246
Kupa A See Eaton VS 2000 58
Kuruvila MT See Sorich W 2008 111
Kyle G See Freeman C 2012 184
Kyriakides P See Rothwell M 2011 290
La Caze AB See Cutts C 2003 70
La Forgia SP Stability and compatibility of morphine midazolam and bupivacaine combinations for intravenous
infusion
2002 65
LaCaze A Adherence and beliefs [editorial] 2012 6
Lakos A See Clifford RM 2011 203
Lakshmi PK Development and use of an independent drug information centre in India 2002 24
Lakshmi PK Doctors' preference for the location of a drug information centre leads to a hospital-based clinical
pharmacy initiative in India
2002 240
Laksmana I See Kairuz TE 2013 117
Lalor D Durg nmae cnofsiuon or drug name confusion? [letter] 2009 246
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 33
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Lam A Octreotide use in gastric antral vascular ectasia 2013 297
Lam SS See Toh CT 2005 106
Lam SS See Turner SJ 2005 119
Lam SS See deClifford JM 2007 284
Lam SS See deClifford JM 2009 39
Lam SS See deClifford JM 2009 286
Lam SS See Pang RK 2011 192
Lam SS See deClifford JM 2012 134
Lam SSH See Lam A 2013 297
Lam V See Brett J 2013 97
Lamb B Weekend leave for rehabilitation patients and its impact on a hospital pharmacy 1995 149
Lambrianides AL See Seleem M 2011 132
Langford J See Pham L 2003 275
Langford JH See Benrimoj SI 1995 119
Langford JH See Benrimoj SI 1995 230
Larizza M ASCO - the ultimate oncology experience [letter] 2008 163
Larizza MA Factors influencing adherence to molecular therapies in haematology-oncology outpatients 2006 115
Larizza MA Individualised foreign language medication lists for non-english speaking hospital patients 2009 277
Larmour I Cultural change and drug expenditure 1995 220
Larmour I Performance indicators in hospital pharmacy practice 1996 89
Larmour I Spend more on pharmacists to spend less on drugs [letter] 1997 335
Larmour I Hospital pharmacists and the challenge of quality 1998 226
Larmour I See Harding AM 1999
Larmour I See Alvarez S J 2001 13
Larmour I Pharmaceutical reform - a long and winding road 2002 255
Larmour I Introduction of PBS reforms at three Victorian public health services 2003 204
Larmour I See Hodgkinson MR 2009 19
Larmour I Marketing pharmaceuticals: are the benefits real? [editorial] 2011 172
Larmour I See George LJ 2011 212
Latimer SL Non-therapeutic medication omissions: incidence and predictors at an Australian hospital 2011 188
Lau D Chemical stability of voriconazole 1% eye drops 2008 179
Lau ET Compounding practices in Queensland: experiences and perceptions of pharmacists and pharmacy
students
2013 19
Lau NR IV incompatibility - dicloxacillin and magnesium [letter] 2008 162
Lau P Recruitment of oncology patients for an adverse drug reaction study [letter] 2000 175
Lauchlan RL What does the future hold? 1995 41
Lauchlan RL First leg of a journey — the national pharmacy casemix study 1995 342
Lauchlan RL Past — present — future of casemix and pharmacy 1996 125
Lauchlan RL See Howitt KM 1997 302
Lauchlan RL See Stowasser DA 1997 362
Lauchlan RL See Bramley-Moore SR 1998 83
Lauchlan RL Private Health Insurance [career opportunities] 1998 268
Law KK See Hung CW 1997 235
Lawler C Omitted medication doses: frequency and severity 2004 174
Lawrence RI Port Arthur tragedy [letter] 1996 370
Le Blanc L See Frost E 2007 172
Le Blanc T See Westaway KP 2014 44
Le Blanc T See Westaway K 2014 138
Le Couteur DG Evidence ethics and medication management in older people 2010 148
Leach H National Inpatient Medication Chart implementation [editorial] 2006 6
Leach H See Dunning TL 2010 203
Leach HJ Developing the continuum of care in the emergency department [letter] 2004 71
Leach HJ See Maslanka E 2004 131
Leach HJ Optimising the medication management continuum in a private hospital 2004 203
Leach HJ Science and medicine-connecting with society [letter] 2004 330
Leach HJ Herbs and natural supplements: an evidence based guide [book review] 2005 81
Leach MJ Medicine use among older Australians before and after hip fracture 2013 265
Leaver AS Anaesthesia in older people 1999 330
LeBlanc T See Bell JS 2011 316
Lee AH See Wee JS 2007 108
Lee CY Exploring medication risk among older residents in supported residential services: a cross-sectional
study
2011 98
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 34
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Lee DC See Rollins BM 2013 198
Lee E See Daftary MN 2003 265
Lee E See Hogue VW 2005 112
Lee FTH Advances in diabetes therapy in the elderly 2009 63
Lee K See Bajorek BV 2009 13
Lee NW See Lee SG 2009 95
Lee R See Cook GK 2007 204
Lee SG Assessing flucloxacillin contamination and decontamination - a laboratory study 2009 95
Lee S-G Surface contamination from cytotoxic chemotherapy following preparation and administration 2007 271
Lee S-G See Ambados F 2008 80
Lee S-G Paclitaxel exposure and its effective decontamination 2009 181
Lee S-G See Ambados F 2012 111
Lee T See Sanburg AL 1996 351
Lee YF Restricted antimicrobial use at transitions of care at an Australian hospital 2011 283
Lee YP See Ramadaniati HU 2014 205
Leelvathy DA See Palaian S 2006 77
Lees J International symposium on supportive care in cancer 2001 236
Lees J Amgen international pharmacy preceptorship [letter] 2005 244
Leggett C See Ditty A 2014 220
Lehnbohm EC See Baysari MT 2013 288
Lehnbom EC Impact of a new insulin chart on hospitalised patients with diabetes 2009 45
Lehnbom EC Management of medicines in chronic illness: views of community pharmacists in NSW 2009 207
Lemanski L See Ientile CS 2005 110
Leng CB Medicines spending trends in a Malaysian public hospital [letter] 2011 250
Leong CK See James CR 2008 44
Leong T See Van De Vreede M 2007 197
Leow CC Review of use of newer antidepressants 1994 250
Leow FH Risk and severity of akathisia following administration of metoclopramide in the ED 2006 194
Leow FH See Hassan FA 2006 266
Leslie B See Ryan RE 2011 295
Leung BK See Toh CT 2005 106
Leung BK See Turner SJ 2005 119
Leung BK See deClifford JM 2007 284
Leung BK See deClifford JM 2009 39
Leung BK See deClifford JM 2009 286
Leung BK See Pang RK 2011 192
Leung BK See deClifford JM 2012 134
Leung L See Lau D 2008 179
Leversha A Rural health education 1999 117
Leversha A Rural initiatives 1999 291
Leversha A Empowering our valuable asset: the pharmacy assistant/technician 1999 347
Leversha A Canadian Society of Hospital Pharmacists annual general meeting and educational sessions 2001 56
Leversha A Ward pharmacy technicians assist clinical pharmacists with admissions 2001 130
Leversha A See Simpson MD 2006 119
Leversha A See Khalil H 2009 166
Leversha A Time to increase mentoring in our profession [editorial] 2010 4
Leversha A Rural members meet at the 2009 SHPA federal conference [letter] 2010 164
Leversha A See Dunning TL 2010 203
Levy R See Lee YF 2011 283
Levy R See Costello N 2013 79
Li G Herbs & natural supplements: an evidence-based guide 2010 250
Li RC See Hung CW 1997 235
Lie HK Early experience with the use of celecoxib in a child and adolescent population 2002 27
Lie K Low adherence to vancomycin guidelines at an Australian paediatric hospital 2011 278
Lie-A-Huen L See Boeker EB 2013 41
Liew D See Chan EW 2012 11
Lightfoot TC Drug management in the palliative care of older people [geriatric therapeutics] 1998 45
Lilley B Australian paediatric pharmacy reference group [letter] 1998 289
Lilley BJ See Angalakuditi M 2005 21
Lim AK See Ho L 2005 219
Lim CB Pharmacokinetics of nasal fentanyl 2003 59
Lim CM Stability of insulin aspart in normal saline infusion 2004 11
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 35
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Lim JW A two-year review of risperidone usage on an acute-care adult psychiatric unit 1997 33
Lim L Treatment and prevention of age-related macular degeneration 2004 53
Lim L See Lockrey G 2011 58
Lim LL See Khu JV 2010 194
Lim SC Pharmacokinetics and bioavailability of hydromorphone nasal spray 2008 191
Lim W See Riley RH 1999
Lim WK Improving medication outcomes in older people 1999 103
Lin FP See Polasek TM 2011 77
Ling JW See Cook GK 2007 204
Linsley RF Performance indicators [letter] 1996 373
Linsley RF Whatever you do don't mention the 'Q' word - perspective on quality in pharmacy and health care 1997 244
Linsley RF Strategies to attract locum pharmacists to hospital practice [practice report] 1998 256
Lipman J See Roberts JA 2009 198
Lipman J See Roberts JA 2009 219
Lipworth W See Day R 2011 94
Lipworth W See Inam S 2014 195
Little PJ See Guidone DM 2014 64
Liu Y See Lim SCB 2008 191
Lloyd A PSA Pharmaceutical Care Project 1996 34
Lo C Electronic medication management systems' influence on hospital pharmacists' work patterns 2010 106
Lo SK See Stuchbery P 2007 102
Lo SK See Stuchbery P 2008 126
Lockrey G Peptic ulcer disease in older people 2011 58
Lockrey GJ Management of peptic ulcer disease in older people 1999 40
Loe EA Inter-regional collaboration for errors and near misses with unfractionated heparin 2008 209
Longworth J 23rd Congress of Collegium Internationale Neuropsychopharmacologicum 2003 48
Longworth JA Child Psychiatry and Drugs 2001 234
Looke DF See Radford JM 1997 140
Looke DF See Radford JM 1998 400
Looke DF See Radford JM 1999
Looke DF See Mackenzie FD 2006 210
Looke DF See Patterson TH 2011 221
Lord JA See Graudins LV 2012 95
Loring S See Patel RP 2013 112
Lourens H See Ho MC 1995 36
Lourens H Introducing ward rounds with visiting medical officers 1999 122
Lovgren S Timeliness and clinical impact of hospital-initiated medication reviews 2009 269
Low J This is your journal calling...[editorial] 1994 7
Low J Standardised documentation of clinical services — the next step? [editorial] 1994 149
Low J Justification of clinical pharmacy services—a new twist? Keep those cards and letters rolling in ...
[editorial]
1994 305
Low J Performance indicators — another challenge? [editorial] 1994 385
Low J If I were a rich man could I buy a pancreas? [editorial] 1995 9
Low J Journal changes [editorial] 1995 10
Low J Pharmacy care [editorial] 1995 117
Low J DUE — dollars or quality? [editorial] 1995 309
Low J Quality use of medicines [editorial] 1995 397
Low J Pharmacy practice — the challenge of new models 1995 501
Low J Conference 1995 [editorial] 1996 5
Low J Pharmaceutical care — an overview 1996 32
Low J Performance indicators— again! [editorial] 1996 209
Low J `...and there's more...' [editorial] 1996 305
Low J Antibiotic resistance: is the horse bolting? [editorial] 1996 521
Low J Technicians and hospital pharmacy [editorial] 1996 621
Low J On a different note [editorial] 1997 5
Low J Electronic publishing [editorial] 1997 107
Low J Drug information - the ongoing challenge [editorial] 1997 286
Low J Adverse drug reactions - where are the case reports? [editorial] 1997 287
Low J Readership survey report 1997 1997 348
Low J Seamless care anyone? [editorial] 1997 356
Low J Research and its sequelae [editorial] 1997 424
Low J Information and privacy [editorial] 1998 2
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 36
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Low J Whither pharmaceutical care? [editorial] 1998 79
Low J PBS APAC & hospital pharmacy [editorial] 1998 153
Low J Career opportunities and hospital pharmacy [editorial] 1998 224
Low J Pharmacy practice in rural and remote areas [editorial] 1998 301
Low J Competency and mutual recognition [editorial] 1998 392
Low J Performance indicators: Queensland public hospitals' data-set 1998 405
Low J Brave new world or future shock? 1999 2
Low J Practice standards 1999 81
Low J Journal changes 1999 82
Low J Standardisation 1999 135
Low J The DATIS solution—no fallacy 1999 195
Low J Two months in another town 1999 253
Low J Complementary therapies 1999 309
Low J Ethical challenges [editorial] 2000 40
Low J A (not very) brave new world? [editorial] 2000 139
Low J Matters professional and matters industrial 2001 5
Low J A few small steps 2001 90
Low J Hospitals and the PBS revisited 2001 179
Low J Journal of Pharmacy Practice and Research 2001 255
Low J The Journal and other matters 2001 258
Low J Health care - going going? 2002 3
Low J Trans-Tasman regulation of therapeutic products 2002 257
Low J Glimpses of the future 2003 91
Low J Glimpses of the future [editorial] 2003 91
Low J Workforce-the critical issue [editorial] 2003 172
Low J The free trade agreement-an unhealthy prescription? [editorial] 2003 256
Low J Where to now? [editorial] 2004 5
Low J The clinical pharmacy intervention study-what now? [editorial] 2004 89
Low J Pharmacist oversupply - myth or mission? [editorial] 2010 262
Low J Credentialing of advanced pharmacy practice [ed] 2014 11
Lowe A See Kilpatrick C 2002 110
Lowe DB See Ryan RE 2011 295
Lowenthal RM Idarubicin: a new effective drug for treatment of adult acute myeloid leukaemia 1994 159
Loy LM See Patterson TH 2011 221
Lu CY Health outcomes conferences [letter] 2006 76
Lu CY See Day R 2007 4
Lu CY Pharmacogenomics and pharmacovigilance for better patient outcomes [letter] 2009 328
Lu PL See Dooley MJ 2002 141
Lubliner M See Van de Vreede MA 2003 290
Lubliner M Minimising medication mishap: introducing a warfarin safety strategy 2005 266
Lubliner M Preventing potassium problems permanently: eliminating concentrated KCl errors 2006 181
Lucas A See McLachlan GB 2006 81
Lucas C Job exchange between AIDS unit pharmacists 1994 426
Luddington J See Ng C 2013 25
Ludington JE Octreotide associated with raised serum zinc concentrations — a case report 1995 422
Ludington JE See Abdelmessiah D 1997 250
Ludington JE Certification in geriatric pharmacy exam 2002 15
Ludington JE See Lehnbom EC 2009 45
Luetsch K Pharmacists for the future [letter] 2012 249
Luinstra MM Clopidogrel prescribing and concordance with the Pharmaceutical Benefits Scheme in hospital patients 2009 265
Lum E See Barras M 2004 157
Lum E Medication reconciliation - the Queensland Health experience [editorial] 2007 7
Lum E See McLeod SE 2008 196
Lum E See Rothwell M 2011 290
Lum EP Clinical Pharmacy in 2020: an alternative future for clinical pharmacy in a rural setting 2001 46
Lumby J Why has the nurse practitioner been granted prescribing privileges? [editorial] 2010 259
Luu C Management of risperidone-induced galactorrhoea [inform] 1995 548
Lyall H Hospital pharmacy technician training in Australia 1996 71
Lynch M Community pharmacy: strategic change management [book review] 2007 334
Maarup N Possible metformin-induced otorrhoea: a rare case 2011 49
Maarup N See Ibrahim MIM 2014 62
MacAulay K PSA and pharmaceutical care [letter] 1997 412
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 37
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
MacBean CE See Wong J 2008 92
Macdonald JJ See Hambridge JA 2001 121
MacFarlane LM See Korajkic A 2011 126
Macintyre PE See Sorich MJ 2004 22
MacIsaac R See Ho L 2009 34
MacIsaac RJ Treatment of dyslipidaemia in the elderly 2002 188
Mackenzie FD Improving concordance between use of proton pump inhibitors and prescribing guidelines 2002 31
Mackenzie FD Pulmonary and hepatic toxicity due to nitrofurantoin 2004 134
Mackenzie FD Experience with drotrecogin in two Australian hospitals 2006 185
Mackenzie FD Audit of ticarcillan/clavulanate usage in a large teaching hospital 2006 210
Mackey PF See Jackson JK 2005 28
Mackie K International symposium on HIV and emerging infectious diseases [letter] 2008 249
Mackie K International workshop on adverse drug reactions and co-morbidities in HIV [letter] 2010 78
MacKinnon NJ Could 7 million Australians and Canadians be wrong? A status report on medication-use safety in
Australia and Canada [editorial]
2008 6
MacKinnon NJ Achieving hospital pharmacy's dream in Canada [editorial] 2010 174
MacKinnon NJ Pharmacists and rural health: the next frontier? [editorial] 2012 89
Mackson J See Weekes LM 1999
Mackson JM See Tulk RL 1996 392
Maclean H Management of ocular problems in older people 1997 239
MacLellan DG See Fergusson JAE 1997 461
MacLeod D See McD Taylor D 2006 96
MacMillan KB See Tan ISP 2013 279
MacPherson R Extemporaneous dispensing 1999 347
MacPherson R See Pappas A 2002 310
MacPherson R Keto-fusion [letter] 2005 79
MacPherson RD Neonatal epilepsy associated with maternal ingestion of blue cohosh 2006 302
MacPherson RD Strategy to eliminate pethidine use in hospitals [editorial] 2008 88
MacPherson RD See Cao BY 2011 102
Madaki S See Parthasarathi G 2003 272
Maddern D Commercialisation corporatisation privatisation. Setting the scene 1996 45
Maddocks I Evaluation of a spring-driven syringe infusion pump in palliative care 1994 400
Maddocks I See Huppatz C 1998 241
Magarey J Inadvertent administration of ergometrine to newborns [letter] 1996 454
Mahannop P See Thawornchaisit P 2012 189
Mahesh PA See Parthasarathi G 2004 245
Mahler SM Application of emerging technologies in genomics and proteomics to drug development 2003 7
Mak VSL See Hassali MA 2014 125
Malik M Strategic solution to malaria eradication in Pakistan [letter] 2011 73
Malipatil V Management of older people with chronic obstructive pulmonary disease 2009 302
Manallack DT See Northfield SE 2007 98
Manan MM Assessing the pharmaceutical care issues of antiepileptic drug therapy in hospitalised epileptic patients 2014 83
Mangan M See Haywood A 2005 181
Mangan M See Haywood A 2006 25
Mangan M See Bowen L 2007 178
Mangoni AA See To TH 2007 30
Mann T Eutectic mixture of local anaesthetics vs nitrous oxide for cannulation of children in the emergency
department
2007 281
Manning AR See Toh CT 2010 27
Manning R Quality use of medicine in the Northern Territory 1999 347
Mannix L Heart lung transplantation symposium [letter] 2005 248
Manser AJ Computerised physician order entry: strategic issues for Australian hospital pharmacists 1996 664
Manser AJ See Larmour I 1998 226
March G See Yu K 2007 22
March G See Nguyen A 2007 111
March G See Owen SM 2008 121
Marmor GO Medication prescribing surveillance and safety in Australasian emergency departments 2011 113
Marotti SB Pharmacist prescribing in the pre-operative setting [letter] 2009 331
Marotti SB To study or not to study that is the question? [letter] 2010 77
Marriot JL See Weeks GR 2008 271
Marriott J Handbook of pharmacy healthcare [book review] 2003 41
Marriott J See Darzins P 2008 64
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 38
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Marriott J See Weeks GR 2010 187
Marriott JL See Vuong T 2006 16
Marriott JL See George J 2006 99
Marriott JL See Simpson MD 2006 119
Marriott JL Pharmacist's role in the hospital discharge process 2008 114
Marriott JL Investigating the hospital discharge medication process 2008 117
Marriott JL See Elliott RA 2010 36
Marsden KA See Bereznicki LR 2007 300
Marshall L See Taylor KL KL 2007 287
Martin ED Managing with casemix in South Australia 1996 129
Martin ED See Howitt KM 1997 302
Martin ED Evaluation of an automated drug distribution system in an Australian teaching hospital. Part 1
Implementation
2000 94
Martin ED Evaluation of an automated drug distribution system in an Australian teaching hospital. Part 2
outcomes
2000 141
Martin J See Brien JE 2009 81
Martin J See Ghiculescu RA 2009 140
Martin J See Avent ML 2010 15
Martin RC See James CR 2008 44
Martin S Medication adherence in solid organ transplant recipients and the impact of clinical pharmacy services
[editorial]
2009 257
Martinac G Dopamine-induced gangrene [inform] 1998 250
Marty S Australian national registration and accreditation scheme [editorial] 2010 10
Maslanka E Expanding the role of a pharmacy technician in a private hospital 2004 131
Masood N Pre-emptive discharge prescription processing system 2006 111
Matthews AJ Geranium leaves for cracked nipples 1995 538
Matthews H Pharmacy's role in the St Vincent's Hospital patient care model 1996 28
Matthews JJ Drug use evaluation of ipratropium at two tertiary referral hospitals 2001 279
Matthews ST See Mitchell SJ 2009 122
Matthews ST See Johnston CF 2011 275
Matthews Z Formulation of an oral vitamin K3 powder for prevention of haemorrhagic disease of the newborn 1994 406
Matthews Z See Wykes C 1995 489
Matthews Z Vancomycin continuous infusion: a cohort of 23 intensive care unit patients 2001 108
Maunsell TA See McFarlane AE 1996 635
Maunsell TA See McFarlane AE 1997 455
Maxwell D Improving and learning from practice 2007 38
Maxwell DJ See Boyle CM 1998 413
Maxwell DJ Infliximab in Behcet's disease 2002 209
Maxwell DJ Observations of pharmacy practice in HIV treatment centres in the United Kingdom 2003 282
Maxwell DJ See Sabet P 2004 36
Maxwell DJ International AIDS conference 2004 46
Maxwell DJ See Samios PA 2004 188
Maxwell DJ Community-acquired pneumonia 2004 212
Maxwell DJ Improving quality improvement models 2006 124
Maxwell P Synthetic cannabinomimetics and ‘legal highs’ [brief report] 2014 238
May F Whither 'rational' use of drugs? [editorial] 2008 89
May F W Pharmacy services to meet the needs of future health care 1999 31
May FW See Cosh DG 1996 673
May FW Pharmaceutical care: a bane or a benefit in defining hospital pharmacy practice? 1998 34
May FW See Nyfort-Hansen K 1998 343
May FW Pharmacoepidemiology - a discipline for hospital pharmacists? [editorial] 2010 256
Maycock B See Joyce AW 2007 42
Maylor Z See Choo CS 2006 246
McAllan Z See Gilbar P 1997 470
McAllister J See Costello N 2013 79
McArthur C Prophylaxis for Pneumocystis carinii pneumonia [Inform] 1995 46
McCauley L See Lie K 2011 278
McClure A See Cosh DG 1996 673
McClure AF The Board of Pharmaceutical Specialties Experience 2000 2001 223
McClure AF See Hebbard GS 2001 285
McColl GJ See Osborne RH 2002 276
McColl GJ Treatment of rheumatoid arthritis in the elderly 2005 151
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 39
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
McConachy KA Surgical antibiotic prophylaxis in a private hospital: compliance with guidelines 1999 5
McConachy KA Monitoring thyroxine dosage with serum concentrations of thyroid stimulating hormone 1999 142
McCormack C See Garrett T 2014 29
McCormick CP See Murnane JM 2013 109
McCrory PR Nutritional management in older people 1996 278
McCrudden E See Stewart P 2000 72
McCrudden EA Review of pharmacist-conducted medication histories at three teaching hospitals 1995 261
McCrudden EA Opportunities in coordinated care 1997 458
McD Taylor D Therapeutic errors reported to the Victorian Poisons Information Centre 2006 96
McD Taylor D See Leow FH 2006 194
McD Taylor D See Hassan FA 2006 266
McD Taylor D See Mann T 2007 281
McD Taylor D See Wong J 2008 92
McD Taylor D Effect of nebulised acetylcysteine on sputum quality and diagnostic yield 2009 24
McD Taylor D See Chan EW 2011 135
McD Taylor D See Chan EW 2012 11
McDonald A Pharmacological thromboprophylaxis 1994 285
McDonald C Liquid formulations [letter] 1995 174
McDonald C See Amadio M 1996 371
McDonald C See Smith BA 1996 560
McDonald C Black: James or Joseph? [letter] 1996 673
McDonald CF Management of chronic airflow obstruction in the elderly 1994 344
McDonald CF See Malipatil V 2009 302
McDonald MI See McConachy KA 1999
McDonald PK Evaluation of academic detailing within a coordinated care trial 2003 114
McDougall DAJ Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy 2014 26
McDowell J Formulation in pharmacy practice. 2nd edition. eMixt 2001 319
McEwen J See Boyd IW 2008 23
McFarlane AE Pharmacy technician training program — a review of the first 60 enrolments 1996 635
McFarlane AE Evaluation of a pharmacy technician training program - early trends 1997 455
McGain F See Tan ISP 2013 279
McGavock H The quality of drug use movement: a global perspective [conference presentation] 1998 24
McGovern TL See Behan KP 2010 222
McGovern TL See Walker MP 2012 291
McGrath A See Taylor SE 2007 214
McGrath A See To TP 2014 89
McGregor S Pfizer Pharmacy Grant 2013: American Society of Hematology Annual Meeting and the San Antonio
Breast Cancer Symposium [grant report]
2014 293
McGuiness JV See Dooley MJ 2011 208
McGuire TM Reproducing published practice research in your hospital — it's open wide! 1994 77
McGuire TM A hitchhiker's guide to establishing a drug utilisation evaluation program 1995 315
McGuire TM A pharmaceutical care liaison model 1996 36
McGuire TM See Sanburg AL 1996 351
McGuire TM Conjoint appointments - a Queensland perspective [editorial] 1997 7
McGuire TM See Stowasser DA 1997 362
McGuire TM Medication liaison: an emerging philosophy 1997 403
McGuire TM Highlights from the1998 National Medicines Week phone-in 1999 55
McGuire TM See Coombes JA 2003 194
McKauge L See Stupans I 2011 118
McKauge LM See Owen SM 2010 97
McKellar A See Couch G 2007 210
McKellar AC Does antibiotic choice affect length of stay for community-acquired pneumonia? 2005 25
McKinnon R See Chui SY 2007 124
McKinnon RA Cytochrome P450 1. Multiplicity and function 2000 54
McKinnon RA Cytochrome P450 2. Pharmacogenetics 2000 102
McKinnon RA Cytochrome P450 3. Clinically significant drug interactions 2000 146
McKinnon RA The emergence of pharmacogenomics 2003 133
McKinnon RA See Toy AC 2006 35
McKinnon RA Cytochrome P450 part 1: multiplicity and function 2008 55
McKinnon RA Cytochrome P450 part 2: genetics of inter-individual variability 2008 226
McKinnon RA See Ward MB 2009 55
McKinnon RA See Ibrahim R 2012 283
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 40
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
McKnight DL A multidisciplinary review of the prescription and administration of medications 1994 260
McKnight DL Topical agents used in the repair of minor dermal lacerations in a paediatric ED 1995 356
McKnight DL Preliminary formulation and stability of a spironolactone oral solution for paediatric use 1997 390
McLachlan A J Media and medical research miracles: sorting the spin [ed] 2013 258
McLachlan AJ See Pearce GA 2004 195
McLachlan AJ See Mukhtar S 2004 276
McLachlan AJ See Giam JA 2007 260
McLachlan AJ See Su EY 2008 292
McLachlan AJ See Le Couteur DG 2010 148
McLachlan AJ See Dolton MJ 2012 33
McLachlan G Medication safety is all fun and games [letter] 2008 81
McLachlan GB Experiencing pharmacy practice in rural Tanzania 2005 205
McLachlan GB Bedside medication lockers: help or hindrance? [letter] 2006 81
McLachlan GB Grow clinical pharmacists on supervised pre-registrant wards 2008 47
McLauchlan R See Gilbar P 2007 115
McLauchlan R American society of clinical oncology meeting 2007 134
McLauchlan R See Siderov J 2009 117
McLauchlan R See Siderov J 2011 181
McLennan DN ICD-10-AM activity codes: an opportunity for standardisation 1999 261
McLennan DN National survey of clinical activity documentation practices 2000 6
McLennan DN See Dooley MJ 2000 150
McLeod S See Lum E 2007 7
McLeod SE Value of medication reconciliation in reducing medication errors on admission to hospital 2008 196
McMahon K See Parshuram CM 1998 290
McManus A See Joyce AW 2007 42
McMullan B See Brett J 2013 97
McNally KM Ward stock and unit-supply drug distribution: influence on nursing time pharmacy time and
medication errors
1997 22
McNamara KP Acceptability of videoconference technology for the delivery of CE of rural pharmacists 2006 187
McNeece J The Drug and Therapeutics Information Service 1994 28
McNeece J Flucloxacillin and hepatic injury [inform] 1996 459
McQuillan A See Peng YG 2004 14
McRae A See Van de Vreede M 2008 263
McRobbie D See Coombes JA 2003 194
McWhinney BC See McDougall DAJ 2014 26
Meagher D See Jenney A 1999
Medos Z See Tucci J 2009 223
Mees A See Lie K 2011 278
Meguid SE See Boyle CM 1998 413
Mellor JD Drug interactions between antiepileptics and chemotherapeutic drugs: value of a pre-treatment
pharmaceutical review
2011 42
Mellor JD Complementary and alternative medicines use by cancer patients and the role of the drug information
pharmacist
2012 181
Melocco T See Brien JE 2003 158
Melocco T See Gallego G 2004 100
Melocco T See Gallego G 2005 18
Melocco T See Baysari MT 2012 246
Melocco T See Baysari MT 2013 288
Melvani S See Ho L 2007 190
Merridew CG See Targett PL 1997 207
Merridew CG See Targett PL 1997 338
Merridew CG See Targett PL 1997 452
Merry H See Tsui M 2008 40
Messini AJ See Baker SJ 1995 47
Mewes B Australian pharmacy law and practice [book review] 2010 82
Meyer E See McCrudden EA 1995 261
Meyer M See Rous J 2000 290
Meyer MP Recombinant erythropoietin for anaemia of prematurity-when should treatment start? 2007 217
Michael W See Radford JM 1998 400
Michels AM See Stott SA 1995 417
Mihaila B Chiral stability study of oral liquid clopidogrel formulations for infants 2012 103
Milder T See Brett J 2013 97
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 41
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Milleer H See Stacey SR 2013 45
Miller J See Slater W 1999 216
Milne DJ Phenytoin infusion revisited: stability and administration 2004 272
Milne R See Mihaila B 2012 103
Milne RW See Milne DJ 2004 272
Milton AG See Ratnaike RN 2000 165
Milton AG See Ratnaike RN 2000 210
Milton AG See Ratnaike RN 2000 230
Ming LC See Manan MM 2014 83
Mirkov A Clinical pathway for monthly pulse intravenous cyclophosphamide therapy for lupus nephritis 2012 278
Mirkov SR Design and pilot of a medication review clinic in a dialysis centre 2003 199
Misaghian J See Gudka S 2013 15
Misan GM SHPA Public Hospital Drug Utilisation Data Collection Feasibility Study 1996 59
Misan GM Hospital pharmacy—an end in itself or just a beginning? 1999 342
Mishra P Vomiting due to inhaled ipratropium bromide [letter] 2005 165
Mishra P Drug and therapeutics committee in Nepal 2006 81
Mishra P See Paudel R 2006 218
Mishra P See Izham MI 2008 331
Mitchell B See Van C 2007 182
Mitchell C See McLeod SE 2008 196
Mitchell C See Rothwell M 2011 290
Mitchell CA See Coombes ID 2005 190
Mitchell E See Khan M 2011 265
Mitchell PL See Siderov J 1998 124
Mitchell PL See Siderov J 2000 229
Mitchell SJ Compliance with paracetamol prescribing policies at a Sydney hospital 2009 122
Mitchell SJ See Johnston CF 2011 275
Mitchinson GH Documentation methods for pharmaceutical care activities 1996 215
Mock P Contemporary therapies for depression in older people 2010 58
Mohite SS Outcome of parent education and counselling [letter] 2006 245
Moles R Learning from international pharmacy colleagues: report of two conferences in Lisbon [letter] 2010 331
Moles RJ New South Wales private hospitals and their pharmacy services 2007 119
Moles RJ Young pharmacists as mentors to pharmacy students: partnerships for the future of the profession 2007 265
Moloney M See Thakerar A 2014 231
Moloney MJ Cetuximab extravasation 2013 49
Molyneux M See van Beurden E 2003 51
Monheit B Drug use in Australia 2nd edition [book review] 2004 332
Monk D Response to 'Who can read consumer product information?' [letter] 1997 250
Monk PM The accuracy of a paediatric dosing device 1997 323
Monteiro VE See Roberts GW 2009 50
Moore AM See Pascuet E 2010 92
Moran JA Delirium in the hospitalised elderly 2001 35
Moran JA Pharmacological management of BPH and prostate cancer in older men 2001 115
Morgan SM See Bereznicki LR 2007 300
Morran JL See Borgstedt J 2009 186
Morris B Patient care in not a ‘tick-box’ exercise [ed] 2014 80
Morris C See Thawornchaisit P 2012 189
Morris PL See Hopwood MJ 1994 190
Morris S Clinical pharmacists in primary care - reform and opportunity? [editorial] 2010 261
Morrison JL See Grzeskowiak LE 2010 46
Morrison JL See Grzeskowiak LE 2010 265
Morrissey H See Flavel D 2012 121
Morrissey H See Ball PA 2013 202
Morrow MK Pharmacists in the ED: workforce survey update [letter] 2012 333
Moses G Complementary and alternative medicine use in the elderly 2005 63
Mottram MC Effect of therapeutic guidelines on surgical antibiotic prophylaxis 1997 290
Mouchaileh N See Elliott RA 2014 95
Moulds R Guidelines and essential drug lists: of horses and carts [editorial] 2010 172
Moulds RF See Dartnell JG 1994 333
Moulds RF See Dartnell JG 1994 392
Moulds RF See Brown GJ 1999
Mount P See To TP 2012 118
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 42
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Moustakos DM See Katsogiannis W 1996 529
Muir PR Burnout among Australian hospital pharmacists 2007 187
Mukhtar S Dissolution of extemporaneous paracetamol capsules 2004 276
Mullan J See Nasser S 2012 129
Mullan J See El-mani SF 2014 113
Mullan JR Community liaison pharmacy: working with the Illawarra division of general practice and the Illawarra
area health service in 1998
1999 217
Mullan JR RAIN SMOG FOG and printed education material 2003 284
Munn CF See Joseph PD 2012 213
Munzner EE Measuring and describing dose omissions using an electronic medication management system 2012 264
Munzner EE See Welch SA 2013 162
Murdoch V See Nasser S 2012 129
Murnane JM Safe prescribing and preparation of continuous subcutaneous infusions in a regional palliative care unit 2013 109
Murnion BP See Mitchell SJ 2009 122
Murphy CE Probable case of ibuprofen-induced neutropenia 2013 135
Murphy CM See Adu A 1995 336
Muscillo N See Lum E 2007 7
Mutavdzic A Hospital pharmacists and behavioural change theory: who why and how? 2010 43
Mutiara R Handbook of pharmacy healthcare [book review] 2003 220
Mutiara R Vancomycin-digging bigger troughs? 2003 293
Myers SP See Drew A 2000 71
Myftiu J See Garg S 2008 28
Myhill KJ In their hour of need – addressing issues of psyche and soma at end of life [ed] 2014 75
Mylrea M Stability of dispersible aspirin tablets repacked into Dosette boxes 2012 204
Naganathan V See Su EY 2008 292
Nagavi BG Drug interactions in prescriptions from selected Indian community pharmacies [letter] 2005 332
Nahata M See Baker S 1998 348
Nair K See Nasser S 2012 129
Nair NM See Palaian S 2006 77
Nair NM See Ghosh S 2006 246
Nair NP A review of the clinical pharmacy services in Kasturba Hospital, India 2003 78
Nair NP See Palaian S 2006 77
Nair S See Thunga G 2013 163
Nashed R See Tucci J 2009 223
Nasser S Documentation of warfarin education provided to hospital patients: a clinical audit 2012 129
Nation R See Baker S 1998 348
Nation R How is the research score card for hospital pharmacy [editorial] 2006 89
Nation RL Pharmacy schools in Australia: when is enough enough? [editorial] 2009 174
Nation RL See Dunning TL 2010 203
Nation RL Accreditation standards for pharmacy courses in Australia: how do we stack up? [editorial] 2011 259
Natoli G See Robinson PJ 1998 160
Naunton M Evaluation of home-based follow-up of high-risk elderly patients discharged from hospital 2003 176
Naunton M See Al Hadithy AF 2005 213
Naunton M See Luinstra MM 2009 265
Naunton M See De Zylva JB 2012 37
NCCTG Standard for the preparation of pharmaceuticals in hospital pharmacy departments 1994 182
Neave G Midazolam for acute agitation in the psychiatric patient [letter] 1994 356
Neave K See Dooley MJ 2011 208
Newby D Australian pharmacoepidemiology course [letter] 1995 52
Newby D Midazolam by mouth [Inform] 1995 192
Newgham C See Adu A 1994 318
Newgreen DB Winning of Australian pharmacy degrees – a retrospect 2009 211
Newman S See O'Leary K 2009 293
Newton JR Presentations of eating disorders later in life 2013 231
Ng C Medication reconciliation challenges at discharge from hospital using an eMMS and electronic
discharge summaries
2013 25
Ng CS Acute renal failure in patients on diuretics and/or NSAID COX-2 inhibitors ACEI ARA 2008 280
Ng D Syndrome of inappropriate antidiuretic hormone secretion associated with SSRIs 1996 358
Ng D Unplanned medication-related admissions to an acute care general teaching hospital 1999 84
Ng K See Lauchlan R 1995 342
Ng K See Abdelmessiah D 1997 250
Ng K Workload measurement practice in Australian hospital pharmacy departments 1997 307
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 43
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Ng K See Cheong EA 2003 212
Ng K See D'Souza DC 2004 190
Ng KH Australian Medicines Handbook Drug Choice Companion: Aged Care [book review] 2003 332
Ng KH Board of pharmaceutical specialities examination in oncology: do it all alone [letter] 2004 158
Ng KH Tranquilliser use in elderly psychiatric patients 2004 183
Ng SPL New system to administer drugs via the central venous catheter in newborn infants 1998 177
Ng YC See Couch G 2007 210
Ngieng MLL See Zolezzi M 2007 225
Ngo SNT See Ibrahim R 2012 283
Ngo-Thai LL See Dooley MJ 2011 208
Nguyen A See Yu K 2007 22
Nguyen A Classification of findings in the home medicines reviews of post-discharge patients at risk of
medication misadventure
2007 111
Nguyen N-A Pharmacist prescribing in warfarin therapy: exploring clinical utility in the hospital setting 2008 35
Nguyen VT Bisphosphonate-associated atypical femur fracture 2014 35
Nguyen YBN Do health professionals on respiratory wards know how to use inhalers? 2010 211
Nibu P Review of a drug information service in an Indian teaching hospital 2001 144
Nicholls KM See Reginato V 2002 94
Nichols C See Moles RJ 2007 265
Nicklason F Post-stroke emotionalism [letter] 2000 175
Nicolas CM See Marmor GO 2011 113
Nielsen F See To T-P 2013 177
Nieman PE Fred J Boyd Award 1999 1996 148
Nigro O See Ratnaike RN 2000 165
Nigro O See Ratnaike RN 2000 210
Nigro O See Ratnaike RN 2000 230
Nigro O See Poh EW 2009 176
Nissen L American Society of Consultant Pharmacists Conference-Geriatrics 06 [letter] 2006 244
Nissen L See Hale A 2009 163
Nissen L See Freeman C 2012 184
Nissen L See Hale A 2013 256
Nissen L See Freeman C 2014 240
Nissen LM Solid medication dosage form modification at the bedside and in the pharmacy of Queensland
hospitals
2009 129
Nissen LM See Lau ET 2013 19
Nissen LM See Thompson W 2013 213
Nita Y Adverse drug reaction reporting: attitudes of Australian hospital pharmacists and doctors 2005 9
Nooney VB See Angley M 2011 27
Norman L Donations to a developing country [letter] 2007 79
Norman TR See Mock P 2010 58
Noroozian M See Ahmadi-Abhari SA 2005 103
Norris DE See Camac KJ 1996 234
Norris PT See Tordoff JM 2004 267
Norris PT New Zealand pharmacists and pharmacist-only medicines 2004 282
Norris PT See Tordoff JM 2005 271
Norris PT See Plant EA 2006 271
Norris RL See Barras M 2011 183
Norris RLG See Anh AV 2006 262
Northfield SE Lipophilicity of beta-adrenoceptor antagonists: a new classification scheme for clinical use 2007 98
Novy M See Welch SA 2000 262
Nutting J Health economics is sexier and management more rewarding [career opportunities] 1998 370
Nyfort-Hansen K Plan or perish 1994 339
Nyfort-Hansen K Clinical Pharmacy a new beginning in India 1998 343
Nyfort-Hansen K See Alderman CP 2000 109
Nyfort-Hansen K Geriatric pharmacy specialisation: the CCGP pathway to Australian accreditation 2001 41
Nyfort-Hansen K See Chu KP 2005 216
Nyfort-Hansen K See Campbell DG 2008 140
Nyfort-Hansen K See Widagdo IS 2011 122
O’Reilly B See Baysari MT 2013 288
O’Reilly BA See Welch SA 2014 161
O’Reilly M See Dunning TL 2010 203
O’Reilly M See Koning SI 2013 261
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 44
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Oberklaid F In reply: Harle's Herbal Baby's Friend [letter] 1995 353
Oborne C A See Elliott RA 2001 19
Oborne CA See Elliott RA 2003 101
O'Callaghan CJ See Pellizzer AM 1998 432
O'Callaghan CJ See Elliott RA 2011 21
O'Connor K Hospital supply of off-label immunomodulatory drugs 2009 135
Odette S See Wein S 2002 212
Odgers CL Drug budget devolution and internal markets - the future for pharmacy [editorial] 1997 105
Odgers CL The Pharmaceutical Benefits Scheme and public hospitals [editorial snapshot] 2000 45
O'Doherty R See Duguid M 2002 94
O'Donnell D See Chase D 2008 312
Ogle SJ See Bajorek BV 2001 93
Olagundoye A See Daftary MN 2003 265
Oldfield B See Zolezzi M 2007 225
Oldman R A guide to pharmacy technicians on safe handling of cytotoxics [practice report] 1998 356
O'Leary K Evidence-based core clinical pharmacy services [editorial] 2004 173
O'Leary K See Duguid MJ 2005 201
O'Leary K Hospital pharmacy technician qualifications [editorial] 2005 259
O'Leary K Link between clinical pharmacy services pharmacy staffing and hospital mortality rates [editorial] 2007 256
O'Leary K Coordinated strategies to attract pharmacists to the public hospital sector in Victoria 2009 293
O'Leary K SHPA continuing professional development program [letter] 2009 327
O'Leary K See Elliott RA 2012 125
O'Leary KM Snapshot of hospital pharmacy workforce in Australia 2002 72
O'Leary KM Survey of implementation levels and pharmacy requirements for the continuum of quality use of
medicines between hospital and community
2003 93
O'Leary KM Snapshot of the Australian public hospital pharmacy workforce in 2003 2004 104
O'Leary KM Pharmacy clinical and distribution service delivery models in Australian public hospitals 2004 114
O'Leary KM See Stowasser DA 2004 293
O'Leary KM Victorian hospital pharmacy technician workforce survey 2006 32
O'Leary KM Snapshot of the Australian public hospital pharmacy workforce in 2005 2006 103
O'Leary KM Pharmaceutical review: resource implications for the pharmacy component in Australian public
hospitals
2006 291
O'Leary KM See Gilbar P 2007 115
O'Leary KM Snapshot of the Australian Public Hospital Pharmacy Workforce in 2007 2009 28
O'Leary KM Clinical pharmacist staffing levels needed to deliver clinical services in Australian hospitals 2010 217
O'Leary KM Two national surveys of hospital pharmacy technician activities to support the review of national
qualifications
2012 43
O'Leary KM A professional development framework for pharmacists [editorial] 2012 259
O'Leary KM Access to pharmacist medication review services [editorial] 2013 88
Olsen WA See Mukhtar S 2004 276
Olver JS See Mock P 2010 58
Omar SH See Jindal D 2005 331
O'Neill MS See Jepsen DM 2013 29
Onishko C See Chui SY 2007 124
Onishko CR Childhood pain - in sickness and in health 2007 45
Ooi S-C See Tong EY 2012 140
O'Reilly B Causes of warfarin resistance [inform] 1995 488
O'Reilly BA See Drew AK 1995 433
O'Reilly M See Jenney A 1999
Osborne GA See Sorich MJ 2004 22
Osborne RH Management of osteoarthritis in older people 2002 276
O'Shea TJ Outcome of restricting antibiotic prescribing 1995 139
O'Shea TJ Accuracy of aseptic dilutions 1996 254
O'Shea TJ Checking prescriptions before dispensing 1997 321
O'Shea TJ Impact of nurse education on the incidence of omitted medication doses in hospital inpatients 2009 114
Osti B See Shankar PR 2009 162
O'Sullivan C Herbal products for babies [inform] 1995 191
O'Sullivan C In reply: Harle's Herbal Baby's Friend [letter] 1995 353
O'Sullivan G See Welch S 2010 333
Ouaida D See Boyle CM 1998 413
Overland V The use of ACE-inhibitors after myocardial infarction 2002 232
Owen S See Stupans I 2011 118
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 45
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Owen SM Experiential placements: nurturing interactive pharmacists by planning and scaffolding for improved
communication
2008 121
Owen SM Support needed by pharmacy students in experiential placements: stakeholders' expectations 2010 97
Padhye V See Angley M 2011 27
Padhye V Alternatives to post-discharge home medication reviews for high-risk patients: doctors' and
pharmacists' views
2012 273
Padma GR See Palaian S 2006 77
Paech MJ See Lim CB 2003 59
Paech MJ See Lim CM 2004 11
Paech MJ See Lim SCB 2008 191
Page MA See McNally KM 1997 22
Page MA Prescribing in teaching hospitals: a qualitative study of social and cultural dynamics 2008 286
Pajkos A See Whiteley RK 2002 153
Palaian S See Mishra P 2005 165
Palaian S Impact of counselling hospitalised diabetic patients [letter] 2006 77
Palaian S See Bedi TRS 2006 164
Palaian S See Paudel R 2006 218
Palaian S See Ghosh S 2006 246
Palaian S See Maarup N 2011 49
Palaian S See Hassali MA 2011 80
Palaian S See Sanburg A 2011 165
Palain S See Hassali MA 2009 245
Palian S Pharmacovigilance sessions for undergraduate pharmacy students in Malaysia [letter] 2009 329
Paloumis S See McCrudden EA 1995 261
Pan M See To TP 2012 118
Pandii W See Thawornchaisit P 2012 189
Pang RK Smart infusion pumps reduce intravenous medication administration errors at an Australian teaching
hospital
2011 192
Pappas A Pharmaceutical calculations student evaluation of computer-assisted learning 1998 312
Pappas A Computer-assisted exam revision by pharmacy students 1999 10
Pappas A Extemporaneous dispensing: opinions of Victorian community pharmacists 1999 196
Pappas A Extemporaneous prescribing: whatever happened to it? A survey of Australian GPs 2002 310
Pappas A The art, science, and technology of pharmaceutical compounding [book review] 2003 42
Pappas A Allen's compounded formulations-the complete U. S. pharmacist collection [book review] 2003 245
Parikh S Cardiovascular risk reduction in the extreme elderly 2013 62
Pariti B See Priyadarshini M 2014 61
Parke J Influencing psychotropic prescribing and auditing the results 1998 13
Parke J Olanzapine for treatment-resistant schizophrenia 1999 54
Parke J Developing a form to enhance the continuum of medication care following hospital discharge 2003 268
Parke J Risk analysis of errors in prescribing dispensing and administering medications within a district
hospital
2006 21
Parker D See Maddocks I 1994 400
Parker D See Huppatz C 1998 241
Parker FC See Pescod DC 1995 280
Parker JM Leading the way in renal medicine [letter] 2004 158
Parker S See Tasker J 1997 251
Parker SM See Bolton PG 2004 8
Parkes SC See Dartnell JG 1994 392
Parkins P See Bogovic A 2000 222
Parkins P A study tour of paediatric total parenteral nutrition services in North American hospitals 2001 307
Parkinson AM Time utilisation study of pharmacy support staff [short communication] 1998 436
Parks TE See Peterson GM 1996 545
Parshuram CM Acceptability of flavoured and unflavoured oral prednisolone solution in children with acute asthma
[letter]
1998 290
Parsons B Tightropes clowns trapeze and performance — casemix in Victoria 1995 1996 128
Parsons B See Magarey J 1996 454
Parsons B AuSPEN conference [letter] 2000 176
Parsotam N See Zolezzi M 2007 225
Parsotam N See Loe EA 2008 209
Parthasarathi G See Nibu P 2001 144
Parthasarathi G Assessment of drug-related problems and clinical pharmacists' interventions in an Indian teaching
hospital
2003 272
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 46
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Parthasarathi G See Ramesh M 2004 218
Parthasarathi G Choosing an inhaled corticosteroid for asthma: making an informed decision [letter] 2004 245
Parthasarathi G See Joseph J 2010 279
Pascuet E Visual thematic analysis of children's illustrations to improve receptiveness to pictorial asthma action
plans
2010 92
Passlow CA See Murnane JM 2013 109
Patel B Pharmaceutical review-a lost opportunity? [editorial] 2006 259
Patel B GlaxoSmithKline Medal of Merit 2011 2011 304
Patel B Providing culturally appropriate palliative care [ed] 2014 78
Patel H See Thunga G 2013 163
Patel RP Stability of diluted iron polymaltose in PVC infusion bags 2013 112
Patterson TH Revisiting guidelines and inappropriate use of ticarcillin/clavulanate at an Australian teaching hospital 2011 221
Patullo C See Avent ML 2010 15
Paudel R Urticarial skin reaction induced by oral clonidine 2006 218
Pearce B British oncology pharmacy association symposium [letter] 2008 78
Pearce G See Day R 2007 4
Pearce GA Bioequivalence: How why and what does it really mean? 2004 195
Pearce MJ Regular paracetamol dosing reduces narcotic requirements in treating post-operative orthopaedic pain 1995 13
Pearson GJ See Barry AR 2009 256
Peck R See Sorensen L 2004 122
Peisah C Pharmacological management of challenging behaviours in people with dementia 1997 49
Peisah C Correction 2 [letter] 1997 159
Pellizzer AM Clinical utility of digoxin in elderly patients in sinus rhythm with chronic heart failure 1997 406
Pellizzer AM Polypharmacy in a major Australian teaching hospital [short communication] 1998 432
Peng L See Lim CM 2004 11
Peng YG Renal function peak anti-Xa levels and enoxaparin dosing 2004 14
Penm J Professional transgressions by Australian pharmacists 2009 192
Perera D See Elliott RA 2012 125
Perera D See Elliott RA 2014 95
Perez AG See Aldama PC 2003 330
Perlman M See Blackah J 1994 281
Pescod DC Postoperative pain management in older people 1995 280
Peterson G See Bereznicki L 2005 173
Peterson GM See Drummond SH 1994 231
Peterson GM See Leow CC 1994 250
Peterson GM TDM: Clinical pharmacy activity with a shortening half-life? [editorial] 1996 305
Peterson GM Pilot study of nebulised morphine for dyspnoea in palliative care patients 1996 545
Peterson GM Pharmaceutical care specialisation and certification [letter] 1997 336
Peterson GM Bring on the all-rounders 1999 48
Peterson GM See Naunton M 2003 176
Peterson GM See Bereznicki LR 2006 162
Peterson GM Bring clinical pharmacy to the community-expand hospital outpatient clinics! [editorial] 2009 88
Peterson GM See Luinstra MM 2009 265
Peterson GM Drug interaction dilemmas [editorial] 2011 7
Petrie AF See Low J 1998 405
Petrie G A quality opportunity 2004 297
Petrie GM See McGuire TM 1995 315
Petrie GM Casemix in Queensland — doing it differently 1996 131
Petrie GM See Stowasser DA 1997 362
Pham L 5-HT3 antagonists in the treatment of postoperative nausea and vomiting 2003 275
Phillips AJ See Grzeskowiak LE 2008 9
Phillips CJ See Dionysopoulos D 2011 75
Phillips CJ Research translation and clinical pharmacy [letter] 2014 63
Phillips PA Pharmacological aspects of electrolyte disturbances in older people 1996 363
Phillips S The importance of independent guidelines [ed] 2013 172
Phosri J Impact of COX-2 inhibitors in Thai orthopaedic outpatients 2005 115
Phulwani K See Tsui M 2008 40
Pilbeam M See Barras M 2011 183
Pillai KK See Jindal D 2005 331
Pillans p See Ghiculescu RA 2008 32
Pillans PI See Radford JM 1999
Pillans PI See Coombes ID 2001 102
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 47
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Pillans PI See Mackenzie FD 2002 31
Pillans PI See Mackenzie FD 2006 185
Pillans PI See Mackenzie FD 2006 210
Pillans PI See Ng CS 2008 280
Pillans PI See Patterson TH 2011 221
Pilotto LSJ See Ball PA 2013 202
Pink JA See Bollella G 2008 107
Piryani R See Shankar PR 2009 245
Piryani RM See Shankar PR 2009 162
Plant EA Workforce and service delivery analysis across NZ hospital pharmacy departments 2006 271
Plianbangchang P Survey of job satisfaction among pharmacists in Thailand 2003 117
Plummer D See Robertson K 2012 193
Plumridge RJ Contracting pharmacy services [editorial] 1996 523
Plumridge RJ Will fallacies in pharmacy determine our future? 1999 193
Plumridge RJ International networking: what is in it for you? [editorial] 2000 4
Plumridge RJ See Clifford RM 2003 208
Plumridge RJ Pharmacoeconomics: challenges in developing the fourth dimension of drug evaluation 2003 287
Plumridge RJ International pharmacy: what role does it play in promoting professional practice? 2004 43
Plumridge RJ See Nita Y 2005 9
Plumridge RJ See James CR 2008 44
Poh EW Pharmaceutical reforms: clinical pharmacy ward service versus a medical team model 2009 176
Poland KE See Inderjeeth CA 2010 229
Polasek TM Beyond CYP2C19 - a new chapter in clopidogrel pharmacogenics [editorial] 2011 14
Polasek TM Clinically relevant information on pharmacokinetic drug-drug interactions [letter] 2011 77
Polasek TM Rapid progress on the clopidogrel PON1 story [editorial] 2011 258
Ponniah AP See Lovgren S 2009 269
Ponniah AP See Angley M 2011 27
Ponniah AP See Padhye V 2012 273
Pont L See Dolton MJ 2012 33
Poole S See Dooley MJ 2011 208
Poole S See Chieng R 2014 105
Poole SG Bleomycin sulphate dosing nomenclature [letter] 1998 211
Poole SG Drugs in ambulatory infusion devices: the appropriate temperature for stability testing 1999 328
Poole SG See Dooley MJ 2008 188
Poole SG See Korajkic A 2011 126
Poudel A See Izham MI 2008 331
Poudel A See Palian S 2009 329
Poulier MV See Rofail S 1999
Poulier MV See Matthews JJ 2001 279
Poulson LK Acute adrenal insufficiency-withholding of medicines in the peri-operative period 2005 311
Power DA Biological drugs and the coming of biosimilars 2008 137
Power DA See Hsieh M 2009 230
Prabhu M See Mishra P 2005 165
Prabhu V See Awasthi S 2013 248
Prabhu V See Singh A 2014 60
Pragnell M Administration support 1996 70
Prankerd RJ Practical aspects of the stability testing of formulated drug products 1995 405
Prankerd RJ In reply: Stability trials — how much degradation is enough? [letter] 1996 291
Prankerd RJ Extemporaneous compounding [editorial] 1997 201
Prankerd RJ See Benson HA 1997 222
Prankerd RJ See Benson HA 1997 313
Prankerd RJ See Benson HA 1997 381
Prankerd RJ See Benson HA 1997 441
Prankerd RJ Optimisation of drug delivery - 7. Bioreversible chemical modifications of drugs 1998 165
Prankerd RJ See Benson HA 1998 13,17,
36,84,
182
Prankerd RJ Optimisation of Drug Delivery: 11. Delivery of therapeutic peptides and proteins 1999 20
Prankerd RJ Optimisation of Drug Delivery: 12. Delivery of gene therapy 1999 149
Prankerd RJ Pharmaceutical preformulation 1999 180
Prankerd RJ Complementary medicines [editorial snapshot] 2000 93
Prankerd RJ Extemporaneous compounding [editorial] 2005 173
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 48
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Prankerd RJ Compounded products - stability studies in hospital pharmacy departments [editorial] 2009 5
Prankerd RJ A new ultimate standard of mass [editorial] 2011 256
Pratt NL See Bell JS 2011 316
Pratt NL See Leach MJ 2013 265
Preisz P See Welch SA 2000 262
Primrose JG See Roughead EE 1998 7
Print SA See Shaw JP 2013 122
Priyadarshini M See Bhagvandas NS 2013 247
Priyadarshini M Occupational hazards of pesticides: plight of farmers [letter] 2014 61
Proietto J See Haywood CC 2013 145
Pson G A new millennium and clinical pharmacy: reasons for optimism [editorial] 2000 2
Pson G Challenges facing academic pharmacy: the provision of quality practical teaching 2000 45
Pson G COX-2 specific inhibitors in cancer [letter] 2000 120
Pson G Assuring quality in pharmacy practice: high time for action 2001 87
Pulver L See McCrudden EA 1995 261
Pulver LK See Matthews Z 1994 406
Pulver LK An Australian PharmD: Doctor of clinical pharmacy The University of Queensland 1999 284
Pym HC National Prescribing Service and educational visits 1999 290
Quah SM See Couch G 2007 210
Quek B See Ng SPL 1998 177
Quinn DI See Welch SA 2000 262
Quinn S See Roberts GW 2013 276
Qumari S See Crosara SLR 2013 221
Rabih N See Tordoff JM 2006 12
Radford JM Vancomycin usage review in the era of vancomycin-resistant enterococci (VRE) 1997 140
Radford JM Reducing inappropriate prescribing of vancomycin 1998 400
Radford JM Drug usage evaluation of antimicrobial therapy for community-acquired pneumonia 1999 317
Radford JM Siestas sangria and selection pressure: antimicrobial resistance and the implications for hospital
practice
2001 60
Radford JM See Coombes ID 2001 102
Radford JM See Mackenzie FD 2002 31
Radoui A See Ibrahim MIM 2014 62
Raehl CL Game changer for US hospitals: medical staff membership for pharmacists [editorial] 2012 89
Raines M Treatment of Fasciola hepatica infection [inform] 1996 273
Ram PL See Clifford RM 2011 203
Ramadaniati HU Snapshot versus continuous documentation of pharmacists’ interventions: are snapshots worthwhile? 2014 205
Ramesh M See Nibu P 2001 144
Ramesh M See Parthasarathi G 2003 272
Ramesh M Aspirin-induced sneezing 2004 218
Ramesh M See Joseph J 2010 279
Ramrattan MA See Boeker EB 2013 41
Ramsay EN See Bell JS 2011 316
Ramsay EN See Kalisch LM 2013 182
Ramzan I See Pearce GA 2004 195
Rando L Diabetes ward management-room for improvement 2004 95
Rao BH See Khan SA 2006 163
Rao DA See Lakshmi PK 2002 240
Rao PG Evaluation of a drug information service in a South Indian teaching hospital 2005 40
Rao PG Prescribing pattern of fluoroquinolones in India [letter] 2005 166
Rao PG See Jose J 2005 333
Rao PG See Khan SA 2006 163
Rao PG See Ghosh S 2006 246
Rashford M Protecting the unborn child from isotretinoin [letter] 1995 539
Ratnaike RN Drug-associated diarrhoea and constipation in older people. Diarrhoea 2000 165
Ratnaike RN Drug-associated diarrhoea and constipation in older people. Constipation 2000 210
Ratnaike RN Chemotherapy-induced diarrhoea. In reply [letter] 2000 230
Ratnapala DN See Seleem M 2011 132
Ravenscroft PJ See Schneider JJ 1997 29
Raymond K See Hung CW 1997 235
Raymond PM Adverse drug reaction reporting in Melbourne teaching hospitals 1994 237
Rayner CR Drug use evaluation of vancomycin 1998 394
Rayner CR PharmD or not PharmD that is the question! 1999 121
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 49
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Rayner CR See Yin C 2002 320
Rayner CR See Taylor MJ 2003 18
Razman I Bioavailability, bioequivalence, generics and switching or substitution: science, emotion and vested
interests [editorial]
2010 90
Read T See Yin C 2002 320
Reed BL See Roller L 2008 79
Reeve J See Brien JE 2009 81
Reeves D See Garrett T 2009 99
Reeves D See Garrett T 2010 269
Reeves M See Seaton SM 2009 104
Reginato V Alteplase: a safe and cost-effective alternative to urokinase 2002 94
Reid CM See Coombes ID 2005 190
Reinhold J See Mackenzie FD 2006 210
Reith DM See Tordoff JM 2004 267
Reith DM See Tordoff JM 2005 271
Reith DM See Kunac DL 2010 290
Renwick J Clinical pharmacists: from bedside to clinical research [career opportunities] 1998 439
Rhodes J See Koning SI 2013 261
Rice CA American Society of Clinical Oncology Conference 2004 207
Rice CA Measuring pharmacy workload associated with clinical trials 2007 303
Rice CA See Hynes KI 2010 300
Richards CV A quality assurance audit for an aseptic dispensing facility [short communication] 1998 329
Richardson K See Baysari MT 2012 246
Richardson K See Baysari MT 2013 288
Richardson KL See Munzner EE 2012 264
Richardson KL See Ng C 2013 25
Richardson KL See Welch SA 2013 162
Richardson KL See Welch SA 2014 161
Richardson V Adapting to change 1994 48
Rigby D See Gilbert A 2013 4
Rigby D See Angley M 2014 6
Rigby D See Freeman C 2014 240
Riley RH See Stott SA 1995 417
Riley RH Premedication for surgery: a survey of Australian practice 1999 206
Riley RH Herbal medicines 1999 346
Riminton S See O'Connor K 2009 135
Robert N See Thunga G 2013 163
Roberts AS See Moles RJ 2007 265
Roberts G See Cosh D 1996 673
Roberts G Australian Clinical Pharmacy Award 2011 2011 307
Roberts G See Grzeskowiak LE 2012 5
Roberts G Personalised e-warfarin initiation charts to improve patient outcomes [letter] 2013 161
Roberts GW BPS-time for an Australian equivalent? 2001 226
Roberts GW Dosing of key renally cleared drugs in the elderly-time to be wary of the eGFR 2006 204
Roberts GW Pattern of high-dose prednisolone-induced hyperglycaemia in COPD exacerbations 2009 50
Roberts GW Immediate post-administration safety of bolus gentamicin 2012 200
Roberts GW Post-operative warfarin re-initiation – modelling a loading dose strategy 2013 276
Roberts J Australian Clinical Pharmacy Award 2012 2012 308
Roberts JA Pharmacists investigating adverse penicillin responses-pilot study 2007 200
Roberts JA Expanding horizons - needs you to travel over them [letter] 2007 333
Roberts JA Midazolam metabolism: implications for individualised dosing? 2009 198
Roberts JA Tissue distribution of beta-lactam antibiotics: continuous versus bolus dosing 2009 219
Roberts L See Robertson K 2012 193
Roberts M The SHPA grants and awards program 1997 351
Roberts M See Lilley B 1998 289
Roberts M Effective pharmacist involvement in the healthcare team improves patient outcomes 2002 171
Roberts M See Kiani M 2011 217
Roberts M See Lie K 2011 278
Roberts M See Blogg LC 2012 287
Roberts MJ See Lim CB 2003 59
Roberts MJ Managing pharmacy beyond the hospital walls: present and future services for home health care 2003 128
Roberts MJ See Lim CM 2004 11
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 50
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Roberts MJ See Angalakuditi M 2005 21
Roberts MS See Sorensen L 2004 122
Roberts MS Home medicines review [letter] 2004 159
Roberts MS See Ientile CS 2005 110
Robertson A See Schwantzer M 1994 439
Robertson JM See McKnight DL 1994 260
Robertson K Complexity and workload of cytotoxic manufacturing at a regional hospital: a comparative study 2012 193
Robertson MB See Raymond PM 1994 237
Robertson MB See Rando L 2004 95
Robertson S See Mylrea M 2012 204
Robertson S See Kockler J 2013 218
Robins M See Lumby J 2010 259
Robinson G See Wheeler AJ 2007 33
Robinson J See McD Taylor D 2006 96
Robinson M See Clark LM 2001 134
Robinson MK Erythropoietin: use in a critically ill patient refusing a blood transfusion 1997 38
Robinson MK Communicating the message - Pharmacists as educators [practice report] 1998 121
Robinson MK Inpatients' satisfaction with clinical pharmacists' counselling 1999 162
Robinson PJ Comparison of high-dose and standard-dose pancreatic enzyme capsules in children with cystic
fibrosis
1998 160
Rocca A See O'Leary KM 2006 32
Rodrigues GS Clinical pharmacy: an Indian surgeon's perspective [letter] 2007 78
Rofail S The quality use of nimodipine: assessing the impact of consensus guidelines 1999 137
Rofail S Are patients on long-term corticosteroids receiving bone loss therapy? 2006 29
Rofe OC See Koning SI 2013 261
Rogerson JW See Moran JA 2001 115
Rokahr C See Dunning TL 2010 203
Roller L See Pappas A 1998 312
Roller L Pre-registrant pharmacists' views on the length of post-Bpharm training in Victoria [letter] 2008 79
Rollins BM Insulin dosage preparation and administration: prefilled pens versus syringes 2013 198
Roman C Acute trauma and resuscitation preceptorship [grant report] 2014 165
Rose ML See Bogovic A 2000 222
Rossi S See Westaway K 2014 138
Rothwell M Retrospective analysis of emergency readmissions to rural and regional hospitals 2011 290
Roufogalis BD See Brown JA 2009 281
Roughead E Building a safer system for Australian health care: essential role of clinical pharmacy services
[editorial]
2004 88
Roughead EE Coding drug-related admissions in medical records: is it adequate for monitoring the quality of
medication use?
1998 7
Roughead EE See Tett S 2000 191
Roughead EE See Kalisch LM 2007 292
Roughead EE Medication use by Australian war veterans in residential aged-care facilities 2008 14
Roughead EE See Bell JS 2011 316
Roughead EE See Kalisch LM 2013 182
Roughead EE See Leach MJ 2013 265
Rous JR Comparison of gentamicin and netilmicin dosing schedules in newborn infants [letter] 2000 290
Rowe L Development of a manual of indicators for drug use in Australian hospitals 1998 38
Rowett D See Westaway KP 2014 44
Rowett D See Westaway K 2014 138
Rowett D Tomorrow’s Pharmacist. Registration Exam Questions III. [book review] 2014 304
Rowett DS See Alderman CP 1995 511
Rowett DS See Cosh D 1996 673
Rowett DS Formation of an SHPA academic detailing/educational outreach COSP 2002 87
Rowett DS Clinical pharmacy: Influencing healthcare decision-making 2002 269
Rozek T See Mihaila B 2012 103
Rucklidge MW See Lim CB 2003 59
Ruff TA See Giles ML 1999
Ruffin RE See Vial RJ 2002 57
Rumsey S Ciprofloxacin-induced seizures — the need for increased vigilance 1995 145
Rusli RA See Manan MM 2014 83
Russell LM See Lehnbom EC 2009 207
Ryan AN See Kunst AM 2009 246
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 51
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Ryan DM Introducing a daily patient report for clinical pharmacists 2005 37
Ryan G See Owen SM 2010 97
Ryan M Hospitals and pharmacy-the next five years [editorial] 2005 6
Ryan M Time for a single system for funding medicines [editorial] 2011 12
Ryan MJ Organisational restructuring in Australian hospitals — implications for pharmacy services 1996 22
Ryan MJ Restructuring healthcare systems — considerations for pharmacists [editorial] 1996 522
Ryan MJ A two-day national consumer medicines information phone-in 1998 304
Ryan MJ Realising the potential [editorial snapshot] 2000 46
Ryan MJ See Jackson JK 2001 262
Ryan MJ Many have a part to play [editorial] 2003 4
Ryan MJ Australian electronic management policy and systems 2007 49
Ryan MJ Don't think don't hope do! [editorial] 2009 91
Ryan RE Evidence on optimal prescribing and medicines use for decision makers: scope and application of the
Rx for Change database
2011 295
Saab YB Attitudes of physicians to professional roles of community pharmacists in Lebanon 2004 18
Sabet P Evaluation of mycophenolate for unregistered indications 2004 36
Sadeghi M See Ahmadi-Abhari SA 2005 103
Saleem F Education and health-related quality of life: are interventions always beneficial? [letter] 2011 333
Samios PA Role of therapeutic drug monitoring in HIV therapy 2004 188
Samios PA Capturing pharmacy activities using barcode technology 2013 207
Sampanthar R Technician's perspective of casemix 1996 68
Sanbrook A See Katsogiannis W 1996 529
Sanburg A Just another boring seminar? [letter] 2008 163
Sanburg A Where there are no pharmacists: a guide to managing medicines for all health workers [book review] 2011 165
Sanburg A Chronic Diseases Workshop, Vanuatu 2011 2012 82
Sanburg AL Stepping out of constipation — an educational campaign 1996 351
Sanburg AL Pharmacy training in the Solomon Islands - a personal account 1997 473
Sanburg AL An opportunity to compare our services 1999 281
Sanburg AL Taking pharmacy on tour in Vanuatu 2006 212
Sanders DC See Coombes ID 2002 17
Sanders DJ See Stott SA 1995 417
Sanders J See Mellor JD 2012 181
Sanders J See Thakerar A 2014 231
Sandhu G Czech-ing out ISOPP [letter] 2011 73
Sankham RD See Kaleemuddin M 2001 26
Sansgiry SS Consumer perceptions of generic drug substitution practices in the USA 2004 262
Sansom L The PBS-its future 2001 257
Sansom L Future healthcare delivery-where is pharmacy? [editorial] 2007 6
Sansom L Pharmacists, pharmacovigilance, unapproved indications and the TGA [editorial] 2010 88
Sansom LN See Roughead EE 1998 7
Sansom LN Hospital pharmacy practice: its place in the future 1998 426
Sansom LN Fred J Boyd Award 2014 2014 297
Santamaria NM See George J 2006 107
Santamaria NM See George J 2006 278
Santoro VA Management of controlled drug (schedule 8) liquid discrepancies to achieve best practice 2013 194
Sardjono DA See Rando L 2004 95
Sattar DA See Sonallah H 2014 159
Saulnier JL See Schlatter J 1997 395
Saunders A Drugs in breast milk — timing of mother's dose and baby's feed [inform] 1995 295
Saunders A In reply: Drugs in breast milk — timing of mother's dose and baby's feed [letter] 1995 486
Saunders A In reply: Dosage of drugs in breast milk [letter] 1996 289
Saunders A Drug information services in Victoria [editorial] 1998 391
Saunders A It is time to abandon 'alternative medicines' and 'complementary medicines' [editorial] 2005 263
Scahill S Applying organisation theory to hospital pharmacy research: the case of 'culture' Down Under
[editorial]
2012 175
Schapel GJ See Dollman WB 1996 229
Schelleman A See To TP 2005 33
Schlatter J Stability of enalapril solutions prepared from tablets in sterile water 1997 395
Schneemann K The Free Trade Agreement is a win-win opportunity [letter] 2004 69
Schneider CR See Clifford RM 2011 203
Schneider H See Dooley MJ 2008 188
Schneider J Report on the Congress of the European Association of Palliative Care 2001 232
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 52
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Schneider JJ A study of the osmolality and pH of subcutaneous drug infusion solution 1997 29
Scholes S Conference on supportive care in cancer [letter] 2005 79
Schubert AL See Dartnell JGA 1994 333
Schwantzer M Folic acid supplementation in the peri-conceptional period [letter] 1994 439
Scollay DA Psoriasis 1994 350
Scott DA Post-operative pain relief 1996 121
Scott IA See Coombes ID 2002 17
Scott S Quality of clinical pharmacy services [editorial] 2004 258
Scott SD Central and peripheral neurotoxicity from metronidazole [case report] 1994 325
Scott SD See Rumsey S 1995 145
Scott SD Pharmaceutical care specialisation and certification [editorial] 1997 201
Scott SD In reply [letter] 1997 337
Scott SD Time to take stock and evaluate [editorial] 2004 90
Scott-Walker TM A review of the prophylaxis and treatment of postoperative nausea and vomiting 2000 157
Scoular D See Pascuet E 2010 92
Seale R See Ryan MJ 1998 304
Seale RE See Jackson JK 2001 262
Searle J See Hattingh HL 2007 174
Seaton SM Oxycodone as a component of multimodal analgesia post-caesarean section in Australia and NZ 2009 104
Seaton SM Impact of a hospital pharmacy technician facilitated medication delivery system 2010 199
See OG See Hassali MA 2014 125
Sekhar-M S The story of metformin continues… [letter] 2014 289
Selby PR See Cheh RM 2010 184
Seleem M Managing patients on antiplatelet drugs requiring emergency non-cardiac surgery 2011 132
Sellars N See Maddocks I 1994 400
Semple S See Roughead L 2004 88
Seng WT Information technology and the pharmacist [editorial] 2005 257
Seng WT See Tan CH 2014 17
Senturk-Raif R See George LJ 2011 212
Seubert LJ See Clifford RM 2011 203
Shadnia S See Abdolkarim P 2002 297
Shafie AA See Hassali MA 2009 245
Shafie AA See Hassali MA 2009 329
Shafie AA See Elkalmi RM 2010 245
Shafie AA See Malik M 2011 73
Shafie AA See Hassali MA 2011 80
Shafie AA Separation of the dispensing role - an indispensable health reform [letter] 2011 163
Shafie AA See Leng CB 2011 250
Shafie AA See Chin KL 2011 332
Shafie AA See Saleem F 2011 333
Shah K Angioedema possibly associated with ezetimibe 2006 301
Shah SS Should pharmacists in Australia have access to a structured general level training program? 2013 129
Shahin D See Garg S 2008 28
Shakib S See Armenores P 2006 40
Shakib S See Yu K 2007 22
Shakib S See Nguyen A 2007 111
Shakib S See Borgstedt J 2009 186
Shakib S See Lovgren S 2009 269
Shakib S See Angley M 2011 27
Shakib S See Padhye V 2012 273
Shankar PR See Das R 2005 310
Shankar PR See Palaian S 2006 77
Shankar PR See Hassali MA 2009 79
Shankar PR Impact of a medicine and therapeutics committee at a new medical college in Nepal [letter] 2009 162
Shankar PR Pharmacovigilance awareness in a medical school in Nepal [letter] 2009 245
Shankar PR Clinical pharmacy and pharmacology in Nepal [letter] 2012 247
Shankar R See Sanburg A 2011 165
Sharkey K See Parikh S 2013 62
Sharley N See Tran MD 2012 218
Sharley NA See La Forgia SP 2002 65
Sharley NA Stability and compatibility of alfentanil HCl and morphine SO4 in polypropylene syringes 2003 279
Sharley NA See Milne DJ 2004 272
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 53
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Sharley NA Stability of mixtures formulated from warfarin tablets or powder 2007 95
Sharley NA See De Rosa NF 2008 212
Sharley NA See Hopkins AM 2012 115
Sharma H See Jindal D 2005 331
Sharratt G See Baysari MT 2012 246
Shastri M See Patel RP 2013 112
Shaw DR See Chu KP 2010 119
Shaw JP The four-year course in New Zealand [editorial] 1996 406
Shaw JP Development of a postgraduate educational program for pharmacist prescribers in New Zealand 2013 122
Shaw JP See Zolezzi M 2014 188
Sheehan M See Feeney GFX 1997 42
Shen S Pharmacotherapy for skin disorders in older people 2012 150
Shenfield GM See Kristoffersen SS 1997 367
Shenfield GM See Bajorek BV 2001 93
Shenfield GM See Kelly M 2004 32
Sheridan J Reporting purchasers of pseudoephedrine products to police: NZ community pharmacists' experiences 2007 19
Sheridan J See Wheeler AJ 2007 33
Sheridan L See Angley M 2011 27
Shilson AD See To TP 2008 219
Shore EG See Shore MF 2011 175
Shore MF Rethinking healthcare leadership [editorial] 2011 175
SHPA Position paper consumer product information [CPI] May 1994 1994 266
SHPA Strategic Plan 1998-2000 1999 244
SHPA Research and Development Grants Program 1999 249
SHPA Strategic Plan 1998-2000 Part 2 1999 305
SHPA Strategic Plan 1998-2000 Part 3 1999 359
SHPA Pharmaceutical funding reforms: proposed introduction of the PBS into public hospitals 2000 254
SHPA Direct to consumer advertising of prescription medicines [position statement] 2000 295
Shrestha R See Hassali MA 2009 245
Shute R See Westaway K 2014 138
Siderov J Cancer chemotherapy in the elderly [geriatric therapeutics] 1998 124
Siderov J See Ang T-S 1998 430
Siderov J See Bayles M 1999
Siderov J BCOP: a new regimen for the oncology pharmacist 1999 338
Siderov J Chemotherapy-induced diarrhoea [letter] 2000 229
Siderov J Non-sedating antihistamines for premedication in ambulatory oncology patients 2002 108
Siderov J Receiving cytotoxic drugs - standard practice or Russian Roulette? 2002 178
Siderov J Workload statistics in cytotoxic preparation - is a one-for-one approach enough? 2003 68
Siderov J Occupational exposure to cytotoxic drugs and health monitoring [letter] 2003 159
Siderov J What the-informing consumers of the cost of cytotoxic admixtures [letter] 2003 244
Siderov J PBS ANS SOS! [letter] 2005 165
Siderov J Safe handling hysteria [letter] 2005 166
Siderov J What's in a name? Lack of pronunciation in Consumer Medicine Information 2005 293
Siderov J Is the death knell for cytotoxic manufacturing in hospitals ringing? [letter] 2006 78
Siderov J See Carrington C 2007 81
Siderov J Tallman lettering - sounds good but where is the evidence? [reply letter] 2009 80
Siderov J Surface contamination of cytotoxic chemotherapy preparation areas in Australian hospital pharmacy
departments
2009 117
Siderov J External surface contamination of cytotoxic admixtures: caveat emptor 2011 181
Silva MA 2009 H1N1 pandemic influenza: let’s get involved! [editorial] 2009 259
Silva MA Stability of two long-acting insulin formalations after 28 days 2013 37
Silva MA See Rollins BM 2013 198
Sim L Patients' understanding of drug allergy and documentation-is there a link? 2005 276
Simioni D Implementation of pharmaceutical care plans in a hospital ward 1996 221
Simpson JM See Adu A 1999
Simpson JM See Smith MA 2002 227
Simpson MD The first graduate cohort at CSU: what impact on the rural pharmacist shortage? 2002 69
Simpson MD See Biddle RA 2003 55
Simpson MD Pharmaceutical care: impact on asthma medication use 2004 26
Simpson MD Developing a mentoring module to enhance an online national pharmacy preceptor training program 2006 119
Sims SA See Cutts C 2001 207
Singh A How safe is high-alert dispensing in the developing world? [letter] 2014 60
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 54
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Singh D Future directions for hospital pharmacy technicians [letter] 2006 164
Singh S See Dooley MJ 2003 111
Singhal R See Ramesh M 2004 218
Singhal R See Nagavi BG 2005 332
Sinnollareddy MG See Nguyen VT 2014 35
Sirianni L See McLachlan GB 2006 81
Sission CM See Cheong EA 2008 267
Sitaram BR See Corallo C 1995 129
Skinner MJ See Tong EY 2012 140
Slader CA Audit of celecoxib and rofecoxib use: St Vincent's Public Hospital Darlinghurst 2003 74
Slader CA The Graduates' Forum [letter] 2003 157
Slader CA See Bennett A 2003 183
Slader SAA Evaluation of a weight-based heparin dosing protocol 2005 15
Slaimankhel J See Tordoff JM 2006 12
Slater W Outstanding prescriptions—the challenge 1999 216
Sless D Response to 'Who can read consumer product information?' [letter] 1997 252
Smart S Treatment of haemophilia A [letter] 1996 291
Smith AJ The efficacy of complementary medicines: where is the evidence? [editorial] 2012 174
Smith BA The stability of foscarnet in the presence of potassium [letter] 1996 560
Smith CD See Blennerhassett JD 2006 175
Smith CL Management of the older patient with multiple myeloma 2004 142
Smith K See Baker S 1998 348
Smith MA General practitioner acceptance of medication review in Sydney nursing homes 2002 227
Smith NA See Hattingh HL 2007 174
Smith T Recent PHARM meeting [letter] 1997 338
Smith W See Garg A 2013 332
Smithson J See Neave G 1994 356
Smyth JP See Yeung MY 1999
Smyth JP See Yeung MY 2000 98
Smyth JP See Yeung MY 2000 172
Smyth JP See Yeung MY 2000 205
Smyth JP See Yeung MY 2001 291
Snell B See Jackson JK 2004 290
Snell B Guidelines and essential drug lists: of horses and carts [letter] 2010 331
Snellgrove CA See Hecker JR 2003 24
Snowdon GM Using genetic algorithms on a PC to compile staff rosters 1998 232
Somasundaram R Low-dose nebulised epoprostenol in the management of acute respiratory distress syndrome 2011 45
Sonallah H Medication reconciliation service conducted by clinical pharmacists in Qatar [letter] 2014 159
Sorensen L In-home medication reviews for war veterans: early experience in Australia 2004 122
Sorensen L See Ientile CS 2005 110
Sorgetti L See Pappas A 1998 312
Sorgetti L See Pappas A 1999
Sorich MJ Comparison of dextropropoxyphene and paracetamol with paracetamol after third molar dental
extractions
2004 22
Sorich MJ See Sorich W 2008 111
Sorich MJ See McKinnon RA 2008 226
Sorich MJ See Ward MB 2009 55
Sorich MJ See Gordon J 2011 271
Sorich W Vitamin B12 deficiency in the elderly using metformin long term: prevalence and relationship to
putative risk factors
2008 111
Soricj MJ See McKinnon RA 2008 55
Spalding AR See O'Shea TJ 2009 114
Spark MJ See Kemp SM 2010 275
Spark MJ See Brown KE 2012 196
Spelman D See Rayner CR 1998 394
Spelman D See Coutsouvelis J 2011 225
Spicer WJ See Rayner CR 1998 394
Spiers M BMS withdraws from New Zealand [letter] 1998 211
Spinks JM See Jackson JK 2004 290
Spooner LM See Silva MA 2009 259
Sprigg J See Sorich MJ 2004 22
Spurling L Pharmacy services to improve continuity of care-is it time for a national approach? 2006 259
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 55
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Spurling LK See To TH 2007 30
Spurling LK See Angley M 2011 27
Spurling LK See Padhye V 2012 273
Srikanth VK Management of stroke in older people: a pharmacological perspective 2000 60
Srikanth VK Post-stroke emotionalism: in reply [letter] 2000 176
Staatz CE See Stowasser DA 2000 47
Stacey SR Paediatric pharmacy in Australia: where have we come from and where do we need to go? 2013 45
Stafford L Comparison of paediatric steroid mixtures [short communication] 1998 246
Stafford L Antiplatelet and proton pump inhibitor prescribing in patients with ACS [letter] 2006 79
Steadman KJ See Nissen LM 2009 129
Steadman KJ See Lau ET 2013 19
Steadman KJ See Kairuz TE 2013 117
Stehlik P See Elliott RA 2013 312
Stell R Successful integration of a clinical pharmacist into a disease management unit 2008 132
Stevens G See Dolton MJ 2012 33
Stevens M The Australian Illicit Drug Guide 2001 320
Stevenson B ISOPP symposium-a gem for oncology [letter] 2003 244
Stevenson B Highlights from the Third ISOPP Australasian regional symposium [letter] 2003 329
Stevenson B Annual MD Anderson Symposium on cancer chemotherapy 2004 41
Stevenson B Taking the midnight train to Georgia [letter] 2006 248
Stevenson B See Carrington C 2007 81
Stewart C See Pascuet E 2010 92
Stewart D Pharmacist prescribing: a view from the UK [ed] 2009 7
Stewart JM See White S 2007 321
Stewart K A practical guide to pharmaceutical care 1999 180
Stewart K Survey methodology [ed] 2000 90
Stewart K See Lau P 2000 175
Stewart K See Pappas A 2002 310
Stewart K Handbook of nonprescription drugs: an interactive approach to self-care [book review] 2003
Stewart K See George J 2006 99
Stewart K See George J 2006 107
Stewart K See Larizza MA 2006 115
Stewart K See George J 2006 278
Stewart K See Lee CY 2011 98
Stewart P Possible myocarditis with clozapine [letter] 2000 72
Stewart P Where should we be going with professional development? 2001 3
Stewart P CPMPlus an innovative web-based patient monitoring system for Clozaril centres 2001 56
Stewart P Academic capacity - missing element from the pharmacy workforce study [ed] 2010 177
Stewart PJ Hospital pharmacy research [editorial] 1997 6
Stewart PJ Where should we be going in pharmacy education? [ed] 2008 176
Stockigt JR Flawed PI and CMI for thyroid and adrenal medications: where to from here? [ed] 2007 88
Stokes J See Hale A 2009 163
Stokes J See Coombes I 2010 111
Storie WJ See Coombes ID 2001 102
Storie WJ See Mackenzie FD 2004 134
Story DA See To T-P 2013 177
Stott SA The cardiovascular effects of nasal Cophenylcaine Forte spray 1995 417
Stowasser D Ninety-seven per cent 2004 315
Stowasser DA Info quality: a major consideration in the development of medication liaison services 1997 362
Stowasser DA See McGuire TM 1997 403
Stowasser DA Can yesterday's events tell you what's going to happen tomorrow? 1999 279
Stowasser DA Identifying drug-related readmissions is there a better way of assessing the contribution of adverse
medication events?
2000 47
Stowasser DA See Coombes ID 2002 15
Stowasser DA See Coombes ID 2002 17
Stowasser DA A randomised controlled trial of medication liaison services-patient outcomes 2002 133
Stowasser DA A randomised controlled trial of medication liaison services - acceptance and use by health
professionals
2002 221
Stowasser DA See O'Leary KM 2003 93
Stowasser DA Understanding the medicines management pathway 2004 293
Stowasser DA See Coombes ID 2005 190
Stowasser DA See Hale A 2009 163
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 56
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Stowasser M See Stowasser DA 2000 47
Stowasser M See Stowasser DA 2002 133
Stowasser M See Stowasser DA 2002 221
Stranks SN See Sorich W 2008 111
Streater J See Dooley MJ 2001 125
Street A See Lubliner M 2005 266
Street A See Dooley MJ 2011 208
Street AM See McDonald A 1994 285
Street PR See Moran JA 2001 115
Stride PJ See Seleem M 2011 132
Strumpman D See Kumar N 2011 108
Stuchbery P Measuring the time required to provide components of clinical pharmacy services 2007 102
Stuchbery P Determining clinical pharmacy workload by patient disease classification in medical and surgical
patients
2008 126
Stuchbery P See O'Leary KM 2010 217
Stupans I See Owen SM 2010 97
Stupans I Indicators of a quality clinical placement in pharmacy: stakeholder perspectives 2011 118
Stupans I Lifelong learning: views of Australian pharmacy interns 2012 30
Sturtevant JM See Mackenzie FD 2006 210
Sturtevant JM See Ng CS 2008 280
Su EY Anticoagulation control in hospitalised patients on warfarin 2008 292
Subish P See Mishra P 2006 81
Sucic Kim A See Armour CL 1998 410
Suen WS See Foran SM 1996 429
Suen WS Ethnic community group presentations 1999 56
Suen WS Introducing the pharmacy management program 2002 91
Suhaj A See Sekhar-M S 2014 289
Sullivan JA Prednisolone disodium phosphate stability in a prednisolone oral solution 1994 397
Summers R Pharmaceutical care — a planned approach 1996 37
Sumpter M See Masood N 2006 111
Sundararajan V See Koning SI 2013 261
Sunderland VB Four-year Bachelor of Pharmacy course in Australia [ed] 1996 405
Sunderland VB See Berbatis CG 1996 671
Sunderland VB See McNally KM 1997 22
Sunderland VB See McKnight DL 1997 390
Sunderland VB See Berbatis CG 1997 470
Sunderland VB See Berbatis CG 2001 309
Sunderland VB See Lim CB 2003 59
Sunderland VB See Angalakuditi M 2005 21
Sunderland VB Registration of pharmacy technicians in the UK [ed] 2005 89
Sunderland VB See Angalakuditi MV 2005 183
Sunderland VB See Joyce AW 2007 42
Sunderland VB Over-the-counter status of medicines [ed] 2009 91
Sunderland VB See Hoti K 2010 175
Sunderland VB See Wibowo Y 2012 26
Sussman G See Weller C 2006 318
Sutherland DM See Riley RH 1999
Suzuki N See Blogg LC 2012 287
Svirskis D See Garg S 2008 28
Swan BJ See Bortoletto DA 2004 288
Swan G Interferon — it should not be all Greek to pharmacists [letter] 1996 560
Swan GT Highly Specialised Drugs Program — time to reflect? [letter] 1994 175
Swan GT See Benzie JL 1997 430
Sweidan M See Jackson JK 2004 290
Sweidan M See Brien JE 2009 81
Swetenham K See Tait P 2014 120
Swift I See Brown KE 2012 196
Szabo F See De Zylva JB 2012 37
Sze RYH See Hung CW 1997 235
Szoeke C See Campbell S 2009 147
Tait P Future directions for pharmacy education 2002 263
Tait P Competency frameworks for hospital pharmacists [letter] 2009 248
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 57
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Tait P Forging an advanced practice role for pharmacists in palliative care 2014 120
Tait PA Assessment drives learning 2005 211
Tait PA See Dubrava S 2007 16
Talegaonkar S See Khan ZI 2005 328
Tan A See Ng SPL 1998 177
Tan AC Medication information transfer: an exploratory study in a rural Queensland community 2012 48
Tan CH Drug cross-contamination of barcode unit dose repackager in a tertiary academic medical centre 2014 17
Tan E Quality use of medicines in children [letter] 2004 330
Tan E See Dooley MJ 2008 216
Tan EL Improving decision outcomes of drug and therapeutics committees 2003 65
Tan EL Stakeholder opinions on the implementation of drug and therapeutics committee decisions 2004 178
Tan ISP Audit of the use of a smart infusion pump’s drug libraries 2013 279
Tan MF See Kowalski SR 2010 180
Tang CD See Hopkins AM 2012 115
Tang T See Baysari MT 2012 178
Tanner F See Ho L 2005 219
Tanner FE See McLachlan GB 2008 47
Tao MM See McCrudden EA 1995 261
Tappley N See Alvarez SJ 2001 13
Targett PL Compatibility and stability of drug adjuvants and morphine tartrate in polypropylene syringes 1997 207
Targett PL Determining stability of haloperidol in 10 mL polypropylene syringes [letter] 1997 338
Targett PL Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes 1997 452
Tasker J Response to 'Who can read consumer product information?' [letter] 1997 251
Tatoulis J Statins play a crucial role in the fight against coronary heart disease [letter] 2013 332
Tattam BN See Graudins LV 2008 276
Taylor D McD See Khan M 2011 265
Taylor DR Sustained success of collaboratively developed ondansetron guidelines 1995 522
Taylor G Continuing professional development program [ed] 1996 623
Taylor G SHPA Postgraduate Studies Board of Review: final report to Federal Council 2000 121
Taylor G See O'Leary KM 2010 217
Taylor G See O'Leary KM 2013 88
Taylor G Clinical pharmacy COSP - Standards of Practice for Clinical Pharmacy Services [ed] 2013 91
Taylor KL Acceptance of a Chlamydia screening program in community pharmacies 2007 287
Taylor MJ Vancomycin: continuously used intermittently debated [letter] 2003 18
Taylor S Making of mentors and role models 2005 323
Taylor S See Simpson MD 2006 119
Taylor S See McD Taylor D 2009 24
Taylor S See Elliott RA 2009 216
Taylor SE Advanced clinical training programs [letter] 1997 412
Taylor SE Pharmacotherapy casebook: a patient-focused approach, 2nd edition [book review] 2000 231
Taylor SE Pharmacotherapy: a pathophysiologic approach, 4th edition [book review] 2000 231
Taylor SE Pharmacokinetics made easy [book review] 2003 245
Taylor SE See Valoppi G 2006 136
Taylor SE See Shah K 2006 301
Taylor SE Intervention to reduce the use of error-prone prescribing abbreviations in the emergency department 2007 214
Taylor SE See Khan M 2011 265
Taylor SE See Tran T 2012 100
Taylor SE See Booth JC 2012 296
Taylor SJ See Gallego G 2004 100
Taylor SJ See Gallego G 2005 18
Tenni P See Peng YG 2004 14
Tenni P See Angley M 2014 6
Tenni PC National survey of clinical pharmacy services 1996 416
Tenni PC See Roberts M 1997 351
Tenni PC See Bright JM 2000 10
Teo CK Understanding compliance to an antibiotic prescribing policy: perspectives of policymakers and
prescribers
2013 32
Tett S Across the dividing range-bridging the divides [ed] 2003 172
Tett SE Hospital TDM with community liaison. a pharmacokinetic study in the real world 1997 435
Tett SE Pharmacy - working together 1997 449
Tett SE See Pulver LK 1999
Tett SE Therapeutic drug monitoring and clinical toxicology-opportunities not to be missed 1999 82
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 58
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Tett SE Quality use of medicines-onwards up the pyramid [ed] 2000 191
Tett SE See Duffull SB 2001 200
Tett SE See Matthews JJ 2001 279
Tett SE See Overland V 2002 232
Tett SE See Cutts C 2003 70
Thakerar A See Mellor JD 2012 181
Thakerar A See Moloney MJ 2013 49
Thakerar A Pharmacist advice on the safety of Complementary and Alternative Medicines during conventional
anticancer treatment
2014 231
Thawornchaisit P Combined neem oil 6% and eucalyptus oil 16% w/w lotion for treating head lice: in vitro and in vivo
efficacy studies
2012 189
Thiele JM See Coombes ID 2002 17
Thien H See Mirkov A 2012 278
Thom J See Peng YG 2004 14
Thomas AE See Grzeskowiak LE 2014 22
Thomas B Warfarin information on discharge summaries [letter] 2005 245
Thomas MG See Aikman KL 2013 272
Thomas S See Parthasarathi G 2004 245
Thompson B See Accordino A 1994 312
Thompson BC See Accordino A 1996 629
Thompson D See Thawornchaisit P 2012 189
Thompson W Australian pharmacists' understanding of their continuing professional development obligations 2013 213
Thomson B Fred J Boyd Award 2011 2011 302
Thomson WA See Lamour I 1997 335
Thomson WA See Pellizzer A-M 1998 432
Thomson WA See Elliott RA 1999
Thomson WA New SHPA constitution [ed] 2000 89
Thomson WA See Larmour I 2003 204
Thornton P Accountable clinical pharmacy practice [ed] 2004 258
Thornton P Health care and notions of risk [book review] 2004 333
Thornton P Reporting the real value of a hospital pharmacy service 2007 138
Thornton PD Assessment of medication errors in a seven-day issue individualised patient drug distribution system 1994 387
Thornton PD See Benrimoj SI 1995 119
Thornton PD See Benrimoj SI 1995 230
Thornton PD Information technology and hospital pharmacy practice 1996 143
Thornton PD Medication errors - a systems approach [editorial] 1997 106
Thornton PD Verification of medication orders [letter] 1997 158
Thornton PD Medication errors 1999 300
Thornton PD A responsible brave new world [editorial] 2000 190
Thornton PD Medication safety - The current state of safety in Australian hospitals 2002 11
Thornton PD Safety briefs 2002 100
Thornton PD GlaxoSmithKline Medal of Merit 2001 2002 265
Thornton PD See D'Souza DC 2004 190
Thornton PD Who is responsible for medication safety? [ed] 2009 258
Thrimawithane T See Garg S 2008 28
Thunga G Successful management of mixed amlodipine and atenolol overdose [letter] 2013 163
Thunga G See Bhagvandas NS 2013 247
Thunga G See Awasthi S 2013 248
Thunga G See Devabhaktuni R 2013 333
Thunga G See Singh A 2014 60
Thunga G See Priyadarshini M 2014 61
Thunga G See Agarwal J 2014 162
Thunga G See Sekhar-M S 2014 289
Thurlow PJ Anticoagulation in older people 1997 328
Tibballs J Eucalyptus oil — medicinal therapy or folk remedy? 1995 516
Ticehurst R See Aikman KL 2013 272
Tierney JM See McFarlane AE 1997 455
Tierney JM See Armour CL 1998 410
Tierney JT See To T-P 2000 202
Titchen T See Kainey S 2004 70
Titchen T See Juliana GS 2005 187
Tkaczuk M See Lee S-G 2007 271
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 59
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Tkaczuk M See Ambados F 2008 80
Tkaczuk M See Lee S-G 2009 181
To NNL Low levels of adherence to antibiotic prescribing guidelines within emergency departments 1999 155
To TH Using personal digital assistants for a pharmacist intervention monitoring database: cost analysis 2007 30
To TP Stability of flucloxacillin in a hospital in the home program [letter] 1998 289
To TP Serotonergic and dopaminergic agents facilitate rehabilitation following hypoxic brain injury 2000 202
To TP Contrast media-implications for pharmacists 2005 33
To TP See Taylor SE 2007 214
To TP Stability of a formulated N-acetylcysteine capsule for prevention of contrast-induced nephropathy 2008 219
To TP See Ho L 2009 34
To TP Stability of intravenous flucloxacillin solutions used for hospital-in-the-home 2010 10
To TP Urinary alkalinisation with oral sodium bicarbonate for patients at risk of contrast-induced
nephropathy
2012 118
To TP See Phillips CJ 2014 63
To TP Feasibility and stability of metaraminol in pre-filled syringes 2014 89
To T-P Oral medication administration in patients with restrictions on oral intake - a snapshot survey 2013 177
Toh CT Impact of increased clinical pharmacy activities 2005 106
Toh CT See Turner SJ 2005 119
Toh CT Barriers to medication adherence in chronic heart failure patients during home visits 2010 27
Tomlin AC See Dionysopoulos D 2011 75
Tong E See Dooley MJ 2011 208
Tong N See Rayner CR 1998 394
Tonkin AL See Armenores P 2006 40
Tonti-Filippini N Ethical issues in casemix funding 1996 136
Tordoff JM Processes for the assessment and introduction of new medicines in New Zealand hospitals 2004 267
Tordoff JM Influence of the national hospital pharmaceutical strategy on the assessment of new medicines in New
Zealand public hospitals
2005 271
Tordoff JM Pharmacoeconomics: a reliable tool for decisions on new medicines? 2006 12
Tordoff JM See Plant EA 2006 271
Touma S See Nasser S 2012 129
Towers KA TSANZ annual scientic meeting [letter] 2008 77
Toy AC Possible role for clinical pharmacists in identifying pharmacogenomic interventions 2006 35
Trajceska L See Booth JC 2012 296
Tran MD Stability of amoxycillin clindamycin and meropenem in peritoneal dialysis solution 2012 218
Tran T See Elliott RA 2009 216
Tran T Development and evaluation of an hospital pharmacy generated interim residential care medication
administration card
2012 100
Tran T See Elliott RA 2014 95
Tran W Over-anticoagulation in elderly warfarinised patients 2013 283
Traverso ML Activities of an Argentinian regional centre of pharmacovigilance [letter] 2004 246
Tremewen DR See Jeffreys AJ 1994 430
Trenerry H Lithium and tardive dyskinesia [inform] 1995 192
Treseder RJ See Graudins LV 2012 95
Tribe KL See Blennerhassett JD 2006 175
Tribe RW TGA's international involvement with GMP [ed] 1997 426
Trinh D See Tucci J 2009 223
Trissel LA See Xu QA 1998 156
Truong J Australian and New Zealand Intensive Care Society meeting [letter] 2009 78
Tsingos C Learning styles: should they be considered? [letter] 2013 334
Tsui M Implementing a hospital vendor-managed inventory system 2008 40
Tsui MK See Larmour I 2003 204
Tsuyuki RT See Zolezzi M 2014 188
Tuan S Clinical pharmacy services to a nursing home — a unique situation 1994 22
Tucci J Paracetamol and ibuprofen for paediatric pain and fever 2009 223
Tuck EJ See Toh CT 2010 27
Tucker IG See Boulton DW 1994 151
Tucker IG Stability trials — how much degradation is enough? [letter] 1996 289
Tuddenham HM Public hospital application of the PBS — PBS or prescription for bureaucratic shambles? 1996 65
Tuffin PH Palliative care in Europe 1995 272
Tuffin PH See Burgess CL 2007 306
Tuffin PH See Kiani M 2011 217
Tulk RL Developing hospital pharmacy practice in Fiji 1996 392
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 60
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Tulk RL Quality improvement conference: what's in it for pharmacists? 2003 218
Turner S Do we need a neonatal and paediatric pharmacists group in Australia? [letter] 1998 68
Turner S Unregistered and off-label drug use in paediatric inpatients 1999 265
Turner S Small patients big problems! 2001 64
Turner S See Kunac DL 2001 139
Turner S See Lie HKH 2002 27
Turner S Medicines for children 2nd edition [book review] 2004 161
Turner S See Angalakuditi M 2005 21
Turner S See Chui SY 2007 124
Turner S Improving safety, reducing risk 2007 136
Turner S See Graudins LV 2009 290
Turner S See Ditty A 2014 220
Turner SC Pain in childhood: the big questions 2004 48
Turner SC See Stacey SR 2013 45
Turner SJ Establishing the role of a clinical pharmacy technician 2005 119
Turnidge J Principles of appropriate prescribing of antimicrobials. Part II — practical examples 1995 202
Twaddle A See Habak JE 2013 101
Udayasiri R See Leow FHP 2006 194
Ullyot N See Pascuet E 2010 92
Unwin S See Patterson TH 2011 221
Upadhyay DK See Mishra P 2005 165
Vaillancourt R See Pascuet E 2010 92
Valiya SN Ximelagatran cost effectiveness for stroke prevention in atrial fibrillation 2005 279
Valoppi G Analagesic selection in patients on abstinence therapies 2006 136
van Beurden E Preventing falls among older people - current practice and attitudes among community pharmacists 2003 51
Van C General practitioner perceptions of extended pharmacy services and modes of collaboration with
pharmacists
2007 182
Van De Vreede M See Lubliner M 2005 266
Van De Vreede M See Lubliner M 2006 181
Van De Vreede M Using the medical emergency team to supplement an existing adverse drug event reporting framework 2007 197
Van De Vreede M Intravenous potassium chloride use in hospitals: current practice 2008 19
Van De Vreede M Options for an ISMP affiliate in Australia 2008 51
Van De Vreede M See Dooley MJ 2008 216
Van De Vreede M Successful introduction of tallman letters to reduce medication selection errors in a hospital network 2008 263
Van De Vreede M See Dunning TL 2010 203
Van De Vreede MA Introducing a multidisciplinary medication safety program in a major hospital 2003 290
Van De Vreede MA European forum on quality improvement in health care 2005 199
Van Dyk DD See Mahler SM 2003 7
van Lent-Evers N See Boeker EB 2013 41
Vandenbroucke J Surface contamination from cytotoxic chemotherapy [letter] 2008 79
Varma M See Bhagvandas NS 2013 247
Varma S See Habak JE 2013 101
Vassarotti R See Angley M 2014 6
Vaughan F Australian medicines handbook drug choice companion: emergency and primary care 2001 237
Vaughan GN NCCTG standard for the preparation of pharmaceuticals in Australian hospital pharmacy departments
[letter]
1994 174
Vaughan GN Non-approved indications for drugs [letter] 1994 356
Vaughan K See Weekes L 2006 91
Verduci L A practical guide to pharmaceutical care [book review] 2003 331
Verma A Folic acid for methotrexate-induced neutropenia [letter] 2005 245
Vernon G Access to drugs and information [ed] 2005 258
Vernon GM Survey of drugs imported by Australian hospital pharmacy departments 1995 32
Vernon GM Development of an international network of drug information centres [on a different note] 1998 115
Vernon GM GlaxoSmithKline Medal of Merit 2000 2001 276
Vernon GM Pharmabridge - colleagues across continents [letter] 2007 80
Vernon GM Australian pharmacists and counterfeit drugs [ed] 2007 256
Vernon GM Pharmacovigilance for new drugs [ed] 2011 262
Verrinder A See Wood PJ 2004 285
Vial JH See Bereznicki LR 2007 300
Vial RJ Smoking cessation program using nicotine patches linking hospital to the community 2002 57
Vickery K See Whiteley RK 2002 153
Vidovic R Supportive care in cancer [letter] 2005 329
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 61
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Viénet M Appointment of a research coordinator 1994 59
Vieyra AC See Aldama PC 2003 330
Vizgoft J See Nasser S 2012 129
Vracar D Australian General Practitioners' views on pharmacist prescribing 2008 96
Vujovic O See Rayner CR 1998 394
Vuong T Unnecessary medicines stored in homes of patients at risk of medicinal misadventure 2006 16
Vuong T See George J 2006 99
Wagner TJ Beyond metropolitan: renal pharmacy study tour [letter] 2010 165
Wainwright C See Nguyen YBN 2010 211
Walker GJ See Dollman WB 1996 229
Walker MP Medication management of adult patients admitted to hospital with epilepsy seizure or convulsion 2012 291
Wall D See Burnett D 2003 296
Wall GC See Crosara SLR 2013 221
Wallace AT See Yeung MY 1996 556
Walsh M Casemix as a management tool — the pros and cons 1996 132
Walsh MK See Lubliner M 2005 266
Walsh RL See Boyd IW 2008 23
Walter MD See Hudson BJ 1995 257
Walton N Rapid desensitisation of an immunocompetent patient with cotrimoxazole hypersensitivity 2010 130
Wan V Meeting of pharmacy students from the Asia-Pacific region [letter] 2005 329
Wan V MPH: a post-graduate study opportunity for pharmacists [letter] 2012 248
Wanandy T See Patel RP 2013 112
Wang L Antiplatelet therapy for acute coronary syndromes 2000 270
Ward M Gene profiles in drug design [book review] 2008 334
Ward M See Tran MD 2012 218
Ward MB See McKinnon RA 2003 133
Ward MB See McKinnon RA 2008 55
Ward MB See McKinnon RA 2008 226
Ward MB Cytochrome P450 part 3: impact of drug-drug interactions 2009 55
Ware GJ Unit-of-issue medicine administration: time and cost-benefits in a geriatric unit 1994 329
Wark JD See Choo CS 2006 246
Warne GL The treatment of growth disorders 1994 444
Warren J See Calabretto JP 2005 99
Warrior N Hospira Young Pharmacist Award in 2013: Optimising your dosing: optimising your practice [grant
report]
2014 291
Wee JS Prolonged antibiotic therapy for recurrent urinary tract infections in aged-care residents: time to
change the dogma?
2007 108
Weekes L Medicines information for consumers [ed] 2006 91
Weekes L Quality use of medicines and the life journey [ed] 2009 172
Weekes LM The impact of the Special Access Scheme on a hospital pharmacy department 1994 307
Weekes LM See Bicknell ME 1995 527
Weekes LM Performance quality and outcomes [ed] 1996 308
Weekes LM See Day R 1996 622
Weekes LM See Rowe L 1998 38
Weekes LM National Prescribing Service and educational visits 1999 290
Weekes LM Understanding influencing and evaluating drug use 2002 161
Weeks G Prescribing for success [letter] 2010 80
Weeks GR Public hospital pharmacists competing in the private sector 1996 49
Weeks GR A journey through quality in health care, medication safety and electronic prescribing 2003 124
Weeks GR See Larmour I 2003 204
Weeks GR Pharmacist prescribing: let's have the debate [ed] 2004 4
Weeks GR See Bortoletto DA 2004 288
Weeks GR See Birdsey GH 2005 287
Weeks GR Collaborative prescribing: views of SHPA pharmacist members 2008 271
Weeks GR Australian hospital pharmacists' experiences of a UK non-medical prescribing course 2010 187
Weeks GR Hospital pharmacist-led lipid clinic for surgical patients with peripheral vascular disease at a regional
Australian hospital
2012 17
Wein S Ketamine as a possible cause of delirium 2002 212
Weir M See Ryan RE 2011 295
Welch S See Weekes LM 1994 307
Welch S Emergency medicine pharmacy [ed] 2006 88
Welch S See Betteridge F 2007 78
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 62
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Welch S Australian Clinical Pharmacy Award 2009 2009 313
Welch S Decanting chlorhexidine antiseptic solution into sterile dishes [letter] 2010 333
Welch S See Baysari MT 2012 246
Welch SA The evolving area of emergency medicine pharmacy 1997 325
Welch SA Promoting rational prescribing by emergency department junior medical officers 2000 262
Welch SA The use of complementary medicines by inpatients at St Vincent's Hospital Sydney 2001 110
Welch SA Role of the pharmacy technician in Emergency 2003 16
Welch SA See Slader CA 2003 74
Welch SA See Lawler C 2004 174
Welch SA See Slader SA 2005 15
Welch SA Pharmaceutical review-emergency medicine pharmacist perspective [ed] 2006 261
Welch SA Scope of pharmacy services to the emergency department 2007 27
Welch SA See Lehnbom EC 2009 45
Welch SA See Munzner EE 2012 264
Welch SA See Morrow MK 2012 333
Welch SA See Ng C 2013 25
Welch SA Fasting and medication omissions [letter] 2013 162
Welch SA Mobile-device-accessible information for emergency department doctors [letter] 2014 161
Welch SA See Heath EK 2014 201
Weller C Wound dressings update 2006 318
Wendel N See Siderov J 2002 108
Went D See Garrett T 2010 269
West KM See Welch SA 2003 16
Westaway K Safe use of statins in elderly people 2014 138
Westaway KP Optimising therapy for patients with neuropathic pain 2014 44
Westbrook JI See Lo C 2010 10
Wheeler AJ Developing clinical practice guidelines for the medication management of acute behavioural
disturbance
2007 33
Whennan LD Impact of pharmaceutical reforms on non-prescription medication management in post-natal women
following discharge from hospital
2012 22
Whicker SD See Welch SA 2000 262
Whitby RM See Radford JM 1997 140
White S See McKnight DL 1997 390
White S Role of adjuvant therapy in older people with breast cancer 2007 321
Whitehead C See Ng D 1999 84
Whiteley RK Biofilms that impact on human health 2002 153
Whitfield K See Coombes I 2010 111
Whitfield K ASHP midyear clinical meeting 2010 [letter] 2011 76
Whitfield K Innovation – an essential leadership skill, limited only be one’s own imagination [grant report] 2014 167
Whitlock A See Dooley MJ 2008 188
Whitty JA To determine the importance of ward pharmacists reviewing discharge prescriptions 2001 300
Whyte IM See Drew A 2000 71
Wibowo Y Comparative analysis of rural community pharmacy practice in Western Australia in 2002 and 2006 2012 26
Widagdo IS Prevalence of potentially inappropriate medication use in elderly hospitalised patients 2011 122
Wiedmann RJ See Andrews HP 2001 183
Wiese MD Raised INR with concurrent warfarin and azithromycin 1999 159
Wiese MD Unexpected orthostatic hypotension with venlafaxine 1999 215
Wilcox C The medication chart as an integral tool in the pharmaceutical care plan 2001 268
Wilkes J Board of Pharmaceutical Specialties Oncology [on a different note] 2000 118
Wilkes J Not just Gatorade and gridiron-bone marrow transplant too 2004 129
Wilkinson JM See Simpson MD 2002 69
Wilkinson JM See Biddle RA 2003 55
Wilkinson TJ See Scott SD 1994 325
Wilkinson TJ See Rumsey S 1995 145
Wilks JJ See Dooley MJ 2001 125
Williams AF See Dunning TL 2010 203
Williams Db See Sharley NA 2007 95
Williams ID See Freeman C 2012 184
Williams ID See Freeman C 2014 240
Williams K See Pham L 2003 275
Williams KA See Gu P 2011 196
Williams L See To TP 2010 101
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 63
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
Williams R Changes in society affecting medicine and pharmacy 1994 83
Williams TJ See Hirth KE 2002 185
Williamson M See Brown JA 2009 281
Willis J See Roberts JA 2007 200
Willis M See Nguyen YBN 2010 211
Wilmot V See Carrington C 2007 81
Wilmott V Variety in Vancouver - International Symposium on Oncology Pharmacy Practice 2002 305
Wilmott V International symposium on oncology pharmacy practice 2004 210
Wilmott V International symposium on oncology pharmacy practice 2007 47
Wilsher ML See Aikman KL 2013 272
Wilson DI See Tsui M 2008 40
Wilson KM See Schneider JJ 1997 29
Wilson R See Larizza MA 2009 277
Wilson RK Severe infusion-related reaction to liposomal amphotericin B 2013 51
Wilson SG See Van De Vreede M 2008 19
Wilson SG See O'Leary KM 2013 88
Wiltshire SL See Armenores P 2006 40
Winearls JR See Ballantine DL 2014 108
Winkle CM See McDonald PK 2003 114
Winspear C See Slater W 1999 216
Winter SJ Evaluation of consumer medicine information provision from an outpatient dispensary 2013 11
Wiseman M See Van De Vreede M 2008 263
Witney KA See Coutsouvelis J 2011 225
Wodak AD See Bramley-Moore SR 1998 83
Wong EM See Larmour I 1998 226
Wong J Prevalence and validity of self-reported antibiotic allergy in emergency department patients 2008 92
Wong VK Stability of Konakion repacked in dropper bottles for oral administration 1996 641
Wood MJ See Larmour I 1998 226
Wood P See Seleem M 2011 132
Wood PJ Community pharmacists and men's health in rural Victoria 2004 285
Woodford HJ Managing behavioural symptoms of dementia [letter] 2005 327
Woodhouse D Correction 1 [letter] 1997 159
Woods DJ See Boulton DW 1994 151
Woods DJ See Fawcett JP 1995 19
Woods DJ Use of tablets to formulate oral liquid preparations [letter] 1995 52
Woods DJ The academic-practitioner — a vital role in pharmacy education [ed] 1996 407
Woods DJ See Fawcett JP 1996 552
Woods DJ See Vernon GM 1998 115
Woods M See Lumby J 2010 259
Woodward M Hypnosedatives and the elderly-are we doing enough to reduce risk and improve outcomes? [ed] 2006 5
Woodward M Immunisation of older people 2012 316
Woodward M See Elliott RA 2014 95
Woodward MC See Fong CM 1995 372
Woodward MC Tacrine — for and against. The case for 1995 566
Woodward MC The management of insomnia in older people 1996 462
Woodward MC See Lim WK 1999
Woodward MC See Elliott RA 2001 19
Woodward MC See Harvey PA 2001 212
Woodward MC Constipation in older people pharmacological management issues 2002 37
Woodward MC See Elliott RA 2003 101
Woodward MC Prevention of Alzheimer's disease and other dementias 2003 138
Woodward MC Deprescribing: achieving better health outcomes for older people through reducing medications 2003 323
Woodward MC Pharmacological treatment of challenging neuropsychiatric symptoms of dementia 2005 228
Woodward MC Managing insomnia in older people 2007 236
Woodward MC See Roughead EE 2008 14
Woodward MC See Elliott RA 2009 109
Woodward MC Drug treatments in development for Alzheimer's disease 2012 58
Workman B See Parikh S 2013 62
Workman BS Management of chronic pain in older people 1998 361
Worswick J See Ryan RE 2011 295
Woulfe J See Owen SM 2010 97
Wright C Advances at AIDS 2014. What does the future look like and how can we better use the tools we have 2014 183
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994-2014 64
Journal of Pharmacy Practice and Research: Cumulative Author Index 1994–2014
Author Title or 1st Author Year Page
now?
Wright F Oncology pharmacy practice in the pharmacogenomic age [letter] 2010 246
Wright M The lion the witch and the wardrobe [letter] 2003 16
Wright S See O'Leary K 2009 293
Wu TS Providing quality patient care that is safe and efficient - is it available? [ed] 2009 11
Wu TS Can pharmacists afford not to champion medication safety? [ed] 2010 176
Wu TS Patient safety must be a priority [ed] 2012 258
Wyer S National Medicines Week activities 1999 57
Wyer SL Documentation of penicillin allergy in a veterans' hospital 1997 296
Wyer SL A review of pharmacy services in Australian collocated hospitals 2000 256
Wykes C Hib vaccine in splenectomised patients [inform] 1995 489
Xu QA Compatibility of paclitaxel in 5% glucose and 0.9% NS injections with EVA minibags 1998 156
Xue Z See Daftary MN 2003 265
Yao M See Lim SCB 2008 191
Yates M Urinary tract infection in the elderly 1999 166
Yau L See Bajorek BV 2009 13
Yeatman HR See Mullan JR 2003 284
Yee J See Young J 2006 275
Yee KC See Bushell MA 2013 292
Yee KC See El-den S 2014 224
Yeung MY Flexible film isolator: an inexpensive option for small volume aseptic dispensing 1996 556
Yeung MY Concurrent frusemide-theophylline dosing reduces serum vancomycin concentrations in preterm
infants
1999 269
Yeung MY Targeting gentamicin concentration in babies: the younger the baby the larger the loading dose and the
longer the dose interval
2000 98
Yeung MY Transient profound thrombocytopenia in a premature infant: is this a ranitidine-induced immune
reaction? [clinical communication]
2000 172
Yeung MY Hypertension and bradycardia associated with high-dose dexamethasone in a premature infant with
borderline hyponatraemia [clinical communication]
2000 205
Yeung MY Targeting gentamicin therapeutic ranges during the first week of life in infants in neonatal intensive
care
2001 291
Yeung S See O'Leary K 2009 293
Yin C Prevalence of complementary and alternative medicine use by adults with cystic fibrosis 2002 320
Yip A Identifying temporal changes to the prescribing of anti-arrhythmics for atrial fibrillation 2010 285
Yip AY See Kiani M 2011 217
Young CE See McFarlane AE 1997 455
Young J Feasibility of monitoring biochemical and haemodynamic effects of ACE inhibitors 2006 275
Young R See Feeney GF 1997 42
Young RS See Peterson GM 1996 545
Youngman J Medicines managers-the next generation [ed] 2005 261
Yu AM See Sharley NA 2007 95
Yu K Enhancing continuity of care in therapeutics: development of a post-discharge home medicines review
model
2007 22
Yu K See Nguyen A 2007 111
Zeglinski P See To TP 2014 89
Zeimer H Medications and falls in older people 2008 148
Zhang G See Lim SC 2008 191
Zhang JY See Boyd IW 2008 23
Zimmet H Beta-blockers for treatment of heart failure in the elderly 2006 229
Zolezzi M Drug use evaluation of ondansetron in postoperative nausea and vomiting 2007 11
Zolezzi M Investigation of trigger tools for detecting adverse drug reactions 2007 225
Zolezzi M Provision of health/disease screening and medication monitoring/management in New Zealand
community pharmacies
2014 188
Zulkifly HH See Abd Wahab MS 2013 162
Zulueta W See Bajorek BV 2009 13